<SEC-DOCUMENT>0001140361-25-023640.txt : 20250625
<SEC-HEADER>0001140361-25-023640.hdr.sgml : 20250625
<ACCEPTANCE-DATETIME>20250625155839
ACCESSION NUMBER:		0001140361-25-023640
CONFORMED SUBMISSION TYPE:	S-1/A
PUBLIC DOCUMENT COUNT:		10
FILED AS OF DATE:		20250625
DATE AS OF CHANGE:		20250625

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Vendome Acquisition Corp I
		CENTRAL INDEX KEY:			0002055879
		STANDARD INDUSTRIAL CLASSIFICATION:	BLANK CHECKS [6770]
		ORGANIZATION NAME:           	05 Real Estate & Construction
		EIN:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-286534
		FILM NUMBER:		251073560

	BUSINESS ADDRESS:	
		STREET 1:		1090 CENTER DRIVE
		CITY:			PARK CITY
		STATE:			UT
		ZIP:			84098
		BUSINESS PHONE:		435-714-7973

	MAIL ADDRESS:	
		STREET 1:		1090 CENTER DRIVE
		CITY:			PARK CITY
		STATE:			UT
		ZIP:			84098
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>ny20046456x10_s1a.htm
<DESCRIPTION>S-1/A
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <br>
  <div>
    <div style="text-align: center; color: #000000; font-weight: bold;">As filed with the Securities and Exchange Commission on June 25, 2025.</div>
    <div style="text-align: right; color: #000000; font-weight: bold;">Registration No. 333-286534</div>
    <div><br>
    </div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold;">UNITED STATES</div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>
    <div><br>
    </div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-weight: bold;">Amendment No. 3 to</div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 18pt; font-weight: bold;">FORM S-1</div>
    <div><br>
    </div>
    <div style="text-align: center; color: #000000; font-weight: bold;">REGISTRATION STATEMENT</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">UNDER</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">THE SECURITIES ACT OF 1933</div>
    <div><br>
    </div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 24pt; font-weight: bold;">Vendome Acquisition Corporation I</div>
    <div style="text-align: center; color: #000000;">(Exact name of registrant as specified in its charter)</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="ze894669d8fc943169f53a0bb319d332e" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 31.85%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 31.85%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 31.85%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 31.85%; vertical-align: top;">
            <div style="text-align: center; color: #000000; font-weight: bold;">Cayman Islands</div>
            <div style="text-align: center; color: #000000;">(State or other jurisdiction of</div>
            <div style="text-align: center; color: #000000;">incorporation or organization)</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 31.85%; vertical-align: bottom;">
            <div style="text-align: center; color: #000000; font-weight: bold;">6770</div>
            <div style="text-align: center; color: #000000;">(Primary Standard Industrial</div>
            <div style="text-align: center; color: #000000;">Classification Code Number)</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 31.85%; vertical-align: bottom;">
            <div style="text-align: center; color: #000000;">N/A</div>
            <div style="text-align: center; color: #000000;">(I.R.S. Employer Identification</div>
            <div style="text-align: center; color: #000000;">Number)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 31.85%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 31.85%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 31.85%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
        </tr>

    </table>
    <div style="text-align: center; color: #000000; font-weight: bold;">1090 Center Drive</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">Park City, UT 84098</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">(435) 714-7973</div>
    <div><br>
    </div>
    <div style="text-align: center; color: #000000;">(Address, including zip code, and telephone number, including area code, of registrant&#8217;s principal executive offices)</div>
    <div><br>
    </div>
    <div style="text-align: center; color: #000000; font-weight: bold;">Scott LaPorta</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">Chief Executive Officer</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">c/o Vendome Acquisition Corporation I</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">1090 Center Drive</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">Park City, UT 84098</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">(435) 714-7973</div>
    <div><br>
    </div>
    <div style="text-align: center; color: #000000;">(Name, address, including zip code, and telephone number, including area code, of agent for service)</div>
    <div><br>
    </div>
    <div style="text-align: center; color: #000000; font-weight: bold;">Copies to:</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z45491348b305493ebd362bfa03d1f43e" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 31.85%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 31.85%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 31.85%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 31.85%; vertical-align: top;">
            <div style="text-align: center; color: #000000; font-weight: bold;">Gil Savir, Esq.</div>
            <div style="text-align: center; color: #000000; font-weight: bold;">Paul Hastings LLP</div>
            <div style="text-align: center; color: #000000; font-weight: bold;">200 Park Avenue</div>
            <div style="text-align: center; color: #000000; font-weight: bold;">New York, NY 10166</div>
            <div style="text-align: center; color: #000000; font-weight: bold;">(212) 318-6000</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 31.85%; vertical-align: top;">
            <div style="text-align: center; color: #000000; font-weight: bold;">Brandon J. Bortner, Esq.</div>
            <div style="text-align: center; color: #000000; font-weight: bold;">Ryan S. Brewer</div>
            <div style="text-align: center; color: #000000; font-weight: bold;">Paul Hastings LLP</div>
            <div style="text-align: center; color: #000000; font-weight: bold;">2050 M Street NW</div>
            <div style="text-align: center; color: #000000; font-weight: bold;">Washington, DC 20036</div>
            <div style="text-align: center; color: #000000; font-weight: bold;">(202) 551-1700</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 31.85%; vertical-align: bottom;">
            <div style="text-align: center; color: #000000; font-weight: bold;">Jeffrey C. Selman, Esq.</div>
            <div style="text-align: center; color: #000000; font-weight: bold;">Elena Nrtina, Esq.</div>
            <div style="text-align: center; color: #000000; font-weight: bold;">DLA Piper LLP (US)</div>
            <div style="text-align: center; color: #000000; font-weight: bold;">555 Mission Street</div>
            <div style="text-align: center; color: #000000; font-weight: bold;">Suite 2400</div>
            <div style="text-align: center; color: #000000; font-weight: bold;">San Francisco, CA 94105-2933</div>
            <div style="text-align: center; color: #000000; font-weight: bold;">Tel: (415) 615 6095</div>
          </td>
        </tr>
        <tr>
          <td style="width: 31.85%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 31.85%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 31.85%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
        </tr>

    </table>
    <div style="text-align: center; color: #000000; font-weight: bold;">Approximate date of commencement of proposed sale to the public:</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">As soon as practicable after the effective date of this registration statement.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 20pt; color: #000000;">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following
      box. &#8201;<font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 20pt; color: #000000;">If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act
      registration statement number of the earlier effective registration statement for the same offering. &#8201;<font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 20pt; color: #000000;">If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of
      the earlier effective registration statement for the same offering. &#8201;<font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 20pt; color: #000000;">If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of
      the earlier effective registration statement for the same offering. &#8201;<font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 20pt; color: #000000;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company.
      See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zb30daef846a2475ba297a99ad68310d3" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 17.78%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 28.89%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 22.22%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 24.44%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 17.78%; vertical-align: top;">
            <div style="color: #000000;">Large accelerated filer</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 28.89%; vertical-align: bottom;">
            <div style="color: #000000; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 22.22%; vertical-align: bottom;">
            <div style="color: #000000;">Accelerated filer</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 24.44%; vertical-align: bottom;">
            <div style="color: #000000;"><font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 17.78%; vertical-align: top;">
            <div style="color: #000000;">Non-accelerated filer</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 28.89%; vertical-align: bottom;">
            <div style="color: #000000; font-family: 'Segoe UI Symbol', sans-serif;">&#9746;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 22.22%; vertical-align: bottom;">
            <div style="color: #000000;">Smaller reporting company</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 24.44%; vertical-align: bottom;">
            <div style="color: #000000; font-family: 'Segoe UI Symbol', sans-serif;">&#9746;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 17.78%; vertical-align: top;">&#160;</td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 28.89%; vertical-align: bottom;">&#160;</td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 22.22%; vertical-align: bottom;">
            <div style="color: #000000;">Emerging growth company</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 24.44%; vertical-align: bottom;">
            <div style="color: #000000; font-family: 'Segoe UI Symbol', sans-serif;">&#9746;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 17.78%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 28.89%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 22.22%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 1.11%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 24.44%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; text-indent: 20pt; color: #000000;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
      accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. &#8201;<font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 20pt; color: #000000; font-weight: bold;">The Registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a
      further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the registration statement shall become effective on
      such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.</div>
    <div style="color: #000000; font-weight: bold; text-align: justify; text-indent: 0px;"> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-align: center; font-weight: bold;">EXPLANATORY NOTE</div>
    <div><br>
    </div>
    <div style="text-align: justify;">Vendome Acquisition Corporation I is filing this Amendment No. 3 to its Registration Statement on Form S-1 (File No. 333-286534) as an exhibits-only filing. Accordingly, this amendment consists only of the facing page,
      this explanatory note, Item 16(a) of Part II of the Registration Statement, the signature page to the Registration Statement and the filed exhibits. The remainder of the Registration Statement is unchanged and has been omitted.</div>
    <div><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div></div>
    <div style="text-align: center; font-weight: bold;">Part II</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">Information not required in prospectus</div>
    <div><br>
    </div>
    <div style="font-weight: bold;">Item 16. <font style="font-style: italic;">Exhibits and Financial Statement Schedules</font></div>
    <div><br>
    </div>
    <div style="text-align: center; color: #000000; font-weight: bold;">EXHIBIT INDEX</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z0f295469e4a040a0be573d6c101868b2" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 6.77%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 0.63%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 0.64%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 91.96%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.77%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="color: #000000; font-weight: bold;">Exhibit</div>
          </td>
          <td style="width: 0.63%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 0.64%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 91.96%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="color: #000000; font-weight: bold;">Description</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.77%; vertical-align: top; background-color: #CCEEFF;">
            <div style="color: #000000;"><a href="ny20046456x10_ex1-1.htm">1.1</a></div>
          </td>
          <td style="width: 0.63%; vertical-align: middle; background-color: #CCEEFF;">
            <div>&#8194;</div>
          </td>
          <td style="width: 0.64%; vertical-align: middle; background-color: #CCEEFF;">
            <div>&#8194;</div>
          </td>
          <td style="width: 91.96%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="color: #000000;">Form of Underwriting Agreement*</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.77%; vertical-align: top;">
            <div style="color: #000000;"><a href="https://www.sec.gov/Archives/edgar/data/2055879/000114036125013881/ny20046456x1_ex3-1.htm">3.1</a></div>
          </td>
          <td style="width: 0.63%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 0.64%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 91.96%; vertical-align: bottom;">
            <div style="color: #000000;">Memorandum and Articles of Association**</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.77%; vertical-align: top; background-color: #CCEEFF;">
            <div style="color: #000000;"><a href="ny20046456x10_ex3-2.htm">3.2</a></div>
          </td>
          <td style="width: 0.63%; vertical-align: middle; background-color: #CCEEFF;">
            <div>&#8194;</div>
          </td>
          <td style="width: 0.64%; vertical-align: middle; background-color: #CCEEFF;">
            <div>&#8194;</div>
          </td>
          <td style="width: 91.96%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="color: #000000;">Amended and Restated Memorandum and Articles of Association*</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.77%; vertical-align: top;">
            <div style="color: #000000;"><a href="https://www.sec.gov/Archives/edgar/data/2055879/000114036125021822/ny20046456x2_ex4-1.htm">4.1</a></div>
          </td>
          <td style="width: 0.63%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 0.64%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 91.96%; vertical-align: bottom;">
            <div style="color: #000000;">Specimen Unit Certificate**</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.77%; vertical-align: top; background-color: #CCEEFF;">
            <div style="color: #000000;"><a href="https://www.sec.gov/Archives/edgar/data/2055879/000114036125021822/ny20046456x2_ex4-2.htm">4.2</a></div>
          </td>
          <td style="width: 0.63%; vertical-align: middle; background-color: #CCEEFF;">
            <div>&#8194;</div>
          </td>
          <td style="width: 0.64%; vertical-align: middle; background-color: #CCEEFF;">
            <div>&#8194;</div>
          </td>
          <td style="width: 91.96%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="color: #000000;">Specimen Class A Ordinary Share Certificate**</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.77%; vertical-align: top;">
            <div style="color: #000000;"><a href="https://www.sec.gov/Archives/edgar/data/2055879/000114036125021822/ny20046456x2_ex4-3.htm">4.3</a></div>
          </td>
          <td style="width: 0.63%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 0.64%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 91.96%; vertical-align: bottom;">
            <div style="color: #000000;">Specimen Warrant Certificate**</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.77%; vertical-align: top; background-color: #CCEEFF;">
            <div style="color: #000000;"><a href="https://www.sec.gov/Archives/edgar/data/2055879/000114036125023280/ny20046456x5_ex4-4.htm">4.4</a></div>
          </td>
          <td style="width: 0.63%; vertical-align: middle; background-color: #CCEEFF;">
            <div>&#8194;</div>
          </td>
          <td style="width: 0.64%; vertical-align: middle; background-color: #CCEEFF;">
            <div>&#8194;</div>
          </td>
          <td style="width: 91.96%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="color: #000000;">Form of Warrant Agreement between Odyssey Trust Company, LLC and the Registrant**</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.77%; vertical-align: top;">
            <div style="color: #000000;"><a href="ny20046456x10_ex5-1.htm">5.1</a></div>
          </td>
          <td style="width: 0.63%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 0.64%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 91.96%; vertical-align: bottom;">
            <div style="color: #000000;">Opinion of Paul Hastings LLP*</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.77%; vertical-align: top; background-color: #CCEEFF;">
            <div style="color: #000000;"><a href="ny20046456x10_ex5-2.htm">5.2</a></div>
          </td>
          <td style="width: 0.63%; vertical-align: middle; background-color: #CCEEFF;">
            <div>&#8194;</div>
          </td>
          <td style="width: 0.64%; vertical-align: middle; background-color: #CCEEFF;">
            <div>&#8194;</div>
          </td>
          <td style="width: 91.96%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="color: #000000;">Opinion of Maples and Calder (Cayman) LLP, Cayman Islands Legal Counsel to the Registrant*</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.77%; vertical-align: top;">
            <div style="color: #000000;"><a href="https://www.sec.gov/Archives/edgar/data/2055879/000114036125023280/ny20046456x5_ex10-1.htm">10.1</a></div>
          </td>
          <td style="width: 0.63%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 0.64%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 91.96%; vertical-align: bottom;">
            <div style="color: #000000;">Form of Letter Agreement among the Registrant, sponsor and its officers and directors**</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.77%; vertical-align: top; background-color: #CCEEFF;">
            <div style="color: #000000;"><a href="https://www.sec.gov/Archives/edgar/data/2055879/000114036125023280/ny20046456x5_ex10-2.htm">10.2</a></div>
          </td>
          <td style="width: 0.63%; vertical-align: middle; background-color: #CCEEFF;">
            <div>&#8194;</div>
          </td>
          <td style="width: 0.64%; vertical-align: middle; background-color: #CCEEFF;">
            <div>&#8194;</div>
          </td>
          <td style="width: 91.96%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="color: #000000;">Form of Letter Agreement among the Registrant and the non-sponsor investors**</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.77%; vertical-align: top;">
            <div style="color: #000000;"><a href="https://www.sec.gov/Archives/edgar/data/2055879/000114036125023280/ny20046456x5_ex10-3.htm">10.3</a></div>
          </td>
          <td style="width: 0.63%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 0.64%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 91.96%; vertical-align: bottom;">
            <div style="color: #000000;">Form of Investment Management Trust Agreement between Odyssey Trust Company, LLC and the Registrant**</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.77%; vertical-align: top; background-color: #CCEEFF;">
            <div style="color: #000000;"><a href="https://www.sec.gov/Archives/edgar/data/2055879/000114036125023280/ny20046456x5_ex10-4.htm">10.4</a></div>
          </td>
          <td style="width: 0.63%; vertical-align: middle; background-color: #CCEEFF;">
            <div>&#8194;</div>
          </td>
          <td style="width: 0.64%; vertical-align: middle; background-color: #CCEEFF;">
            <div>&#8194;</div>
          </td>
          <td style="width: 91.96%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="color: #000000;">Form of Registration Rights Agreement between the Registrant and certain security holders**</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.77%; vertical-align: top;">
            <div style="color: #000000;"><a href="https://www.sec.gov/Archives/edgar/data/2055879/000114036125013881/ny20046456x1_ex10-4.htm">10.5</a></div>
          </td>
          <td style="width: 0.63%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 0.64%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 91.96%; vertical-align: bottom;">
            <div style="color: #000000;">Securities Subscription Agreement, between the Registrant and the Sponsor**</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.77%; vertical-align: top; background-color: #CCEEFF;">
            <div style="color: #000000;"><a href="https://www.sec.gov/Archives/edgar/data/2055879/000114036125023280/ny20046456x5_ex10-6.htm">10.6</a></div>
          </td>
          <td style="width: 0.63%; vertical-align: middle; background-color: #CCEEFF;">
            <div>&#8194;</div>
          </td>
          <td style="width: 0.64%; vertical-align: middle; background-color: #CCEEFF;">
            <div>&#8194;</div>
          </td>
          <td style="width: 91.96%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="color: #000000;">Form of Private Placement Warrants Purchase Agreement between the Registrant and the Sponsor**</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.77%; vertical-align: top;">
            <div style="color: #000000;"><a href="ny20046456x10_ex10-7.htm">10.7</a></div>
          </td>
          <td style="width: 0.63%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 0.64%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 91.96%; vertical-align: bottom;">
            <div style="color: #000000;">Form of Indemnity Agreement*</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.77%; vertical-align: top; background-color: #CCEEFF;">
            <div style="color: #000000;"><a href="https://www.sec.gov/Archives/edgar/data/2055879/000114036125023280/ny20046456x5_ex10-8.htm">10.8</a></div>
          </td>
          <td style="width: 0.63%; vertical-align: middle; background-color: #CCEEFF;">
            <div>&#8194;</div>
          </td>
          <td style="width: 0.64%; vertical-align: middle; background-color: #CCEEFF;">
            <div>&#8194;</div>
          </td>
          <td style="width: 91.96%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="color: #000000;">Form of Administrative Services Agreement by and between the Registrant and the Sponsor**</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.77%; vertical-align: top;">
            <div style="color: #000000;"><a href="https://www.sec.gov/Archives/edgar/data/2055879/000114036125023280/ny20046456x5_ex10-9.htm">10.9</a></div>
          </td>
          <td style="width: 0.63%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 0.64%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 91.96%; vertical-align: bottom;">
            <div style="color: #000000;">Promissory Note, dated May 23, 2025, issued to the Sponsor**</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.77%; vertical-align: top; background-color: #CCEEFF;">
            <div style="color: #000000;"><a href="https://www.sec.gov/Archives/edgar/data/2055879/000114036125023280/ny20046456x5_ex10-10.htm">10.10</a></div>
          </td>
          <td style="width: 0.63%; vertical-align: middle; background-color: #CCEEFF;">
            <div>&#8194;</div>
          </td>
          <td style="width: 0.64%; vertical-align: middle; background-color: #CCEEFF;">
            <div>&#8194;</div>
          </td>
          <td style="width: 91.96%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="color: #000000;">Form of Working Capital Convertible Note to be issued to Vendome Acquisition Sponsor I LLC**</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.77%; vertical-align: top;">
            <div style="color: #000000;"><a href="https://www.sec.gov/Archives/edgar/data/2055879/000114036125023280/ny20046456x5_ex14.htm">14</a></div>
          </td>
          <td style="width: 0.63%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 0.64%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 91.96%; vertical-align: bottom;">
            <div style="color: #000000;">Form of Code of Ethics**</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.77%; vertical-align: top; background-color: #CCEEFF;">
            <div style="color: #000000;"><a href="https://www.sec.gov/Archives/edgar/data/2055879/000114036125023280/ny20046456x5_ex23-1.htm">23.1</a></div>
          </td>
          <td style="width: 0.63%; vertical-align: middle; background-color: #CCEEFF;">
            <div>&#8194;</div>
          </td>
          <td style="width: 0.64%; vertical-align: middle; background-color: #CCEEFF;">
            <div>&#8194;</div>
          </td>
          <td style="width: 91.96%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="color: #000000;">Consent of Adeptus Partners, LLC**</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.77%; vertical-align: top;">
            <div style="color: #000000;"><a href="ny20046456x10_ex5-1.htm">23.2</a></div>
          </td>
          <td style="width: 0.63%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 0.64%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 91.96%; vertical-align: bottom;">
            <div style="color: #000000;">Consent of Paul Hastings LLP (included in Exhibit 5.1)*</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.77%; vertical-align: top; background-color: #CCEEFF;">
            <div style="color: #000000;"><a href="ny20046456x10_ex5-2.htm">23.3</a></div>
          </td>
          <td style="width: 0.63%; vertical-align: middle; background-color: #CCEEFF;">
            <div>&#8194;</div>
          </td>
          <td style="width: 0.64%; vertical-align: middle; background-color: #CCEEFF;">
            <div>&#8194;</div>
          </td>
          <td style="width: 91.96%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="color: #000000;">Consent of Maples and Calder (Cayman) LLP (included in Exhibit 5.2)*</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.77%; vertical-align: top;">
            <div style="color: #000000;"><a href="https://www.sec.gov/Archives/edgar/data/2055879/000114036125013881/ny20046456x1_s1.htm#tPOA">24</a></div>
          </td>
          <td style="width: 0.63%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 0.64%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 91.96%; vertical-align: bottom;">
            <div style="color: #000000;">Power of Attorney (included on signature page of the initial filing of this Registration Statement)**</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.77%; vertical-align: top; background-color: #CCEEFF;">
            <div style="color: #000000;"><a href="https://www.sec.gov/Archives/edgar/data/2055879/000114036125023280/ny20046456x5_ex99-1.htm">99.1</a></div>
          </td>
          <td style="width: 0.63%; vertical-align: middle; background-color: #CCEEFF;">
            <div>&#8194;</div>
          </td>
          <td style="width: 0.64%; vertical-align: middle; background-color: #CCEEFF;">
            <div>&#8194;</div>
          </td>
          <td style="width: 91.96%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="color: #000000;">Form of Audit Committee Charter**</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.77%; vertical-align: top;">
            <div style="color: #000000;"><a href="https://www.sec.gov/Archives/edgar/data/2055879/000114036125023280/ny20046456x5_ex99-2.htm">99.2</a></div>
          </td>
          <td style="width: 0.63%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 0.64%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 91.96%; vertical-align: bottom;">
            <div style="color: #000000;">Form of Compensation Committee Charter**</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.77%; vertical-align: top; background-color: #CCEEFF;">
            <div style="color: #000000;"><a href="https://www.sec.gov/Archives/edgar/data/2055879/000114036125023280/ny20046456x5_ex99-3.htm">99.3</a></div>
          </td>
          <td style="width: 0.63%; vertical-align: middle; background-color: #CCEEFF;">
            <div>&#8194;</div>
          </td>
          <td style="width: 0.64%; vertical-align: middle; background-color: #CCEEFF;">
            <div>&#8194;</div>
          </td>
          <td style="width: 91.96%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="color: #000000;">Form of Nominating and Corporate Governance Committee Charter**</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.77%; vertical-align: top;">
            <div style="color: #000000;"><a href="https://www.sec.gov/Archives/edgar/data/2055879/000114036125013881/ny20046456x1_ex99-4.htm">99.4</a></div>
          </td>
          <td style="width: 0.63%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 0.64%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 91.96%; vertical-align: bottom;">
            <div style="color: #000000;">Consent of Brett Wyard to be named as director nominee**</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.77%; vertical-align: top; background-color: #CCEEFF;">
            <div style="color: #000000;"><a href="https://www.sec.gov/Archives/edgar/data/2055879/000114036125013881/ny20046456x1_ex99-5.htm">99.5</a></div>
          </td>
          <td style="width: 0.63%; vertical-align: middle; background-color: #CCEEFF;">
            <div>&#8194;</div>
          </td>
          <td style="width: 0.64%; vertical-align: middle; background-color: #CCEEFF;">
            <div>&#8194;</div>
          </td>
          <td style="width: 91.96%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="color: #000000;">Consent of Brian Webber to be named as director nominee**</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.77%; vertical-align: top;">
            <div style="color: #000000;"><a href="https://www.sec.gov/Archives/edgar/data/2055879/000114036125013881/ny20046456x1_ex99-6.htm">99.6</a></div>
          </td>
          <td style="width: 0.63%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 0.64%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 91.96%; vertical-align: bottom;">
            <div style="color: #000000;">Consent of Jonathan Gray to be named as director nominee**</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.77%; vertical-align: top; background-color: #CCEEFF;">
            <div style="color: #000000;"><a href="https://www.sec.gov/Archives/edgar/data/2055879/000114036125023280/ny20046456x5_ex99-7.htm">99.7</a></div>
          </td>
          <td style="width: 0.63%; vertical-align: middle; background-color: #CCEEFF;">
            <div>&#8194;</div>
          </td>
          <td style="width: 0.64%; vertical-align: middle; background-color: #CCEEFF;">
            <div>&#8194;</div>
          </td>
          <td style="width: 91.96%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="color: #000000;">Form of Clawback Policy**</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.77%; vertical-align: top;">
            <div style="color: #000000;"><a href="https://www.sec.gov/Archives/edgar/data/2055879/000114036125021822/ny20046456x2_ex107.htm">107</a></div>
          </td>
          <td style="width: 0.63%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 0.64%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 91.96%; vertical-align: bottom;">
            <div style="color: #000000;">Filing Fee Table**</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.77%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 0.63%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 0.64%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
          <td style="width: 91.96%; vertical-align: middle;">
            <div>&#8194;</div>
          </td>
        </tr>

    </table>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="ze6a7a294306348c488ae13fdfd88e84d" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 5%; vertical-align: top;">
            <div style="color: #000000;">*</div>
          </td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: #000000;">Filed herewith.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z02325bfcc79f4bf4a6d437397688af4e" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 5%; vertical-align: top;">
            <div style="color: #000000;">**</div>
          </td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: #000000;">Previously filed.</div>
          </td>
        </tr>

    </table>
    <br>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div>
      <div style="text-align: center; color: #000000; font-weight: bold;">SIGNATURES</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 20pt; color: #000000;">Pursuant to the requirements of the Securities Act of 1933 the registrant has duly caused this amended registration statement to be signed on its behalf by the undersigned,
        thereunto duly authorized, in the City of Park City, Utah on the 25th of June 2025.</div>
      <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z70bc49da780243d7927ce12c2c9c4d8e" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 46.15%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td colspan="7" style="width: 51.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 46.15%; vertical-align: top;">&#160;</td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td colspan="7" style="width: 51.28%; vertical-align: bottom;">
              <div style="color: #000000; font-weight: bold;">Vendome Acquisition Corporation I</div>
            </td>
          </tr>
          <tr>
            <td style="width: 46.15%; vertical-align: top;">&#160;</td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 3.09%; vertical-align: bottom;">&#160;</td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 32.81%; vertical-align: bottom;">&#160;</td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 10.26%; vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 46.15%; vertical-align: top;">&#160;</td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 3.09%; vertical-align: bottom;">
              <div style="color: #000000;">By:</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 32.81%; vertical-align: bottom;">&#160;</td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 10.26%; vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 46.15%; vertical-align: top;">&#160;</td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 3.09%; vertical-align: bottom;">&#160;</td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">&#160;</td>
            <td style="width: 32.81%; vertical-align: bottom; border-bottom: #000000 2px solid;">
              <div style="color: #000000;">/s/ Diana Derycz-Kessler</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 10.26%; vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 46.15%; vertical-align: top;">&#160;</td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 3.09%; vertical-align: bottom;">&#160;</td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 32.81%; vertical-align: bottom;">
              <div style="color: #000000;">Name: Diana Derycz-Kessler</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 10.26%; vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 46.15%; vertical-align: top;">&#160;</td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 3.09%; vertical-align: bottom;">&#160;</td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 32.81%; vertical-align: bottom;">
              <div style="color: #000000;">Title: President</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">&#160;</td>
            <td style="width: 10.26%; vertical-align: middle;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 46.15%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 3.09%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 32.81%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">&#160;</td>
            <td style="width: 10.26%; vertical-align: middle;">&#160;</td>
          </tr>

      </table>
      <div style="text-align: justify; text-indent: 20pt; color: #000000;">Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed below by the following persons in the capacities and on the dates
        indicated.</div>
      <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z0e02be8072d14654bde50f3549202df1" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 23.08%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 56.41%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 15.38%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23.08%; vertical-align: bottom; border-bottom: #000000 2px solid;">
              <div style="text-align: center; color: #000000; font-weight: bold;">Name</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 56.41%; vertical-align: bottom; border-bottom: #000000 2px solid;">
              <div style="text-align: center; color: #000000; font-weight: bold;">Position</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 15.38%; vertical-align: bottom; border-bottom: #000000 2px solid;">
              <div style="text-align: center; color: #000000; font-weight: bold;">Date</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23.08%; vertical-align: top;">&#160;</td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 56.41%; vertical-align: bottom;">&#160;</td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 15.38%; vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 23.08%; vertical-align: top; border-bottom: #000000 2px solid;">
              <div style="color: #000000;">/s/ Scott LaPorta</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td rowspan="2" style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td rowspan="2" style="width: 56.41%; vertical-align: bottom;">
              <div style="color: #000000;">Chief Executive Officer and Chief Financial Officer</div>
              <div>&#160;</div>
              <div style="color: #000000;">(Principal Executive, Financial and Accounting Officer)</div>
            </td>
            <td rowspan="2" style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td rowspan="2" style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td rowspan="2" style="width: 15.38%; vertical-align: middle;">
              <div style="color: #000000;">June 25, 2025</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23.08%; vertical-align: top;">
              <div style="color: #000000;">Scott LaPorta</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23.08%; vertical-align: top;">&#160;</td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 56.41%; vertical-align: bottom;">&#160;</td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 15.38%; vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 23.08%; vertical-align: top; border-bottom: #000000 2px solid;">
              <div style="color: #000000;">/s/ Diana Derycz-Kessler</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 56.41%; vertical-align: bottom;">
              <div style="color: #000000;">President and Director</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 15.38%; vertical-align: bottom;">
              <div style="color: #000000;">June 25, 2025</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23.08%; vertical-align: top;">
              <div style="color: #000000;">Diana Derycz-Kessler</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 56.41%; vertical-align: bottom;">&#160;</td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 15.38%; vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 23.08%; vertical-align: top;">&#160;</td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 56.41%; vertical-align: bottom;">&#160;</td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 15.38%; vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 23.08%; vertical-align: top; border-bottom: #000000 2px solid;">
              <div style="color: #000000;">/s/ Paul Kessler</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 56.41%; vertical-align: bottom;">
              <div style="color: #000000;">Executive Chairman</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 15.38%; vertical-align: bottom;">
              <div style="color: #000000;">June 25, 2025</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23.08%; vertical-align: top;">
              <div style="color: #000000;">Paul Kessler</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 56.41%; vertical-align: bottom;">&#160;</td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 1.28%; vertical-align: middle;">
              <div>&#8194;</div>
            </td>
            <td style="width: 15.38%; vertical-align: bottom;">&#160;</td>
          </tr>

      </table>
      <div><br>
      </div>
      <div><br>
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ny20046456x10_ex1-1.htm
<DESCRIPTION>EXHIBIT 1.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade">
    <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 1.1</font><br>
    </div>
    <div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div style="text-align: center; font-weight: bold;">UNDERWRITING AGREEMENT</div>
      <div><br>
      </div>
      <div style="text-align: center; font-weight: bold;">between</div>
      <div><br>
      </div>
      <div style="text-align: center; font-weight: bold;">VENDOME ACQUISITION CORPORATION I</div>
      <div><br>
      </div>
      <div style="text-align: center; font-weight: bold;">and</div>
      <div><br>
      </div>
      <div style="text-align: center; font-weight: bold;">D. BORAL CAPITAL LLC,</div>
      <div><br>
      </div>
      <div style="text-align: center; font-weight: bold;">as Representative of the Several Underwriters</div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: center; font-weight: bold;">UNDERWRITING AGREEMENT</div>
      <div><br>
      </div>
      <div style="text-align: center; font-weight: bold;">between</div>
      <div><br>
      </div>
      <div style="text-align: center; font-weight: bold;">VENDOME ACQUISITION CORPORATION I</div>
      <div><br>
      </div>
      <div style="text-align: center; font-weight: bold;">and</div>
      <div><br>
      </div>
      <div style="text-align: center; font-weight: bold;">D. BORAL CAPITAL LLC,</div>
      <div><br>
      </div>
      <div style="text-align: center; font-weight: bold;">as Representative of the Several Underwriters</div>
      <div><br>
      </div>
      <div style="text-align: right;">New York, New York</div>
      <div style="text-align: right;">_____________, 2025</div>
      <div><br>
      </div>
      <div><font style="font-variant: small-caps;">D. Boral Capital</font> LLC</div>
      <div>as Representative of the several Underwriters named on Schedule 1 hereto</div>
      <div>590 Madison Avenue, 39<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Floor</div>
      <div>New York, New York 10022</div>
      <div><br>
      </div>
      <div>Ladies and Gentlemen:</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">The undersigned, VENDOME ACQUISITION CORPORATION I, a Cayman Islands exempted company (the &#8220;<font style="font-weight: bold;">Company</font>&#8221;), hereby confirms its agreement (this &#8220;<font style="font-weight: bold;">Agreement</font>&#8221;) with D. Boral Capital LLC (hereinafter referred to as &#8220;you&#8221; (including its correlatives) or the &#8220;<font style="font-weight: bold;">Representative</font>&#8221;), and with the other underwriters named on
        Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the &#8220;<font style="font-weight: bold;">Underwriters</font>&#8221; or, individually, an &#8220;<font style="font-weight: bold;">Underwriter</font>&#8221;) as follows:</div>
      <div><br>
      </div>
      <div>1. <font style="font-weight: bold;"><u>Purchase and Sale</u></font>.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">1.1. <font style="font-weight: bold;"><u>Firm Units</u></font>.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">1.1.1. <u>Purchase of Firm Units</u>.&#8239;On the basis of the representations and warranties herein contained, and subject to the terms and conditions herein set forth, the Company agrees to issue and
        sell to the several Underwriters, severally and not jointly, and the Underwriters agree to purchase from the Company, severally and not jointly, an aggregate of 20,000,000 units (each individually a &#8220;<font style="font-weight: bold;">Firm</font>&#160;<font style="font-weight: bold;">Unit</font>&#8221; and collectively, &#8220;<font style="font-weight: bold;">Firm</font>&#160;<font style="font-weight: bold;">Units</font>&#8221;) of the Company, each Unit representing one Class A ordinary share, par value $0.0001 per
        share, of the Company (the &#8220;<font style="font-weight: bold;">Ordinary Shares</font>&#8221;) and one half (1/2) of one warrant to purchase one Ordinary Share at a price of $11.50 per share (the &#8220;<font style="font-weight: bold;">Warrants</font>&#8221;), as set
        forth opposite their respective names on <u>Schedule 1</u> hereto, at a purchase price (net of underwriting discounts and commissions) of $9.95 per Unit, being equal to 99.5% of the initial public offering price of the Firm Units. The Firm Units
        are to be offered initially to the public (the &#8220;<font style="font-weight: bold;">Offering</font>&#8221;) at the offering price of $10.00 per Firm Unit.&#160; The Ordinary Shares and Warrants included in the Firm Units will trade separately on the fifty-second
        (52nd) day following the date hereof (or if such date is not a Business Day (as defined in <u>Section 1.1.2</u>), the following Business Day) unless the Representative determines to allow earlier separate trading. Notwithstanding the immediately
        preceding sentence, in no event will the Ordinary Shares and the Warrants included in the Firm Units trade separately until (i) the Company has filed with the Securities and Exchange Commission (the &#8220;<font style="font-weight: bold;">Commission</font>&#8221;)



        a Current Report on Form 8-K that includes an audited balance sheet reflecting the Company&#8217;s receipt of the gross proceeds of the Offering and the Private Placement (as defined in <u>Section 1.4.2</u>) and updated financial information with
        respect to any proceeds the Company receives from the exercise of the Over-allotment Option (as defined in <u>Section 1.2.1</u>) if such option is exercised prior to the filing of the Current Report on Form 8-K, and (ii) the Company has issued a
        press release announcing when such separate trading will begin.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">1.1.2. &#8239;<u>Payment and Delivery</u>. Delivery and payment for the Firm Units shall be made at 10:00 a.m., New York City time, on the first (1st) Business Day (as defined below) following the
        commencement of trading of the Units (as defined in <u>Section 1.2.1</u>), or at such earlier time as shall be agreed upon by the Representative and the Company, at the offices of DLA Piper LLP (US), counsel to the Underwriters (&#8220;<font style="font-weight: bold;">DLA Piper</font>&#8221;), or at such other place (or remotely by facsimile or other electronic transmission) as shall be agreed upon by the Representative and the Company. The hour and date of delivery and payment for the
        Firm Units is called the &#8220;<font style="font-weight: bold;">Closing Date</font>&#8221;. Payment for the Firm Units shall be made on the Closing Date by wire transfer in federal (same day) funds, payable as follows: $200,000,000 of the proceeds received by
        the Company for the Firm Units and the sale of the Private Placement Warrants (as defined in <u>Section 1.4.2</u>) shall be deposited in the trust account (the &#8220;<font style="font-weight: bold;">Trust Account</font>&#8221;) established by the Company for
        the benefit of the Public Shareholders (as defined below), as described in the Registration Statement (as defined in <u>Section 2.1.1</u>) pursuant to the terms of an Investment Management Trust Agreement (the &#8220;<font style="font-weight: bold;">Trust



          Agreement</font>&#8221;) between the Company and Odyssey Transfer and Trust Company (&#8220;<font style="font-weight: bold;">Odyssey</font>&#8221;). The remaining proceeds received by the Company for the Firm Units and the sale of the Private Placement Warrants
        (less commissions and actual expense payments or other fees payable pursuant to this Agreement), if any, shall be paid to the order of the Company upon delivery to the Representative of certificates (in form and substance satisfactory to the
        Representative) representing the Firm Units (or through the facilities of The Depository Trust Company (&#8220;<font style="font-weight: bold;">DTC</font>&#8221;)) for the account of the Underwriters. The Firm Units shall be registered in such name or names
        and in such authorized denominations as the Representative may request in writing at least two (2) Business Days prior to the Closing Date. If delivery is not made through the facilities of DTC, the Company will permit the Representative to examine
        and package the Firm Units for delivery, at least one (1) full Business Day prior to the Closing Date. The Company shall not be obligated to sell or deliver any of the Firm Units except upon tender of payment by the Representative for all the Firm
        Units. The Representative may, at its option, delegate one of the other Underwriters (with such Underwriter&#8217;s consent) to take delivery of the Firm Units and the Option Units (as defined in Section 1.2.1) and to make payment therefor as set forth
        above and below. As used herein, the term &#8220;<font style="font-weight: bold;">Public Shareholders</font>&#8221; means the holders of Ordinary Shares sold as part of the Units in the Offering or acquired in the aftermarket, including the Sponsor (as defined
        in <u>Section 1.4.1</u>) and any officer or director of the Company, to the extent, he, she or it acquires such Ordinary Shares in the aftermarket (and solely with respect to such Ordinary Shares). The term &#8220;<font style="font-weight: bold;">Business
          Day</font>&#8221; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to
        be authorized or required by law to remain closed due to &#8220;stay-at-home,&#8221; &#8220;shelter-in-place,&#8221; &#8220;non-essential employee&#8221; or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental
        authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally are open for use by customers on such day.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">1.2. <font style="font-weight: bold;"><u>Over-allotment Option</u></font>.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">1.2.1. <u>Option Units</u>.&#160; The Representative is hereby granted an option (the &#8220;<font style="font-weight: bold;">Over-allotment Option</font>&#8221;) to purchase up to an additional 3,000,000 units
        (the &#8220;<font style="font-weight: bold;">Option Units</font>&#8221;), the net proceeds of which will be deposited in the Trust Account, solely for the purposes of covering any over-allotments, if any, in connection with the distribution and sale of the
        Firm Units. Such Option Units shall be identical in all respects to the Firm Units. Such Option Units shall be purchased for each account of the several Underwriters in the same proportion as the number of Firm Units, set forth opposite such
        Underwriter&#8217;s name on <u>Schedule 1</u> hereto, bears to the total number of Firm Units (subject to adjustment by the Representative to eliminate fractions). The Firm Units and the Option Units are hereinafter collectively referred to as the &#8220;<font style="font-weight: bold;">Units</font>,&#8221; and the Units, the Ordinary Shares and the Warrants included in the Units, and the Ordinary Shares issuable pursuant to the Warrants are hereinafter referred to collectively as the &#8220;<font style="font-weight: bold;">Public Securities</font>.&#8221; No Option Units shall be sold or delivered unless the Firm Units previously have been, or simultaneously are, sold and delivered. The right to purchase the Option Units, or any portion
        thereof, may be exercised from time to time and to the extent not previously exercised may be surrendered and terminated at any time upon notice by the Representative to the Company. The purchase price to be paid for each Option Unit will be $10.00
        per Option Unit.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">1.2.2. <u>Exercise of Option</u>. The Over-allotment Option granted pursuant to Section 1.2.1 hereof may be exercised by the Representative as to all (at any time) or any part (from time to time)
        of the Option Units within forty-five (45) days after the effective date (&#8220;<font style="font-weight: bold;">Effective Date</font>&#8221;) of the Registration Statement (as defined in <u>Section 2.1.1</u> hereof). The Underwriters shall not be under any
        obligation to purchase any Option Units prior to the exercise of the Over-allotment Option. The Over-allotment Option granted hereby may be exercised by the giving of oral notice to the Company from the Representative, which must be confirmed in
        accordance with Section 1.2.1 hereof setting forth the number of Option Units to be purchased and the date and time for delivery of and payment for the Option Units (the &#8220;<font style="font-weight: bold;">Option Closing Date</font>&#8221;), which shall
        not be later than five (5) Business Days after the date of the notice or such other time as shall be agreed upon by the Company and the Representative, at the offices of counsel to the Underwriters or at such other place (including remotely by
        facsimile or other electronic transmission) as shall be agreed upon by the Company and the Representative. If such delivery and payment for the Option Units does not occur on the Closing Date, the Option Closing Date will be as set forth in the
        notice. Upon exercise of the Over-allotment Option with respect to all or any portion of the Option Shares subject to the terms and conditions set forth herein, the Company shall become obligated to sell to the Underwriters the number of Option
        Units specified in such notice and, subject to the terms and conditions set forth herein, the Underwriters, acting severally and not jointly, shall purchase the number of Option Units specified in such notice.</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">1.2.3. <u>Payment and Delivery</u>. Payment for the Option Units shall be made on the Option Closing Date by wire transfer in federal (same day) funds, payable as follows: $10.00 per Option Unit
        shall be deposited in the Trust Account pursuant to the Trust Agreement upon delivery to the Representative of certificates (in form and substance satisfactory to the Representative) representing the Option Units (or through the facilities of DTC)
        for the account of the Representative. The certificates representing the Option Units to be delivered will be in such denominations and registered in such names as the Representative requests in writing not less than two (2) full Business Days
        prior to the Closing Date or the Option Closing Date, as the case may be, and will be made available to the Representative for inspection, checking and packaging at the aforesaid office of the Company&#8217;s transfer agent or correspondent not less than
        one (1) full Business Day prior to such Closing Date. The Company shall not be obligated to sell or deliver the Option Units except upon tender of payment by the Representative for applicable Option Units.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">1.3. <u>Private Placements</u>.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">1.3.1 <u>Founder Shares</u>. On February 21, 2025, the Company issued an aggregate of 5,750,000 Class B ordinary shares (the &#8220;<font style="font-weight: bold;">Founder Shares</font>&#8221;), $0.0001 par
        value per share, of the Company in a private placement exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended (the &#8220;<font style="font-weight: bold;">Act</font>&#8221;), for a total subscription price of $25,000 to
        Vendome Acquisition Sponsor I LLC (&#8220;<font style="font-weight: bold;">Sponsor</font>&#8221;). On May 24, 2025, the Sponsor transferred an aggregate of 75,000 of its Founder Shares to the independent director nominees of the Company. No underwriting
        discounts, commissions or placement fees have been or will be payable in connection with the purchase or sale of Founder Shares. Except as described in the Registration Statement, none of the Founder Shares may be sold, assigned or transferred by
        the Sponsor until the earlier of (a) six (6) months following the completion of the Business Combination or (b) subsequent to the Business Combination, (i) if the closing price of the Company&#8217;s ordinary shares equals or exceeds $12.00 per share (as
        adjusted for share sub-divisions, share dividends, reorganizations, recapitalizations and other similar transactions) for any 20 trading days within any 30-trading day period commencing 150 days after completion of the Business Combination and (ii)
        the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the Public Shareholders having the right to exchange its Ordinary Shares for cash, securities or other property. The
        holders of Founder Shares shall have no right to any liquidating distributions with respect to any portion of the Founder Shares in the event the Company fails to consummate a Business Combination. The holders of the Founder Shares shall not have
        redemption rights with respect to the Founder Shares. In the event that the Over-allotment Option is not exercised in full, the Sponsor will be required to forfeit such number of Founder Shares (up to 750,000 Founder Shares) such that the Founder
        Shares then outstanding will comprise 20% of the issued and outstanding Ordinary Shares after giving effect to the Offering and exercise, if any, of the Over-allotment Option.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">1.3.2 <u>Private Placement</u>. Simultaneously with the Closing Date, the Sponsor will purchase from the Company in a private placement pursuant to the Warrant Purchase Agreement (as defined in <u>Section



          2.21.2</u> hereof), an aggregate of 2,648,000 private placement warrants (the &#8220;<font style="font-weight: bold;">Private</font>&#160;<font style="font-weight: bold;">Placement Warrants</font>&#8221;) (whether or not the over-allotment option is exercised),
        each Private Placement Warrant is exercisable to purchase one Class&#160; A ordinary share at $11.50 per share (&#8220;<font style="font-weight: bold;">Private Shares</font>&#8221;), subject to adjustment, at a price of $1.00 per warrant.&#160; Private Placement
        Warrants are substantially identical to the Warrants included in the Firm Units, subject to certain exceptions. The private placement is exempt from registration under the Act pursuant to Section 4(a)(2) of the Act. The private placement of the
        Private Placement Warrants to the Sponsor is referred to herein as the &#8220;<font style="font-weight: bold;">Private Placement</font>.&#8221; Certain proceeds from the sale of the Private Placement Warrants shall be deposited into the Trust Account. None of
        the Private Placement Warrants or Private Shares (collectively, the &#8220;<font style="font-weight: bold;">Placement Securities</font>&#8221;) may be sold, assigned or transferred by the Sponsor or its permitted transferees until thirty (30) days after
        consummation of a Business Combination. The Company shall cause to be deposited an amount of additional proceeds from the sale of the Private Placement Warrants into the Trust Account such that the amount of funds in the Trust Account shall be
        $10.00 per Public Share sold in the Offering.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">1.3.3 <u>No fees</u>.&#160; No underwriting discounts, commissions, or placement fees have been or will be payable in connection with the Private Placement Warrants sold in the Private Placement. The
        Private Placement Warrants are identical to the Warrants except that the Private Placement Warrants (including the underlying shares) are subject to certain transfer restrictions and the holders thereof are entitled to certain registration rights,
        and: (1)&#160; will not be redeemable by the Company and (2) may be exercised by the holders on a cashless basis. The Public Securities, the Placement Securities, and the Founder Shares are hereinafter referred to collectively as the &#8220;<font style="font-weight: bold;">Securities</font>.&#8221;</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">1.4. <u>Working Capital</u>. Upon consummation of the Offering and the Private Placement, it is intended that approximately $840,000 of the proceeds from the Offering and the Private Placement
        Warrants (whether or not the Over-Allotment Option is exercised) will be released to the Company and held outside of the Trust Account to fund the working capital requirements of the Company. In the event that the Offering expenses are less than
        $808,000, the amount of funds available outside of the Trust Account to fund the working capital requirements of the Company would increase by a corresponding amount.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">1.5. <u>Interest Income</u>. Prior to the Company&#8217;s consummation of a Business Combination or the Company&#8217;s liquidation, interest earned on the Trust Account may be released to the Company from
        the Trust Account in accordance with the terms of the Trust Agreement to (i) pay any taxes, other than excise taxes, payable by the Company, (ii) pay up to $100,000 for dissolution expenses, all as more fully described in the Prospectus (as defined
        in <u>Section 2.1.1</u>), and (iii) to fund our working capital requirements in an amount equal up to five percent (5.0%) of the interest earned on the Trust Account (collectively, items (i), (ii) and (iii), &#8220;<font style="font-weight: bold;">permitted



          withdrawals</font>&#8221;). Additionally, all permitted withdrawals can only be made from interest and not from the principal held in the Trust Account.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div>2. <font style="font-weight: bold;"><u>Representations and Warranties of the Company</u></font>.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">The Company represents and warrants to the Underwriters as of the Time of Sale (as defined below), as of the Closing Date and as of the Option Closing Date, if any, as follows:</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">2.1. <font style="font-weight: bold;"><u>Filing of Registration Statement</u></font>.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">2.1.1. <u>Pursuant to the Act</u>. The Company has filed with the Commission a registration statement and an amendment or amendments thereto, on Form S-1 (File No. 333-286534), including any
        related preliminary prospectus (&#8220;<font style="font-weight: bold;">Preliminary Prospectus</font>&#8221;), including any prospectus that is included in the Registration Statement immediately prior to the effectiveness of the Registration Statement, for the
        registration of the offer and sale of the Public Securities under the Act, which registration statement and amendment or amendments have been prepared by the Company in conformity with the requirements of the Act, and the rules and regulations (the
        &#8220;<font style="font-weight: bold;">Regulations</font>&#8221;) of the Commission under the Act. The conditions for use of Form S-1 to register the Offering under the Act, as set forth in the General Instructions to such Form, have been satisfied. Except as
        the context may otherwise require, such registration statement, as amended, on file with the Commission at the time the registration statement becomes effective (including the prospectus, financial statements, schedules, exhibits and all other
        documents filed as a part thereof or incorporated therein and all information deemed to be a part thereof as of such time pursuant to Rule 430A of the Regulations), is hereinafter called the &#8220;<font style="font-weight: bold;">Registration Statement</font>,&#8221;



        and the form of the final prospectus dated the Effective Date included in the Registration Statement (or, if applicable, the form of final prospectus containing information permitted to be omitted at the time of effectiveness by Rule 430A of the
        Regulations, filed by the Company with the Commission pursuant to Rule 424 of the Regulations), is hereinafter called the &#8220;<font style="font-weight: bold;">Prospectus</font>.&#8221; For the purposes of this Agreement, &#8220;<font style="font-weight: bold;">Time




          of Sale</font>,&#8221; as used in the Act, means [___] p.m. New York City time, on the date of this Agreement. Prior to the Time of Sale, the Company prepared a Preliminary Prospectus, which was included in the Registration Statement filed on [____],
        2025, for distribution by the Underwriters (such Preliminary Prospectus used most recently prior to the Time of Sale, the &#8220;<font style="font-weight: bold;">Sale Preliminary Prospectus</font>&#8221;). Unless otherwise specified, any reference herein to
        the term &#8220;<font style="font-weight: bold;">Registration Statement</font>&#8221; shall be deemed to include any Registration Statement filed pursuant to Rule 462(b) under the Act registering additional securities (a &#8220;<font style="font-weight: bold;">Rule
          462(b) Registration Statement</font>&#8221;). Other than a Rule 462(b) Registration Statement and the Form 8-A registration statement referred to below in <u>Section 2.1.2</u>, which, if filed, becomes effective upon filing, no other document with
        respect to the Registration Statement has been filed with the Commission. The offer and sale of all Public Securities have been registered under the Act pursuant to the Registration Statement. The Registration Statement has been declared effective
        by the Commission on the date hereof. If, subsequent to the date of this Agreement, the Company or the Representative determines that at the Time of Sale, the Sale Preliminary Prospectus includes an untrue statement of a material fact or omits a
        statement of material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading and the Company and the Representative agrees to provide an opportunity to purchasers of the Units to
        terminate their old purchase contracts and enter into new purchase contracts, then the Sale Preliminary Prospectus will be deemed to include any additional information available to purchasers at the time of entry into the first such new purchase
        contract.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">2.1.2. <u>Pursuant to the Exchange Act</u>. The Company has filed with the Commission a Registration Statement on Form 8-A (File Number 001-[______]) providing for the registration under the
        Securities Exchange Act of 1934, as amended (the &#8220;<font style="font-weight: bold;">Exchange Act</font>&#8221;), of the Units, the Public Shares and the Warrants. The registration of the Units, Public Shares and Warrants under the Exchange Act has been
        declared effective by the Commission on the date hereof and the Units, the Public Shares and the Warrants have been registered pursuant to Section 12(b) of the Exchange Act.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">2.1.3 <u>No Stop Orders, Etc</u>. Neither the Commission nor, to the Company&#8217;s knowledge, assuming reasonable inquiry, any federal, state or other regulatory authority has issued any order or
        threatened to issue any order preventing or suspending the use of the Registration Statement, any Preliminary Prospectus, the Sale Preliminary Prospectus or Prospectus or any part thereof, or has instituted or, to the Company&#8217;s knowledge, assuming
        reasonable inquiry, threatened to institute any proceedings with respect to such an order.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">2.2. <font style="font-weight: bold;"><u>Disclosures in Registration Statement</u></font>.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">2.2.1. <u>10b-5 Representation</u>. At the time of effectiveness of the Registration Statement (or at the time of any post-effective amendment to the Registration Statement) and at all times
        subsequent thereto up to the Closing Date and the Option Closing Date, if any, the Registration Statement, the Sale Preliminary Prospectus and the Prospectus contained and will contain all material statements that are required to be stated therein
        in accordance with the Act and the Regulations, and did or will, in all material respects, conform to the requirements of the Act and the Regulations. The Registration Statement, as of the Effective Date, did not, and the amendments and supplements
        thereto, as of their respective dates, will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, not misleading. The Prospectus, as of its
        date and the Closing Date or the Option Closing Date, as the case may be, did not and will not, and the amendments and supplements thereto, as of their respective dates, will not, include any untrue statement of a material fact or omit to state a
        material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The Sale Preliminary Prospectus, as of the Time of Sale (or such subsequent Time of Sale pursuant to
        Section 2.1.1), did not include any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. When any
        Preliminary Prospectus or the Sale Preliminary Prospectus was first filed with the Commission (whether filed as part of the Registration Statement for the registration of the Public Securities or any amendment thereto or pursuant to Rule 424(a) of
        the Regulations) and when any amendment thereof or supplement thereto was first filed with the Commission, such Preliminary Prospectus or the Sale Preliminary Prospectus and any amendments thereof and supplements thereto complied or will have been
        corrected in the Sale Preliminary Prospectus and the Prospectus to comply in all material respects with the applicable provisions of the Act and the Regulations and did not and will not contain an untrue statement of a material fact or omit to
        state any material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The representation and warranty made in this Section 2.2.1
        does not apply to statements made or statements omitted in reliance upon and in conformity with written information furnished to the Company with respect to the Underwriters by the Underwriters expressly for use in the Registration Statement, the
        Sale Preliminary Prospectus or the Prospectus or any amendment thereof or supplement thereto. The parties acknowledge and agree that such information provided by or on behalf of the Underwriters consists solely of the following: the names of the
        Underwriters, the information with respect to dealers&#8217; concessions and reallowances contained in the section entitled &#8220;Underwriting,&#8221; the information with respect to short positions and stabilizing transactions contained in the section entitled
        &#8220;Underwriting&#8221; and the identity of counsel to the Underwriters contained in the section entitled &#8220;Legal Matters&#8221; (such information, collectively, the &#8220;<font style="font-weight: bold;">Underwriters&#8217; Information</font>&#8221;).</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">2.2.2. <u>Disclosure of Agreements</u>. The agreements and documents described in the Registration Statement, the Sale Preliminary Prospectus and the Prospectus conform to the descriptions thereof
        contained therein in all material respects and there are no agreements or other documents required to be described in the Registration Statement, the Sale Preliminary Prospectus or the Prospectus or to be filed with the Commission as exhibits to
        the Registration Statement, that have not been so described or filed. Each agreement or other instrument (however characterized or described) to which the Company is a party or by which its property or business is or may be bound or affected and
        (i) that is referred to in the Registration Statement, Sale Preliminary Prospectus or the Prospectus or attached as an exhibit thereto, or (ii) that is material to the Company&#8217;s business, has been duly authorized and validly executed by the
        Company, is in full force and effect and is enforceable against the Company and, to the Company&#8217;s knowledge, assuming reasonable inquiry, the other parties thereto, in accordance with its terms, except (x) as such enforceability may be limited by
        bankruptcy, insolvency, reorganization or similar laws affecting creditors&#8217; rights generally; (y) as enforceability of any indemnification or contribution provision may be limited under the foreign, federal and state securities laws; and (z) that
        the remedy of specific performance and injunctive and other forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding therefor may be brought, and no such agreement or
        instrument has been assigned by the Company, and neither the Company nor, to the Company&#8217;s knowledge, assuming reasonable inquiry, any other party is in breach or default thereunder and, to the Company&#8217;s knowledge, assuming reasonable inquiry, no
        event has occurred that, with the lapse of time or the giving of notice, or both, would constitute a breach or default thereunder. To the Company&#8217;s knowledge, assuming reasonable inquiry, the performance by the Company of the material provisions of
        such agreements or instruments will not result in a violation of any existing applicable law, rule, regulation, judgment, order or decree of any governmental agency or court, domestic or foreign, having jurisdiction over the Company or any of its
        assets or businesses, including, without limitation, those relating to environmental laws and regulations.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">2.2.3. <u>Prior Securities Transactions</u>. No securities of the Company have been sold by the Company or by or on behalf of, or for the benefit of, any person or persons controlling, controlled
        by, or under common control with the Company since the date of the Company&#8217;s formation, except as disclosed in the Registration Statement.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">2.2.4. <u>Regulations</u>. The disclosures in the Registration Statement, the Sale Preliminary Prospectus and the Prospectus concerning the effects of federal, foreign, state and local regulation
        on the Company&#8217;s business as currently contemplated are correct in all material respects and do not omit to state a material fact necessary to make the statements therein, in the light of the circumstances in which they were made, not misleading.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">2.3. <font style="font-weight: bold;"><u>Changes After Dates in Registration Statement</u></font>.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">2.3.1. <u>No Material Adverse Change</u>. Since the respective dates as of which information is given in the Registration Statement, the Sale Preliminary Prospectus and the Prospectus, except as
        otherwise specifically stated therein, (i) there has been no material adverse change in the condition, financial or otherwise, or business prospects of the Company, (ii) there have been no material transactions entered into by the Company, other
        than as contemplated pursuant to this Agreement, (iii) no member of the Company&#8217;s board of directors (the &#8220;<font style="font-weight: bold;">Board of Directors</font>&#8221;) or management has resigned from any position with the Company and (iv) no event
        or occurrence has taken place which materially impairs, or would likely materially impair, with the passage of time, the ability of the members of the Board of Directors or management to act in their capacities with the Company as described in the
        Registration Statement, the Sale Preliminary Prospectus and the Prospectus.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">2.3.2. <u>Recent Securities Transactions</u>. Subsequent to the respective dates as of which information is given in the Registration Statement, the Sale Preliminary Prospectus and the Prospectus,
        and except as may otherwise be indicated or contemplated herein or therein, the Company has not (i) issued any securities or incurred any liability or obligation, direct or contingent, for borrowed money; or (ii) declared or paid any dividend or
        made any other distribution on or in respect to its share capital.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">2.4. <font style="font-weight: bold;"><u>Independent Accountants</u></font>. To the Company&#8217;s knowledge, Adeptus Partners, LLC (&#8220;<font style="font-weight: bold;"><u>Adeptus</u></font>&#8221;), whose
        report is filed with the Commission as part of, and is included in, the Registration Statement, the Sale Preliminary Prospectus, and the Prospectus, is an independent registered public accounting firm as required by the Act, the Regulations and the
        Public Company Accounting Oversight Board (the &#8220;<font style="font-weight: bold;">PCAOB</font>&#8221;), including the rules and regulations promulgated by such entity. To the Company&#8217;s knowledge, Adeptus is currently registered with the PCAOB. Adeptus has
        not, during the periods covered by the financial statements included in the Registration Statement, the Sale Preliminary Prospectus and the Prospectus, provided to the Company any non-audit services, as such term is used in Section 10A(g) of the
        Exchange Act.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">2.5. <font style="font-weight: bold;"><u>Financial Statements, etc</u></font>.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">2.5.1. <u>Financial Statements</u>. The financial statements, including the notes thereto and supporting schedules (if any) included in the Registration Statement, the Sale Preliminary Prospectus
        and the Prospectus fairly present the financial position, the results of operations and the cash flows of the Company at the dates and for the periods to which they apply; such financial statements have been prepared in conformity with United
        States generally accepted accounting principles (&#8220;<font style="font-weight: bold;">GAAP</font>&#8221;), consistently applied throughout the periods involved; and the supporting schedules included in the Registration Statement, the Sale Preliminary
        Prospectus and the Prospectus present fairly the information required to be stated therein in conformity with the Regulations. No other financial statements or supporting schedules are required to be included or incorporated by reference in the
        Registration Statement, the Sale Preliminary Prospectus or the Prospectus. The Registration Statement, the Sale Preliminary Prospectus and the Prospectus disclose all material off-balance sheet transactions, arrangements, obligations (including
        contingent obligations), and other relationships of the Company with unconsolidated entities or other persons that may have a material current or future effect on the Company&#8217;s financial condition, changes in financial condition, results of
        operations, liquidity, capital expenditures, capital resources, or significant components of revenues or expenses. There are no pro forma or as adjusted financial statements that are required to be included in the Registration Statement, the Sale
        Preliminary Prospectus and the Prospectus in accordance with Regulation S-X or Form S-1 that have not been included as required.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">2.5.2. <u>Statistical Data</u>. The statistical, industry-related and market-related data included in the Registration Statement, the Sale Preliminary Prospectus and/or the Prospectus are based on
        or derived from sources that the Company reasonably and in good faith believes are reliable and accurate, and such data materially agree with the sources from which they are derived.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">2.6. <font style="font-weight: bold;"><u>Authorized Capital; Options, etc</u></font>. The Company had, at the date or dates indicated in the Registration Statement, the Sale Preliminary Prospectus
        and the Prospectus, the duly authorized, issued and outstanding capitalization as set forth therein. Based on the assumptions stated in the Registration Statement, the Sale Preliminary Prospectus and the Prospectus, the Company will have on the
        Closing Date the adjusted capitalization set forth therein. Except as set forth in, or contemplated by, the Registration Statement, the Sale Preliminary Prospectus and the Prospectus, on the Effective Date, as of the Applicable Time and on the
        Closing Date and any Option Closing Date, there will be no stock options, warrants, or other rights to purchase or otherwise acquire any authorized, but unissued Ordinary Shares or any security convertible or exercisable into Ordinary Shares, or
        any contracts or commitments to issue or sell Ordinary Shares or any such options, warrants, rights or convertible securities.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-indent: 36pt;">2.7. <font style="font-weight: bold;"><u>Valid Issuance of Securities, etc</u></font>.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">2.7.1. <u>Outstanding Securities</u>. All issued and outstanding securities of the Company issued prior to the transactions contemplated by this Agreement have been duly authorized and validly
        issued and are fully paid and non-assessable; the holders thereof have no rights of rescission with respect thereto, and are not subject to personal liability by reason of being such holders; and none of such securities was issued in violation of
        the preemptive rights of any holders of any security of the Company or similar contractual rights granted by the Company. The authorized and outstanding securities of the Company conform in all material respects to all statements relating thereto
        contained in the Registration Statement, the Sale Preliminary Prospectus and the Prospectus. All offers and sales and any transfers of the outstanding securities of the Company were at all relevant times either registered under the Act and the
        applicable state securities or Blue Sky laws or, based in part on the representations and warranties of the purchasers of such securities, exempt from such registration requirements.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">2.7.2. <u>Securities Sold Pursuant to this Agreement</u>. The Public Securities have been duly authorized and reserved for issuance and when issued and paid for in accordance with this Agreement,
        will be validly issued, and the Ordinary Shares will be fully paid and non-assessable; the holders thereof are not and will not be subject to personal liability by reason of being such holders; the Public Securities are not and will not be subject
        to the preemptive rights of any holders of any security of the Company or similar contractual rights granted by the Company; and all corporate action required to be taken for the authorization, issuance and sale of the Public Securities has been
        duly and validly taken. The form of certificates for the Public Securities conform to the corporate law of the jurisdiction of the Company&#8217;s incorporation and applicable securities laws. The Public Securities conform in all material respects to the
        descriptions thereof contained in the Registration Statement, the Sale Preliminary Prospectus and the Prospectus, as the case may be.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">2.7.3. <u>Placement Securities</u>. The Placement Securities have been duly authorized and reserved for issuance and when issued and paid for in accordance with the Warrant Purchase Agreement,
        will be validly issued; the holders thereof are not and will not be subject to personal liability by reason of being such holders; the Placement Securities are not and will not be subject to the preemptive rights of any holders of any security of
        the Company or similar contractual rights granted by the Company; and all corporate action required to be taken for the authorization, issuance and sale of the Placement Securities has been duly and validly taken.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">2.7.4. <u>No Integration</u>. Neither the Company nor any of its affiliates has, prior to the date hereof, made any offer or sale of any securities which are required to be or may be &#8220;integrated&#8221;
        pursuant to the Act or the Regulations with the Offering.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">2.8. <font style="font-weight: bold;"><u>Registration Rights of Third Parties</u></font>. Except as set forth in the Registration Statement, the Sale Preliminary Prospectus and the Prospectus, no
        holders of any securities of the Company or any rights exercisable for or convertible or exchangeable into securities of the Company have the right to require the Company to register any such securities of the Company under the Act or to include
        any such securities in a registration statement to be filed by the Company.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">2.9. <font style="font-weight: bold;"><u>Validity and Binding Effect of Agreements</u></font>. This Agreement, the Trust Agreement, the Insider Letter (as defined in <u>Section 2.21.1</u>), the
        Non-Sponsor Investor Letter (as defined in Section 2.23), the Services Agreement (as defined in <u>Section 2.21.3</u>), the Registration Rights Agreement (as defined in <u>Section 2.21.4</u>), the Warrant Purchase Agreement (as defined in <u>Section



          2.21.2</u>), and the Warrant Agreement (as defined in Section 2.23) (collectively all such documents with this Agreement, the &#8220;<font style="font-weight: bold;">Transaction Documents</font>&#8221;) have been duly and validly authorized by the Company
        and, when executed and delivered, will constitute the valid and binding agreements of the Company, enforceable against the Company in accordance with their respective terms, except (i) as such enforceability may be limited by bankruptcy,
        insolvency, reorganization or similar laws affecting creditors&#8217; rights generally; (ii) with respect to this Agreement only, as enforceability of any indemnification or contribution provision may be limited under the foreign, federal and state
        securities laws; and (iii) that the remedy of specific performance and injunctive and other forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding therefor may be brought.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">2.10. <font style="font-weight: bold;"><u>No Conflicts, etc</u></font>. The execution, delivery, and performance by the Company of the Transaction Documents, the consummation by the Company of the
        transactions herein and therein contemplated and the compliance by the Company with the terms hereof and thereof do not and will not, with or without the giving of notice or the lapse of time or both, (i) result in a breach or violation of, or
        conflict with any of the terms and provisions of, or constitute a default under, or result in the creation, modification, termination or imposition of any lien, charge or encumbrance upon any property or assets of the Company pursuant to the terms
        of any agreement, obligation, condition, covenant or instrument to which the Company is a party or bound or to which its property is subject except pursuant to the Trust Agreement; (ii) result in any violation of the provisions of the Amended and
        Restated Memorandum and Articles of Association, as may be amended from time to time, of the Company (the &#8220;<font style="font-weight: bold;">Charter Documents</font>&#8221;); or (iii) violate any existing applicable statute, law, rule, regulation,
        judgment, order or decree of any governmental agency or court, domestic or foreign, having jurisdiction over the Company or any of its properties, assets or business constituted as of the date hereof.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">2.11. <font style="font-weight: bold;"><u>No Defaults; Violations</u></font>. No default or violation exists in the due performance and observance of any term, covenant or condition of any
        license, contract, indenture, mortgage, deed of trust, note, loan or credit agreement, or any other agreement or instrument evidencing an obligation for borrowed money, or any other agreement or instrument to which the Company is a party or by
        which the Company may be bound or to which any of the properties or assets of the Company is subject, except for any such default or violation that would not have a Material Adverse Effect (as defined in <u>Section 2.15</u>). The Company is not
        (a) in violation of any term or provision of its Charter Documents or (b) in violation of any franchise, license, permit, applicable law, rule, regulation, judgment or decree of any governmental agency or court, domestic or foreign, having
        jurisdiction over the Company or any of its properties or businesses, except in the case of clause (b) above for any such violation that would not have a Material Adverse Effect.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">2.12. <font style="font-weight: bold;"><u>Corporate Power; Licenses; Consents</u></font>.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">2.12.1. <u>Conduct of Business</u>. The Company has all requisite corporate power and authority, and has all necessary authorizations, approvals, orders, licenses, certificates and permits of and
        from all governmental regulatory officials and bodies that it needs as of the date hereof to conduct its business purpose as described in the Registration Statement, the Sale Preliminary Prospectus and the Prospectus. The disclosures in the
        Registration Statement, the Sale Preliminary Prospectus and the Prospectus concerning the effects of foreign, federal, state and local regulation on the Offering and the Company&#8217;s business purpose as currently contemplated are correct in all
        material respects and do not omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. Since its formation, the
        Company has conducted no business and has incurred no liabilities other than in connection with its formation and in furtherance of the Offering or as otherwise described in the Registration Statement, the Sale Preliminary Prospectus or the
        Prospectus, as applicable.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">2.12.2. <u>Transactions Contemplated Herein</u>. The Company has all requisite corporate power and authority to enter into the Transaction Documents and to carry out the provisions and conditions
        hereof and thereof, and all consents, authorizations, approvals and orders required in connection herewith and therewith have been obtained. No consent, authorization, or order of, and no filing with, any court, government agency or other body,
        foreign or domestic, is required for the valid issuance, sale and delivery, of the Securities and the consummation of the transactions and agreements contemplated by the Transaction Documents and as contemplated by the Registration Statement, the
        Sale Preliminary Prospectus and the Prospectus, except with respect to applicable foreign, federal and state securities laws, the rules of The Nasdaq Global Market (&#8220;<font style="font-weight: bold;">Nasdaq</font>&#8221;) and the rules and regulations
        promulgated by FINRA.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">2.12.3. <u>Jurisdiction and Designation</u>. The Company has the power to submit, and pursuant to <u>Section 9.7</u> of this Agreement has, to the extent permitted by law, legally, validly,
        effectively and irrevocably submitted, to the jurisdiction of any New York State or United States Federal court sitting in the City of New York, Borough of Manhattan.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">2.13. <font style="font-weight: bold;"><u>D&amp;O Questionnaires</u></font>. To the Company&#8217;s knowledge, assuming reasonable inquiry, all information contained in the questionnaires (&#8220;<font style="font-weight: bold;">Questionnaires</font>&#8221;) completed by each of the Company&#8217;s officers, directors and shareholders as of the date hereof (together with the Sponsor, the &#8220;<font style="font-weight: bold;">Insiders</font>&#8221;) and provided to
        the Representative and their counsel and the biographies of the Insiders and other persons contained in the Registration Statement, Sale Preliminary Prospectus and the Prospectus (to the extent a biography is contained) is true and correct in all
        material respects and the Company has not become aware of any information which would cause the information disclosed in the Questionnaires completed by each Insider to become inaccurate, incorrect or incomplete.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">2.14. <font style="font-weight: bold;"><u>Litigation; Governmental Proceedings</u></font>. There is no action, suit, proceeding, inquiry, arbitration, investigation, litigation or governmental
        proceeding pending, or to the Company&#8217;s knowledge, assuming reasonable inquiry, threatened against or involving the Company or, to the Company&#8217;s knowledge, assuming reasonable inquiry, any Insider or any shareholder or member of an Insider that has
        not been disclosed, that is required to be disclosed, in the Registration Statement, the Sale Preliminary Prospectus, the Prospectus or the Questionnaires.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">2.15. <font style="font-weight: bold;"><u>Due Incorporation; Valid Existence</u></font>. The Company has been duly incorporated and is validly existing as a corporation and is in good standing
        under the laws of its jurisdiction of incorporation. The Company is duly qualified to do business and is in good standing as a foreign corporation in each jurisdiction in which its ownership or lease of property or the conduct of business requires
        such qualification, except where the failure to qualify would not have a material adverse effect on the condition (financial or otherwise), earnings, assets, prospects, business, operations or properties of the Company, whether or not arising from
        transactions in the ordinary course of business (a &#8220;<font style="font-weight: bold;">Material Adverse Effect</font>&#8221;).</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">2.16. <font style="font-weight: bold;"><u>No Contemplation of a Business Combination</u></font>. As of the date of this Agreement, the Company has not selected any specific Business Combination
        target (each a &#8220;<font style="font-weight: bold;">Target Business</font>&#8221;) and it has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly with any Target Business.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">2.17. <font style="font-weight: bold;"><u>Transactions Affecting Disclosure to FINRA</u></font>.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">2.17.1. <u>Finder&#8217;s Fees</u>. Except as disclosed in the Registration Statement, the Sale Preliminary Prospectus or the Prospectus, there are no claims, payments, arrangements, agreements or
        understandings relating to the payment of a brokerage commission or finder&#8217;s, consulting or origination fee by the Company or any Insider with respect to the sale of the Securities hereunder or any other arrangements, agreements or understandings
        of the Company or to the Company&#8217;s knowledge, assuming reasonable inquiry, any Insider that may affect the Underwriters&#8217; compensation, as defined by FINRA.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">2.17.2. <u>Payments Within 180 Days</u>. The Company has not made any direct or indirect payments (in cash, securities or otherwise) to: (i) any person, as a finder&#8217;s fee, consulting fee or
        otherwise, in consideration of such person raising capital for the Company or introducing to the Company persons who raised or provided capital to the Company; or (ii) to the Company&#8217;s knowledge, any &#8220;participating member,&#8221; as defined in FINRA Rule
        5110(j)(15), (a &#8220;<font style="font-weight: bold;">Participating Member</font>&#8221;), with respect to the Offering, within the 180-day period prior to the initial filing of the Registration Statement, other than any prior payments to the Representative
        in connection with the Offering. The Company has not issued any warrants or other securities, or granted any options, directly or indirectly, to any Participating Member within the 180-day period prior to the initial filing date of the Registration
        Statement. To the Company&#8217;s knowledge, no person to whom securities of the Company have been privately issued within the 180-day period prior to the initial filing date of the Registration Statement has any relationship or affiliation or
        association with any Participating Member. Except with respect to the Representative in connection with the Offering, the Company has not entered into any agreement or arrangement (including, without limitation, any consulting agreement or any
        other type of agreement) during the 180-day period prior to the initial filing date of the Registration Statement with the Commission, which arrangement or agreement provides for the receipt of any &#8220;underwriting compensation&#8221; as defined in FINRA
        Rule 5110, by any Participating Member.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">2.17.3. <u>FINRA Affiliation</u>. Except as disclosed in the FINRA Questionnaires provided to the Representative, to the Company&#8217;s knowledge, no officer or director or any direct or indirect
        beneficial owner (including the Insiders) of any class of the Company&#8217;s unregistered securities (whether debt or equity, registered or unregistered, regardless of the time acquired or the source from which derived) has any direct or indirect
        affiliation or association with any Participating Member (as defined in accordance with the rules and regulations of FINRA). The Company will advise the Representative and DLA Piper if it learns that any officer or director or any direct or
        indirect beneficial owner (including the Insiders) is or becomes an affiliate or associated person of a Participating Member.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">2.17.4. <u>Share Ownership</u>. Except as disclosed in the FINRA Questionnaires provided to the Representative, to the Company&#8217;s knowledge, no officer or director or any direct or indirect
        beneficial owner (including the Insiders) of any class of the Company&#8217;s unregistered securities is an owner of shares or other securities of any Participating Member (other than securities purchased on the open market).</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">2.17.5. <u>Loans</u>. To the Company&#8217;s knowledge, no officer or director or any direct or indirect beneficial owner (including the Insiders) of any class of the Company&#8217;s unregistered securities
        has made a subordinated loan to any Participating Member in the Offering.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">2.17.6. <u>Proceeds of the Offering</u>. Except as disclosed in the Registration Statement, the Sale Preliminary Prospectus or the Prospectus, no proceeds from the sale of the Public Securities
        (excluding underwriting compensation) or the Private Placement Warrants, will be paid to any Participating Member, except as specifically authorized herein.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">2.17.7. <u>Conflicts of Interest</u>. To the Company&#8217;s knowledge, assuming reasonable inquiry, no Participating Member in the Offering has a conflict of interest with the Company. For this
        purpose, a &#8220;<font style="font-weight: bold;">conflict of interest</font>&#8221; exists when a Participating Member and/or its associated persons, parent or affiliates in the aggregate beneficially own 10% or more of the Company&#8217;s outstanding common
        equity or 10% or more of the Company&#8217;s preferred equity.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">2.18. <font style="font-weight: bold;"><u>Taxes</u></font>.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">2.18.1. There are no transfer taxes or other similar fees or charges under U.S. federal law or the laws of any U.S. state or any political subdivision of the United States, or under the laws of any
        non-U.S. jurisdiction, required to be paid in connection with the execution and delivery of this Agreement or the issuance or sale by the Company of the Public Securities, save that Cayman Islands stamp duty may be payable if the original of this
        Agreement is brought to or executed in the Cayman Islands.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">2.18.2. The Company has filed all U.S. federal, state and local, and non-U.S., tax returns required to be filed with taxing authorities prior to the date hereof in a timely manner or has duly
        obtained extensions of time for the filing thereof. The Company has paid all taxes shown as due on such returns that were filed and has paid all taxes imposed on it and any other assessment, fine or penalty levied against it, to the extent that any
        of the foregoing is due and payable. In the case of each of the foregoing, except where the failure to file or pay, as applicable, would not have a Material Adverse Effect. The Company has made appropriate provisions in the applicable financial
        statements referred to in <u>Section 2.5.1</u> above in respect of all federal, state, local and foreign income and franchise taxes for all current or prior periods as to which the tax liability of the Company has not been finally determined.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">2.19. <font style="font-weight: bold;"><u>Foreign Corrupt Practices Act; Anti-Money Laundering; Patriot Act</u></font>.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">2.19.1.<font style="font-weight: bold;"><u>&#160;</u></font><u>U.S. Foreign Corrupt Practices Act</u>. Neither the Company nor to the Company&#8217;s knowledge, assuming reasonable inquiry, any of the
        Insiders or any other person acting on behalf of the Company has, directly or indirectly, given or agreed to give any money, gift or similar benefit (other than legal price concessions to customers in the ordinary course of business) to any
        customer, supplier, employee or agent of a customer or supplier, or official or employee of any governmental agency or instrumentality of any government (domestic or foreign) or any political party or candidate for office (domestic or foreign) or
        other person who was, is, or may be in a position to help or hinder the business of the Company (or assist it in connection with any actual or proposed transaction) that (i) might subject the Company to any damage or penalty in any civil, criminal
        or governmental litigation or proceeding; (ii) if not given in the past, might have had a Material Adverse Effect; or (iii) if not continued in the future, might adversely affect the assets, business or operations of the Company. The Company has
        taken reasonable steps to ensure that its accounting controls and procedures are sufficient to cause the Company to comply in all material respects with the Foreign Corrupt Practices Act of 1977, as amended.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">2.19.2. <u>Compliance with Sanction Laws</u>. None of the Company, any of the Subsidiaries or, to the knowledge of the Company, any directors, officers or employees of the Company or any of the
        Subsidiaries or any agent, affiliate or other person associated with or acting on behalf of the Company or any of the Subsidiaries is currently the subject or the target of any sanctions administered or enforced by the U.S. government, (including,
        without limitation, the Office of Foreign Assets Control (OFAC) of the U.S. Department of the Treasury or the U.S. Department of State and including, without limitation, the designation as a &#8220;specially designated national&#8221; or &#8220;blocked person&#8221;), the
        United Nations Security Council, the European Union (the &#8220;<font style="font-weight: bold;">EU</font>&#8221;), the Office of Financial Sanctions Implementation of the United Kingdom of Great Britain and Northern Ireland (OFSI) or other relevant sanctions
        authority (collectively, &#8220;<font style="font-weight: bold;">Sanctions</font>&#8221;), nor is the Company or any of the Subsidiaries located, organized or resident in a country or territory that is the subject or target of Sanctions, including, without
        limitation, the Republic of Belarus, Crimea, the Russian Federation, Republic of Cuba, the Islamic Republic of Iran, Democratic People&#8217;s Republic of Korea (North Korea), the Libyan Arab Republic, the Syrian Arab Republic, the Bolivarian Republic of
        Venezuela and the Republic of Yemen (each, a &#8220;<font style="font-weight: bold;">Sanctioned Country</font>&#8221;); and the Company will not directly or indirectly use the proceeds of the Offering, or lend, contribute or otherwise make available such
        proceeds to any subsidiary, joint venture partner or other person or entity (i) to fund or facilitate any activities of or business with any person that, at the time of such funding or facilitation, is the subject or target of Sanctions, (ii) to
        fund or facilitate any activities of or business in any Sanctioned Country or (iii) in any other manner that will result in a violation by any person (including any person participating in the transaction, whether as underwriter, advisor, investor
        or otherwise) of Sanctions. The Company has not knowingly engaged in and is not now knowingly engaged in any dealings or transactions with any person that at the time of the dealing or transaction is or was the subject or the target of Sanctions or
        with any Sanctioned Country.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">2.19.3. <u>Compliance with Anti-Money Laundering Laws</u>. The operations of the Company are and have been conducted at all times in compliance with (i) the requirements of the U.S. Treasury
        Department Office of Foreign Asset Control and (ii) applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transaction Reporting Act of 1970, as amended, including the Money Laundering Control Act of 1986, as
        amended, the rules and regulations thereunder and any related or similar money laundering statutes, rules, regulations or guidelines, issued, administered or enforced by any Federal governmental agency (collectively, the &#8220;<font style="font-weight: bold;">Money Laundering Laws</font>&#8221;) and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company with respect to the Money Laundering Laws is pending or, to the
        Company&#8217;s knowledge, threatened.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">2.19.4. <u>Patriot Act</u>. Neither the Company nor to the Company&#8217;s knowledge, assuming reasonable inquiry, any Insider has violated the Bank Secrecy Act of 1970, as amended, or the Uniting and
        Strengthening of America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism (USA PATRIOT) Act of 2001, and/or the rules and regulations promulgated under any such law, or any successor law.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">2.20. <font style="font-weight: bold;"><u>Officers&#8217; Certificates</u></font>. Any certificate signed by any duly authorized officer of the Company and delivered to the Representative or to counsel
        to the Underwriters on the Closing Date or on the Option Closing Date shall be deemed a representation and warranty by the Company to the Underwriters as to the matters covered thereby.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">2.21. <font style="font-weight: bold;"><u>Agreements With Insiders.</u></font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">2.21.1. <u>Insider Lette</u>r. The Company has caused to be duly executed a legally binding and enforceable agreement, a form of which is annexed as an exhibit to the Registration Statement (the &#8220;<font style="font-weight: bold;">Insider Letter</font>&#8221;), pursuant to which each of the Insiders of the Company agree to certain matters. The Insider Letter shall not be amended, modified or otherwise changed without the prior written consent of the
        Representative, which consent shall not be unreasonably delayed, conditioned or withheld by the Representative.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">2.21.2. <u>Warrant Purchase Agreement</u>. The Company and the Sponsor have executed and delivered a Private Placement Warrant Purchase Agreement, the form of which is annexed as an exhibit to the
        Registration Statement (the &#8220;<font style="font-weight: bold;">Warrant Purchase Agreement</font>&#8221;), pursuant to which the Sponsor will, among other things, on the Closing Date, consummate the purchase of and deliver the purchase price for the
        Private Placement Warrants to be sold to the Sponsor as provided in the Warrant Purchase Agreement. Pursuant to the Insider Letter, the Sponsor has waived any and all rights and claims it may have to any proceeds, and any interest thereon, held in
        the Trust Account in respect of the Private Placement Warrants. Certain proceeds from the sale of the Private Placement Warrants will be deposited by the Company in the Trust Account in accordance with the terms of the Trust Agreement on the
        Closing Date as provided for in the Warrant Purchase Agreement.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">2.21.3. <u>Administrative Services</u>. The Company and the Sponsor have entered into an agreement (&#8220;<font style="font-weight: bold;">Services Agreement</font>&#8221;) substantially in the form annexed
        as an exhibit to the Registration Statement, pursuant to which the Sponsor will make available to the Company office space, utilities, and secretarial and administrative support for $10,000 per month, and the Company will reimburse the Sponsor for
        any reasonable and documented out-of-pocket expenses related to identifying, investigating and completing a Business Combination. Upon completion of the Business Combination, the Company will cease paying such monthly fees.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">2.21.4. <u>Registration Rights Agreement</u>. The Company, the Sponsor and the Insiders have entered into a Registration Rights Agreement (&#8220;<font style="font-weight: bold;">Registration Rights
          Agreement</font>&#8221;) substantially in the form annexed as an exhibit to the Registration Statement, whereby such parties will be entitled to certain registration rights with respect to the securities they hold or may hold, as set forth in such
        Registration Rights Agreement and described more fully in the Registration Statement, the Sale Preliminary Prospectus and the Prospectus.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">2.21.5. <u>Loans</u>. The Sponsor has agreed to make loans to the Company in the aggregate amount of up to $300,000 (the &#8220;<font style="font-weight: bold;">Offering Insider Loans</font>&#8221;) pursuant
        to a promissory note substantially in the form annexed as an exhibit to the Registration Statement. The Offering Insider Loans do not bear any interest and are repayable by the Company on the earlier of December 31, 2025 or the consummation of the
        Offering. In addition, the Sponsor has agreed to make loans to the Company in the aggregate amount of up to $840,000 (the &#8220;<font style="font-weight: bold;">BCA Insider Loans</font>&#8221;) pursuant to a convertible promissory note substantially in the
        form annexed as an exhibit to the Registration Statement. The BCA Insider Loans do not bear any interest and are repayable by the Company on the earlier of the earlier of (a) six months after the date of the consummation of the Business Combination
        or (b) subsequent to the Business Combination, (i) if the last reported sale price of the Company&#8217;s Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share dividends, rights issuances, reorganizations,
        recapitalizations and the like) for any 20 trading days within any 30-trading day period, commencing at least 150 days after the Business Combination or (ii) the date on which the Company completes a liquidation, merger, share exchange,
        reorganization or other similar transaction that results in all of the Company&#8217;s public shareholders having the right to exchange their ordinary shares for cash, securities or other property .</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">2.22. <font style="font-weight: bold;"><u>Investment Management Trust Agreement</u></font>. The Company has entered into the Trust Agreement with respect to certain proceeds of the Offering and
        the Private Placement substantially in the form annexed as an exhibit to the Registration Statement.
        <div> <br>
        </div>
        <div style="text-indent: 36pt;">2.23. <font style="font-weight: bold;"><u>Warrant Agreement</u><u></u></font>. The Company has entered into a warrant agreement with respect to the Warrants with Odyssey substantially in the form annexed as an
          exhibit to the Registration Statement (the &#8220;<font style="font-weight: bold;">Warrant Agreement</font>&#8221;).</div>
      </div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">2.24. <font style="font-weight: bold;"><u>Non-Sponsor Investor Letter Agreement</u></font>. The Company has caused to be duly executed a legally binding and enforceable agreement, a form of which
        is annexed as an exhibit to the Registration Statement (the &#8220;<font style="font-weight: bold;">Non-Sponsor Investor Letter</font>&#8221;), pursuant to which each of the non-sponsor investors agree to certain matters. The Non-Sponsor Investor Letter shall
        not be amended, modified or otherwise changed without the prior written consent of the Representative, which consent shall not be unreasonably delayed, conditioned or withheld by the Representative.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">2.25. <font style="font-weight: bold;"><u>No Existing Non-Competition Agreements</u></font>. To the Company&#8217;s knowledge, no Insider is subject to any non-competition agreement or non-solicitation
        agreement with any employer or prior employer which could materially affect his ability to be an employee, officer and/or director of the Company, except as disclosed in the Registration Statement.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">2.26. <font style="font-weight: bold;"><u>Investments</u></font>. No more than 45% of the &#8220;value&#8221; (as defined in Section 2(a)(41) of the Investment Company Act of 1940, as amended (the &#8220;<font style="font-weight: bold;">Investment Company Act</font>&#8221;)) of the Company&#8217;s total assets consist of, and no more than 45% of the Company&#8217;s net income after taxes is derived from, securities other than &#8220;government securities&#8221; (as defined in
        Section 2(a)(16) of the Investment Company Act) or money market funds meeting the conditions of Rule 2a-7 of the Investment Company Act.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">2.27. <font style="font-weight: bold;"><u>Investment Company Act</u></font>. The Company is not required, and upon the issuance and sale of the Securities as herein contemplated and the
        application of the net proceeds therefrom as described in the Registration Statement, the Sale Preliminary Prospectus and the Prospectus will not be required, to register as an &#8220;investment company&#8221; under the Investment Company Act.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">2.28. <font style="font-weight: bold;"><u>Subsidiaries</u></font>. The Company does not own an interest in any corporation, partnership, limited liability company, joint venture, trust or other
        business entity.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">2.29. <font style="font-weight: bold;"><u>Related Party Transactions</u></font>. No relationship, direct or indirect, exists between or among the Company, on the one hand, and any Insider, on the
        other hand, which is required by the Act, the Exchange Act or the Regulations to be described in the Registration Statement, the Sale Preliminary Prospectus and the Prospectus which is not so described as required. There are no outstanding loans,
        advances (except normal advances for business expenses in the ordinary course of business), or guarantees of indebtedness by the Company to or for the benefit of any of the officers or directors of the Company or any of their respective family
        members, except as disclosed in the Registration Statement, the Sale Preliminary Prospectus and the Prospectus. The Company has not extended or maintained credit, arranged for the extension of credit, or renewed an extension of credit, in the form
        of a personal loan to or for any director or officer of the Company.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">2.30. <font style="font-weight: bold;"><u>No Influence</u></font>. The Company has not offered, or caused the Underwriters to offer, the Firm Units to any person or entity with the intention of
        unlawfully influencing (a) a customer or supplier of the Company or any affiliate of the Company to alter the customer&#8217;s or supplier&#8217;s level or type of business with the Company or such affiliate or (b) a journalist or publication to write or
        publish favorable information about the Company or any such affiliate.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">2.31.<font style="font-weight: bold;"><u> Sarbanes-Oxley Compliance</u></font>. The Company is, and on the Closing Date will be, in material compliance with the provisions of the Sarbanes-Oxley Act
        of 2002, as amended (&#8220;<font style="font-weight: bold;">Sarbanes-Oxley Act</font>&#8221;), and the rules and regulations promulgated thereunder and related or similar rules or regulations promulgated by any governmental or self-regulatory entity or
        agency, that are applicable to it as of the date hereof.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">2.32.<font style="font-weight: bold;"><u> Board of Directors</u></font>. As of the Effective Date, the Board of Directors of the Company will be comprised of the persons set forth as &#8220;Directors&#8221; or
        &#8220;Director nominees&#8221; under the heading of the Sale Preliminary Prospectus and the Prospectus captioned &#8220;Management.&#8221; As of the Effective Date, the qualifications of the persons serving as board members and the overall composition of the board will
        comply with the Sarbanes-Oxley Act and the rules promulgated thereunder and the rules of Nasdaq that are, in each case, applicable to the Company. As of the Effective Date, the Company will have an Audit Committee that satisfies the applicable
        requirements under the Sarbanes-Oxley Act and the rules promulgated thereunder and the rules of Nasdaq, subject to the permitted phase-in requirements under the rules of Nasdaq.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">2.33. <font style="font-weight: bold;"><u>Emerging Growth Company Status</u></font><font style="font-style: italic;">. </font>From its formation through the date hereof, the Company has been and
        is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Act (an &#8220;<font style="font-weight: bold;">Emerging Growth Company</font>&#8221;).</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">2.34. <font style="font-weight: bold;"><u>No Disqualification Events</u>.</font> Neither the Company, nor any of its predecessors or any affiliated issuer, nor any director, executive officer, or
        other officer of the Company participating in the Offering, nor any beneficial owner of 20% or more of the Company&#8217;s outstanding voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule
        405 under the Act) connected with the Company in any capacity at the Time of Sale (each, a &#8220;<font style="font-weight: bold;">Company Covered Person</font>&#8221; and, together, &#8220;<font style="font-weight: bold;">Company Covered Persons</font>&#8221;) is subject
        to any of the &#8220;Bad Actor&#8221; disqualifications described in Rule 506(d)(1)(i) to (viii) under the Act (a &#8220;<font style="font-weight: bold;">Disqualification Event</font>&#8221;), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The
        Company has exercised reasonable care to determine whether any Company Covered Person is subject to a Disqualification Event. The Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished
        to the Underwriters a copy of any disclosures provided thereunder.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">2.35. <font style="font-weight: bold;"><u>Free-Writing Prospectus and Testing-the-Waters</u></font>. The Company has not made any offer relating to the Public Securities that would constitute an
        issuer free writing prospectus, as defined in Rule 433 under the Act, or that would otherwise constitute a &#8220;free writing prospectus&#8221; as defined in Rule 405 under the Act. The Company: (a) has not engaged in any Testing-the-Waters Communication
        other than Testing-the-Waters Communications with the consent of the Representative with entities that are qualified institutional buyers within the meaning of Rule 144A under the Act or institutions that are accredited investors within the meaning
        of Rule 501(a) of Regulation D under the Act and (b) has not authorized anyone to engage in Testing-the-Waters Communications other than its officers and the Representative and individuals engaged by the Representative. The Company has not
        distributed any written Testing-the-Waters Communications other than those listed on <u>Schedule 2</u> hereto. &#8220;<font style="font-weight: bold;">Testing-the-Waters Communication</font>&#8221; means any oral or written communication with potential
        investors undertaken in reliance on Section 5(d) of the Act.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">2.36. <font style="font-weight: bold;"><u>No Fee Arrangements</u></font>. As of the date hereof, the Company has not entered into any agreement, written or oral, pursuant to which the Company will
        be obligated to pay any Insider or an affiliate of any Insider a consulting, finder or success fee for assisting the Company in consummating a Business Combination.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">2.37. <font style="font-weight: bold;"><u>Loans to Directors or Officers</u></font>. There are no outstanding loans, advances (except normal advances for business expenses in the ordinary course
        of business) or guarantees or indebtedness by the Company for the benefit of any of the officers or directors of the Company, or any of their respective family members, except as disclosed in the Registration Statement, the Sale Preliminary
        Prospectus and the Prospectus.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">2.38. <font style="font-weight: bold;"><u>Forward-Looking Statements</u></font>. No forward-looking statement (within the meaning of Section 27A of the Securities Act and Section 21E of the
        Exchange Act) contained in the Registration Statement, the Sale Preliminary Prospectus or the Prospectus has been made or reaffirmed without a reasonable basis or has been disclosed other than in good faith.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">2.39. <font style="font-weight: bold;"><u>Integration</u></font>. Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf has, directly or indirectly, made any
        offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause the Offering to be integrated with prior offerings by the Company for purposes of the Securities Act that would require the
        registration of any such securities under the Securities Act.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">2.40. <font style="font-weight: bold;"><u>Corporate Records</u></font>. The minute books of the Company have been made available to the Representative and counsel to the Underwriters and such
        books (i) contain minutes of all material meetings and actions of the Board of Directors (including each board committee) and shareholders of the Company, and (ii) reflect all material transactions referred to in such minutes.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">2.41. <font style="font-weight: bold;"><u>Disclosures in Commission Filings</u></font><u>.</u> None of the Company&#8217;s filings with the Commission, at the time of such filings, contained in any
        untrue statement of a material fact or omitted to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; and the Company has made all filings with the
        Commission required under the Exchange Act and the rules and regulations promulgated of the Commission promulgated thereunder.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify;">3. <font style="font-weight: bold;"><u>Covenants of the Company</u></font>.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">The Company covenants and agrees as follows:</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.1. <font style="font-weight: bold;"><u>Amendments to Registration Statement</u></font>. The Company will deliver to the Representative, prior to filing, any amendment or supplement to the
        Registration Statement, any Preliminary Prospectus or the Prospectus proposed to be filed after the Effective Date and the Company shall not file any such amendment or supplement to which the Representative reasonably object in writing.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">3.2. <font style="font-weight: bold;"><u>Federal Securities Laws</u></font>.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">3.2.1. <u>Compliance</u>. During the time when a Prospectus is required to be delivered under the Act, the Company will use its commercially reasonable efforts to comply with all requirements
        imposed upon it by the Act, the Regulations, and the Exchange Act, and by the regulations under the Exchange Act, as from time to time in force, so far as necessary to permit the continuance of sales of or dealings in the Securities in accordance
        with the provisions hereof and the Sale Preliminary Prospectus and the Prospectus. If at any time when a Prospectus relating to the Securities is required to be delivered under the Act, any event shall have occurred as a result of which, in the
        opinion of counsel for the Company or counsel for the Underwriters, the Prospectus, as then amended or supplemented, includes an untrue statement of a material fact or omits to state any material fact required to be stated therein or necessary to
        make the statements therein, in the light of the circumstances under which they were made, not misleading, or if it is necessary at any time to amend or supplement the Prospectus to comply with the Act, the Company will notify the Representative
        promptly and prepare and file with the Commission, subject to <u>Section 3.1</u> hereof, an appropriate amendment or supplement in accordance with Section 10 of the Act.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">3.2.2. <u>Filing of Final Prospectus</u>. The Company will file the Prospectus (in form and substance reasonably satisfactory to the Underwriters) with the Commission pursuant to the requirements
        of Rule 424 of the Regulations.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">3.2.3. <u>Exchange Act Registration</u>. The Company will use its commercially reasonable efforts to maintain the registration of the Ordinary Shares (and Warrants prior to consummation of the
        Business Combination) under the provisions of the Exchange Act (except in connection with a going-private transaction) for a period of five (5) years from the Effective Date, or until the Company is required to be liquidated or is acquired, if
        earlier. The Company will not deregister the Ordinary Shares (and Warrants prior to consummation of the Business Combination) under the Exchange Act (except in connection with a going private transaction after the completion of a Business
        Combination) without the prior written consent of the Representative.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">3.2.4. <u>Exchange Act Filings</u>. From the Effective Date until the earlier of the Company&#8217;s initial Business Combination, or its liquidation and dissolution, the Company shall timely file with
        the Commission via the Electronic Data Gathering, Analysis and Retrieval System (&#8220;<font style="font-weight: bold;">EDGAR</font>&#8221;) such statements and reports as are required to be filed by a company registered under Section 12(b) of the Exchange
        Act.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">3.2.5. <u>Sarbanes-Oxley Act Compliance</u>. As soon as it is legally required to do so, the Company shall take all actions necessary to obtain and thereafter maintain material compliance with
        each applicable provision of the Sarbanes-Oxley Act and the rules and regulations promulgated thereunder and related or similar rules and regulations promulgated by any other governmental or self-regulatory entity or agency with jurisdiction over
        the Company.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">3.2.6. <u>Free Writing Prospectuses</u>. The Company agrees that it will not make any offer relating to the Public Securities that would constitute an issuer free writing prospectus, as defined in
        Rule 433 under the Act, or that would otherwise constitute a &#8220;free writing prospectus&#8221; as defined in Rule 405 under the Act, without the prior consent of the Underwriters.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">3.2.7. <u>Testing-the-Waters Communications</u>. If at any time following the distribution of any Written Testing-the-Waters Communication there occurred or occurs an event or development as a
        result of which such Written Testing-the-Waters Communication included or would include an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements therein, in the light of the
        circumstances existing at that subsequent time, not misleading, the Company shall promptly notify the Representative and shall promptly amend or supplement, at its own expense, such Written Testing-the-Waters Communication to eliminate or correct
        such untrue statement or omission.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.3. <font style="font-weight: bold;"><u>Delivery to the Underwriters of Registration Statements</u></font>. The Company has delivered or made available or shall deliver or make available to the
        Representative and counsel to the Underwriters, without charge, conformed copies of the Registration Statement as originally filed and each amendment thereto (including exhibits filed therewith) and signed copies of all consents and certificates of
        experts, and will also deliver to each Underwriter, without charge, a conformed copy of the Registration Statement as originally filed and each amendment thereto (without exhibits) upon receipt of a written request therefor from such Underwriter.
        The copies of the Registration Statement and each amendment thereto furnished to the Underwriters will be identical to the electronically transmitted copies thereof filed with the Commission pursuant to EDGAR, except to the extent permitted by
        Regulation S-T.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.4. <font style="font-weight: bold;"><u>Delivery to the Underwriters of Prospectuses.</u></font> The Company will deliver to the Underwriters, without charge and from time to time during the
        period when the Prospectus is required to be delivered under the Act or the Exchange Act, such number of copies of each of the Preliminary Prospectus and the Prospectus as the Underwriters may reasonably request and, as soon as the Registration
        Statement or any amendment or supplement thereto becomes effective, deliver to the Underwriters, upon their request, two (2) manually executed Registration Statements, including exhibits, and all post-effective amendments thereto and copies of all
        exhibits filed therewith or incorporated therein by reference and all manually executed consents of certified experts.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.5. <font style="font-weight: bold;"><u>Effectiveness and Events Requiring Notice to the Representative</u></font>. The Company will use its commercially reasonable efforts to cause the
        Registration Statement to remain effective and will notify the Representative immediately and confirm the notice in writing (i) of the effectiveness of the Registration Statement and any amendment thereto; (ii) of the issuance by the Commission of
        any stop order suspending the effectiveness of the Registration Statement or any post-effective amendment thereto or preventing or suspending the use of any Preliminary Prospectus or the Prospectus or of the initiation, or the threatening, of any
        proceeding for that purpose; (iii) of the issuance by any foreign or state securities commission of any proceedings for the suspension of the qualification of the Public Securities for offering or sale in any jurisdiction or of the initiation, or
        the threatening, of any proceeding for that purpose; (iv) of the mailing and delivery to the Commission for filing of any amendment or supplement to the Registration Statement or Prospectus; (v) of the receipt of any comments or request for any
        additional information from the Commission; and (vi) of the happening of any event that, in the reasonable judgment of the Company, makes any statement of a material fact made in the Registration Statement or the Prospectus untrue or that requires
        the making of any changes in the Registration Statement or the Prospectus in order to make the statements therein, and in the light of the circumstances under which they were made, not misleading. If the Commission or any foreign or state
        securities commission shall enter a stop order or suspend such qualification at any time, the Company will make every reasonable effort to obtain promptly the lifting of such order.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.6 <font style="font-weight: bold;"><u>Affiliated Transactions</u></font>.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">3.6.1 <u>Business Combinations</u>. In the event the Company seeks to consummate a Business Combination with any entity that is affiliated with any Insider, the Company, or a committee of its
        independent directors, shall obtain an opinion from an independent investment banking firm that is a member of FINRA, or from an independent accounting firm, that the Business Combination is fair to the Company from a financial point of view.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">3.6.2 <u>Compensation to Insiders</u>. Except as disclosed in the Registration Statement, the Sale Preliminary Prospectus or the Prospectus, the Company shall not pay any of the Insiders or any of
        their affiliates any fees or compensation from the Company, for services rendered to the Company prior to, or in connection with, the consummation of a Business Combination.</div>
      <div style="text-align: center;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.7. <font style="font-weight: bold;"><u>Reports to the Representative</u></font>. For a period of five (5) years from the Effective Date or until such earlier time upon which the Company is
        required to be liquidated or is no longer required to file reports under the Exchange Act, the Company will furnish to the Representative and their counsel copies of such financial statements and other periodic and special reports as the Company
        from time to time furnishes generally to holders of any class of its securities, and promptly furnish to the Underwriters (i) a copy of each periodic report the Company shall be required to file with the Commission, (ii) a copy of every press
        release and every news item and article with respect to the Company or its affairs that was released by the Company, (iii) a copy of each Current Report on Form 8-K or Schedules 13D, 13G, 14D-1 or 13E-4 received or prepared by the Company, (iv) two
        (2) copies of each registration statement filed by the Company with the Commission under the Act, and (v) such additional documents and information with respect to the Company and the affairs of any future subsidiaries of the Company as the
        Representative may from time to time reasonably request; provided the Representative shall sign, if requested by the Company, a Regulation FD compliant confidentiality agreement which is reasonably acceptable to the Representative and their counsel
        in connection with the Representative&#8217;s receipt of such information. Documents filed or furnished with the Commission pursuant to its EDGAR system shall be deemed to have been delivered to the Representative pursuant to this <u>Section 3.7</u>.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.8. <font style="font-weight: bold;"><u>Transfer Agent</u></font>. For a period of five (5) years following the Effective Date or until such earlier time upon which the Company is required to be
        liquidated, the Company shall retain a transfer agent reasonably acceptable to the Representative. Odyssey is acceptable to the Representative. Until the consummation of the Business Combination or until such earlier time upon which the Company is
        required to be liquidated, the Company shall retain a rights agent.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.9. <font style="font-weight: bold;"><u>Payment of Expenses</u></font>. The Company hereby agrees to pay on each of the Closing Date and the Option Closing Date, if any, to the extent not paid at
        the Closing Date, all Company expenses incident to the performance of the obligations of the Company under this Agreement, including but not limited to (i) the Company&#8217;s legal and accounting fees and disbursements; (ii) the preparation, printing,
        filing, mailing and delivery (including the payment of postage with respect to such mailing) of the Registration Statement, the Sale Preliminary Prospectus and the Prospectus, including any pre- or post-effective amendments or supplements thereto,
        and the printing and mailing of this Agreement and related documents, including the cost of all copies thereof and any amendments thereof or supplements thereto supplied to the Underwriters in quantities as may be required by the Underwriters;
        (iii) fees incurred in connection with conducting background checks of the Company&#8217;s management team; (iv) the preparation, printing, engraving, issuance and/or delivery of the Units, the Ordinary Shares and the Warrants included in the Units,
        including any transfer or other taxes payable thereon; (v) filing fees incurred in registering the Offering with FINRA and the reasonable fees of counsel of the Underwriters in connection therewith and including, without limitation, fees associated
        with qualifying the Offering under the &#8220;Blue Sky&#8221; laws of any states specified by the Representative; (vi) fees, costs and expenses incurred in listing the Securities on the Nasdaq Global Market or such other stock exchanges as the Company and the
        Underwriters together determine; (vii) all fees and disbursements of the transfer and rights agent; (viii) all of the Company&#8217;s expenses associated with &#8220;due diligence&#8221; and &#8220;road show&#8221; meetings arranged by the Representative and any presentations
        made available by way of a net roadshow, including without limitation, trips for the Company&#8217;s management to meet with prospective investors, all travel, food and lodging expenses associated with such trips incurred by the Company or such
        management; and (ix) all other documented out-of-pocket costs and expenses customarily borne by an issuer incident to the performance of its obligations hereunder which are not otherwise specifically provided for in this <u>Section 3.9</u>. If the
        Offering is consummated, the Representative may deduct from the net proceeds of the Offering payable to the Company on the Closing Date the expenses set forth above (which shall be mutually agreed upon between the Company and the Representative
        prior to the Closing Date) to be paid by the Company to the Representative and others.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.10. <font style="font-weight: bold;"><u>Application of Net Proceeds</u></font>. The Company will apply the net proceeds from the Offering and the Private Placement received by it in a manner
        consistent in all material respects with the application described under the caption &#8220;Use of Proceeds&#8221; in the Prospectus.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.11. <font style="font-weight: bold;"><u>Delivery of Earnings Statements to Security Holders</u></font>. The Company will make generally available to its security holders as soon as practicable
        an earnings statement (which need not be certified by an independent registered public accounting firm unless required by the Act or the Regulations, but which shall satisfy the provisions of Rule 158(a) under Section 11(a) of the Act) covering a
        period of at least twelve (12) consecutive months beginning after the Effective Date.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.12. <font style="font-weight: bold;"><u>Notice to FINRA</u></font>.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">3.12.1. <u>Notice to the Representative</u>. For a period of sixty (60) days after the date of the Prospectus, in the event any person or entity (regardless of any FINRA affiliation or
        association) is engaged, in writing, to assist the Company in its search for a Target Business or to provide any other services in connection therewith, the Company will provide the following to the Representative prior to the consummation of the
        Business Combination: (i) complete details of all services and copies of agreements governing such services, and (ii) justification as to why the person or entity providing the merger and acquisition services should not be considered a
        Participating Member with respect to the Offering, as such term is defined in FINRA Rule 5110. The Company also agrees that, if required by law, proper disclosure of such arrangement or potential arrangement will be made in the tender offer
        documents or proxy statement which the Company will file with the Commission in connection with the Business Combination.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">3.12.2. <u>FINRA</u>. The Company shall advise the Representative if it is aware that any 10% or greater shareholder of the Company becomes an affiliate or associated person of a Participating
        Member.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">3.12.3. <u>Broker/Dealer</u>. In the event the Company intends to register as a broker/dealer, merge with or acquire a registered broker/dealer, or otherwise become a member of FINRA, it shall
        promptly notify FINRA.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.13. <font style="font-weight: bold;"><u>Stabilization</u></font>. Neither the Company, nor to its knowledge, any of its employees, directors or shareholders (without the consent of the
        Representative) has taken, and the Company will not take, and has directed its employees, directors or shareholders to not take, directly or indirectly, any action without the consent of the Representative that is designed to or that has
        constituted or that might reasonably be expected to cause or result in, under the Exchange Act, or otherwise, stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Units.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.14. <font style="font-weight: bold;"><u>Existing Lock-Up Agreement</u></font>. The Company will use its reasonable best efforts to enforce all existing agreements between the Company and any of
        its security holders that prohibit the sale, transfer, assignment, pledge or hypothecation of any of the Securities in connection with the Offering. In addition, the Company will direct the Company&#8217;s transfer agent to place stop transfer
        restrictions upon any such Securities of the Company that are bound by such existing &#8220;lock-up&#8221; agreements for the duration of the periods contemplated in such agreements.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.15. <font style="font-weight: bold;"><u>Internal Controls</u></font>. The Company will maintain a system of internal accounting controls sufficient to provide reasonable assurances that (i)
        transactions are executed in accordance with management&#8217;s general or specific authorization, (ii) transactions are recorded as necessary in order to permit preparation of financial statements in accordance with GAAP and to maintain accountability
        for assets, (iii) access to assets is permitted only in accordance with management&#8217;s general or specific authorization, and (iv) the recorded accountability for assets is compared with existing assets at reasonable intervals and appropriate action
        is taken with respect to any differences.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.16. <font style="font-weight: bold;"><u>Accounting Firm</u></font>. Until the earlier of the consummation of the Company&#8217;s initial Business Combination or until such earlier time upon which the
        Company is required to be liquidated, the Company shall retain Adeptus or another independent registered public accounting firm.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.17. <font style="font-weight: bold;"><u>Form 8-K</u></font>. The Company shall, on or prior to the date hereof, retain its independent registered public accounting firm to audit the balance
        sheet of the Company as of the Closing Date (&#8220;<font style="font-weight: bold;">Audited Financial Statements</font>&#8221;) reflecting the receipt by the Company of the proceeds of the Offering and the Private Placement. Within four (4) Business Days
        after the Closing Date, the Company shall file a Current Report on Form 8-K with the Commission, which Report shall contain the Company&#8217;s Audited Financial Statements. Promptly after the Option Closing Date, if the Over-allotment Option is
        exercised after the Closing Date and to the extent not reflected in the Current Report on Form 8-K referenced in the immediately preceding sentence, the Company shall file with the Commission a Current Report on Form 8-K or an amendment to the Form
        8-K to provide updated financial information to reflect the exercise of such option.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.18. <font style="font-weight: bold;"><u>Corporate Proceedings</u></font>. All corporate proceedings and other legal matters necessary to carry out the provisions of this Agreement and the
        transactions contemplated hereby shall have been effected, except where the failure to do so would not have a Material Adverse Effect.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.19. <font style="font-weight: bold;"><u>Investment Company</u></font>. The Company shall cause the proceeds of the Offering to be held in the Trust Account to be invested only as provided for in
        the Trust Agreement and disclosed in the Prospectus. The Company will conduct its business in a manner so that it will not become subject to the Investment Company Act. Furthermore, once the Company consummates a Business Combination, it shall be
        engaged in a business other than that of investing, reinvesting, owning, holding or trading securities.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.20. <font style="font-weight: bold;"><u>Amendments to Charter Documents</u></font>. The Company covenants and agrees, that prior to its initial Business Combination, it will not seek to amend or
        modify its Charter Documents, except in accordance with the procedures set forth therein.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.21. <font style="font-weight: bold;"><u>Press Releases</u></font>. The Company agrees that it will not issue press releases or engage in any other publicity relating to the Offering or which
        includes the name of any Underwriter, without the Representative&#8217;s prior written consent (not to be unreasonably withheld), for a period of twenty-five (25) days after the Closing Date. Notwithstanding the foregoing, in no event shall the Company
        be prohibited from issuing any press releases or engaging in any other publicity required by law, except that including the name of any Underwriter therein shall require the prior written consent of such Underwriter.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.22. <font style="font-weight: bold;"><u>Insurance</u></font>. Until the earlier of the consummation of the Company&#8217;s initial Business Combination or until such earlier time upon which the
        Company is required to be liquidated, the Company will maintain directors&#8217; and officers&#8217; insurance (including, without limitation, insurance covering the Company, its directors and officers for liabilities or losses arising in connection with the
        Offering, including, without limitation, liabilities or losses arising under the Act, the Exchange Act, the Regulations and any applicable foreign securities laws).</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.23. <font style="font-weight: bold;"><u>Electronic Prospectus</u></font>. The Company shall cause to be prepared and delivered to the Underwriters, at the Company&#8217;s expense, promptly, but in no
        event later than two (2) Business Days from the effective date of this Agreement, an Electronic Prospectus to be used by the Underwriters in connection with the Offering. As used herein, the term &#8220;<font style="font-weight: bold;">Electronic
          Prospectus</font>&#8221; means a form of prospectus, and any amendment or supplement thereto, that meets each of the following conditions: (i) it shall be encoded in an electronic format, satisfactory to the Representative, that may be transmitted
        electronically by the Underwriters to offerees and purchasers of the Units for at least the period during which a prospectus relating to the Units is required to be delivered under the Act; (ii) it shall disclose the same information as the paper
        prospectus and prospectus filed pursuant to EDGAR, except to the extent that graphic and image material cannot be disseminated electronically, in which case such graphic and image material shall be replaced in the electronic prospectus with a fair
        and accurate narrative description or tabular representation of such material, as appropriate; and (iii) it shall be in or convertible into a paper format or an electronic format, satisfactory to the Representative, that will allow recipients
        thereof to store and have continuously ready access to the prospectus at any future time, without charge to such recipients (other than any fee charged for subscription to the Internet as a whole and for on-line time).</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.24. <font style="font-weight: bold;"><u>Private Placement Proceeds</u></font>. On or prior to the Closing Date, the Company shall have caused the applicable proceeds from the Private Placement
        to be deposited in the Trust Account pursuant to the terms of the Warrant Purchase Agreement.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.25. <font style="font-weight: bold;"><u>Future Financings</u></font>. The Company agrees that neither it, nor any successor or subsidiary of the Company, will consummate any public or private
        equity or debt financing prior to the consummation of a Business Combination, unless all investors in such financing expressly waive, in writing, any rights in or claims against the Trust Account.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.26. <font style="font-weight: bold;"><u>Amendments to Certain Agreements</u></font>. The Company shall not amend, modify or otherwise change the Insider Letter, the Non-Sponsor Investor Letter
        and the Trust Agreement without the prior written consent of the Representative, which such consent shall not be unreasonably delayed, conditioned or withheld by the Representative. The Trust Agreement shall provide that the Trustee is required to
        obtain a joint written instruction signed by both the Company and the Representative with respect to the transfer of the funds held in the Trust Account from the Trust Account, prior to commencing any liquidation of the assets of the Trust Account
        in connection with the consummation of any Business Combination, and such provision of the Trust Agreement shall not be permitted to be amended without the prior written consent of the Representative.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.27. <font style="font-weight: bold;"><u>Maintenance of Listing on Nasdaq</u></font>. Until the consummation of a Business Combination, the Company will use its commercially reasonable efforts to
        maintain the listing of the Public Securities on Nasdaq or a national securities exchange acceptable to the Representative.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.28. <font style="font-weight: bold;"><u>Reservation of Shares</u></font>. The Company will reserve and keep available that maximum number of its authorized but unissued securities which are
        issuable (i) pursuant to the Warrants and the Placement Securities (as well as any other rights that may be issued and covered by the Warrant Agreement) and (ii) upon conversion of the Founder Shares.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.29. <font style="font-weight: bold;"><u>Notice of Disqualification Events</u></font>. The Company will notify the Underwriters in writing, prior to the Closing Date, of (i) any Disqualification
        Event relating to any Company Covered Person and (ii) any event that would, with the passage of time, become a Disqualification Event relating to any Company Covered Person.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.30. <font style="font-weight: bold;"><u>Disqualification of S-1</u></font>. Until the earlier of seven (7) years from the date hereof or until the Warrants have either expired and are no longer
        exercisable or have all been exercised or redeemed or the Company has earlier liquidated and dissolved, the Company will not take any action or actions that would be reasonably be expected to prevent or disqualify the Company&#8217;s use of Form S-1 (or
        other appropriate form) for the registration of the Ordinary Shares issuable upon exercise of the Warrants under the Act.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.31. <font style="font-weight: bold;"><u>Business Combination Securities Disclosure Documents</u></font>. If any Underwriter that performs any marketing, capital markets advisory or securities
        placement activities in connection with a Business Combination at the request of the Company pursuant to a separate agreement between such Underwriter and the Company (such Underwriter, a &#8220;<font style="font-weight: bold;">Business Combination
          Advisor</font>&#8221;) may be deemed, in its sole judgment, to be an underwriter of any securities issued pursuant to any registration statement or tender offer document filed with the Commission in connection with the consummation of the Business
        Combination by the Company, a Target Business or any direct or indirect parent or subsidiary of any of them (any such issuer or co-issuer, a &#8220;<font style="font-weight: bold;">Registrant</font>,&#8221; and any such securities, the &#8220;<font style="font-weight: bold;">Business Combination Securities</font>&#8221;), the Company shall use its commercially reasonable efforts to provide or cause to be provided to such Business Combination Advisor information and access to all persons,
        properties and documents to the extent necessary for such Business Combination Advisor to complete a due diligence investigation sufficient (in the view of such Business Combination Advisor in its sole discretion) to provide such Business
        Combination Advisor with a &#8220;reasonable due diligence&#8221; defense in respect of any claims that could be brought against an underwriter of the applicable Business Combination Securities under federal and state securities laws, rules and regulations,
        including, without limitation, Section 11 of the Act. As used herein, the term &#8220;<font style="font-weight: bold;">reasonable due diligence</font>&#8221; means a reasonable investigation that provides the investigating person a reasonable ground to believe
        that at the time of the applicable offer, issuance or distribution of any Business Combination Securities, no registration statement, preliminary or final prospectus, proxy statement, tender offer document or offering memorandum, including, without
        limitation, any document incorporated by reference into any of the foregoing, or any amendment or supplement to any of the foregoing, or any other marketing document used by any Registrant, filed with or furnished by the Company to the Commission
        in connection with the Business Combination but excluding any filing under Rule 425 of the Act or Rule 14a-12 of the Exchange Act (each, a &#8220;<font style="font-weight: bold;">Business Combination Securities Disclosure Document</font>&#8221;), in each case
        relating to such offer, issuance or distribution, contained an untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary to make the statements made therein, in light of the circumstances
        under which they were made, not misleading. The Company agrees to use its commercially reasonable efforts to provide to such Business Combination Advisor notice of each filing under Rule 425 of the Act or Rule 14a-12 of the Exchange Act and each
        other form of public communication about the Business Combination reasonably in advance of such filing or public communication. The Company further covenants that it will use its reasonable best efforts to ensure that any projections provided to
        such Business Combination Advisor by any Registrant or prepared by any Registrant or any representative of such Registrant (a &#8220;<font style="font-weight: bold;">Registrant Representative</font>&#8221;) and contained in any Business Combination Securities
        Disclosure Document, in each case, at the time they were prepared, will have been prepared in good faith and will be based upon assumptions which, in light of the circumstances under which they are made, are reasonable.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.32. <font style="font-weight: bold;"><u>Obligations in Connection with Business Combination</u></font>. If requested in writing by a Business Combination Advisor, if it may be deemed, in its
        sole judgment, to be an underwriter of any Business Combination Securities, the following shall apply:</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.32.1. Prior to entering into any definitive agreement with respect to the Business Combination (or amendment thereto) and until such time as such Business Combination is consummated:</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">(a) The Company agrees to notify such Business Combination Advisor with respect to, and to permit such Business Combination Advisor, at its request, to participate in, all diligence sessions with
        any Registrant or any Registrant Representative and all drafting sessions in respect of any Business Combination Securities Disclosure Document.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">(b) The Company shall provide drafts of all Business Combination Securities Disclosure Documents to such Business Combination Advisor and its legal counsel reasonably in advance of the filing by
        the Company (or, if such filing is to be made by a Registrant other than the Company, any filing which is required to be approved by the Company) of any Business Combination Securities Disclosure Document with the Commission or the circulation by
        any Registrant of any Business Combination Securities Disclosure Document to any prospective investor, sufficient to allow such Business Combination Advisor and its legal counsel to request changes determined by them to be reasonably necessary to
        such Business Combination Securities Disclosure Document before its filing or circulation. The Company shall not permit the filing with or furnishing to the Commission of any Business Combination Securities Disclosure Document without the consent
        of such Business Combination Advisor, which consent shall not unreasonably be withheld, delayed or conditioned.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.32.2. Notwithstanding any provision to the contrary herein, the Company agrees that such Business Combination Advisor shall have the right, in connection with its reasonable due diligence under <u>Section



          3.32</u>, (i) to retain counsel and other consultants and experts as it may deem necessary or desirable in connection with its reasonable due diligence under <u>Section 3.32.1</u> (it being understood that the retention of any such consultant or
        expert or other advisor, other than outside legal counsel, will be made with the prior written approval of the Company, which approval will not be unreasonably withheld, conditioned or delayed); (ii) to use its commercially reasonable efforts to
        ensure that each counsel to the Company and to any other Registrant provides customary legal opinions and negative assurance letters to such Business Combination Advisor dated as of (x) the date of effectiveness of the Business Combination
        Securities Disclosure Document, and (y) the date of the shareholder vote to approve the Business Combination, in form and substance reasonably satisfactory to such Business Combination Advisor, (iii) to use its commercially reasonable efforts to
        ensure that each accounting firm or firms that were retained by the Company or by any other Registrant and that have audited any financial statements set forth in any Business Combination Securities Disclosure Document provide customary &#8220;comfort
        letters&#8221; to such Business Combination Advisor dated as of (x) the date of effectiveness of the Business Combination Securities Disclosure Document, and (y) the date of the shareholder vote to approve the Business Combination; and (iv) to take and
        shall use its reasonable best efforts to take any other actions reasonably requested by such Business Combination Advisor.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.32.3. In connection with the Business Combination, to the extent the Company retains an unaffiliated party (the &#8220;<font style="font-weight: bold;">Fairness Opinion Provider</font>&#8221;) to prepare a
        report and provide an opinion (the &#8220;<font style="font-weight: bold;">Fairness Opinion</font>&#8221;) concerning the fairness, from a financial point of view, of the Business Combination to the Company and its unaffiliated shareholders, the Company shall,
        pursuant to, and in accordance with, applicable law, disclose in reasonable detail in a Business Combination Securities Disclosure Document the results of that report and, as necessary or appropriate, a copy of that report. Each Registrant shall
        provide the Fairness Opinion Provider with all information and access to persons and documents that the Fairness Opinion Provider deems reasonably necessary and appropriate in connection with the preparation of its Fairness Opinion.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.32.4. Prior to the consummation of the Business Combination, the Company shall include in the definitive agreement for the Business Combination (i) a covenant for the assignment and assumption,
        by the public entity resulting from the initial Business Combination, of all of the Company&#8217;s obligations hereunder and (ii) that such Business Combination Advisor may rely on the representations and warranties contained therein as if it were a
        party thereto. The Company shall use its commercially reasonable efforts to ensure that each Target Business in the Business Combination agrees to deliver to such Business Combination Advisor a certificate of an officer of such Target Business
        stating that to such officer&#8217;s knowledge the representations and warranties made by the Target Business in the definitive agreement for the Business Combination are true and correct as of the date of such certificate, subject to (i) a customary
        materiality standard, (ii) any applicable carve-out with reference to disclosure included in the Business Combination Securities Disclosure Document and (iii) required adjustments for such representations and warranties that speak as of a specific
        date. In addition, in connection with the Business Combination, the Company will, and will use its reasonable best efforts to cause each Registrant to, comply in all material respects with (i) the obligations and covenants of the Company which
        relate to the period following the consummation of the Business Combination set forth in Sections 3 and 5 of this Agreement and (ii) all laws, rules and regulations applicable either to the Registrant and its business activities or to the Business
        Combination, as such laws, rules and regulations may be in effect at the time of the consummation of the Business Combination.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.32.5. Nothing herein shall be deemed to require the Underwriters to limit their rights to compensation or to reimbursement of expenses without their express agreement or otherwise to assume any
        liability other than as may be expressly required under the Act.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.32.6. The Company acknowledges and agrees that nothing in this <u>Section 3.32</u> shall be interpreted to obligate the Underwriters to take any action, including by serving as a Business
        Combination Advisor, or to refrain from taking any action, in connection with the Business Combination and any such actions will be undertaken by each Underwriter, in respect of itself, in its sole discretion.</div>
      <div><br>
      </div>
      <div>4. <font style="font-weight: bold;"><u>Conditions of Underwriters&#8217; Obligations</u></font>.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">The obligations of the Underwriters to purchase and pay for the Units, as provided herein, shall be subject to (i) the continuing accuracy of the representations and warranties of the Company as of
        the date hereof and as of each of the Closing Date and the Option Closing Date, if any; (ii) the accuracy of the statements of officers of the Company made pursuant to the provisions hereof; (iii) the performance by the Company of its obligations
        hereunder; and (iv) the following conditions:</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">4.1. <font style="font-weight: bold;"><u>Regulatory Matters</u></font>.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">4.1.1. <u>Effectiveness of Registration Statement</u>. The Registration Statement shall have become effective not later than 4:30 p.m., New York time, on the date of this Agreement or such later
        date and time as shall be consented to in writing by the Representative, and, at each of the Closing Date and each Option Closing Date, no stop order suspending the effectiveness of the Registration Statement shall have been issued and no
        proceedings for the purpose shall have been instituted or shall be pending or contemplated by the Commission and any request on the part of the Commission for additional information shall have been complied with to the reasonable satisfaction of
        the Representative.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">4.1.2. <u>FINRA Clearance</u>. By the Effective Date, the Underwriters shall have received a letter of no objections from FINRA as to the terms and arrangement and amount of compensation allowable
        or payable to the Underwriters as described in the Registration Statement.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">4.1.3 <u>No Blue Sky Stop Orders</u>. No order suspending the sale of the Units in any jurisdiction designated by the Underwriters pursuant to <u>Section 3.5</u> hereof shall have been issued on
        each of the Closing Date or any Option Closing Date, and no proceedings for that purpose shall have been instituted or, to the Company&#8217;s knowledge, shall be contemplated.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">4.1.4 <u>No Commission Stop Order</u>. At the Closing Date and each Option Closing Date, the Commission has not issued any order or threatened to issue any order preventing or suspending the use
        of any Preliminary Prospectus, the Prospectus or any part thereof, and has not instituted or, to the Company&#8217;s knowledge, assuming reasonable inquiry, threatened to institute any proceedings with respect to such an order.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">4.1.5 <u>Approval of Listing on Nasdaq</u>. The Public Securities shall have been approved for listing on the Nasdaq Global Market, subject to official notice of issuance and evidence of
        satisfactory distribution, satisfactory evidence of which shall have been provided to the Representative.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">4.2. <font style="font-weight: bold;"><u>Company Counsel Matters</u></font>.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">4.2.1. <u>Closing Date and Option Closing Date Opinions of Counsels</u>. On the Closing Date and each Option Closing Date, if any, the Representative shall have received the (i) favorable opinions
        and negative assurance statements of Paul Hastings LLP and (ii) the favorable opinions of Maples and Calder (Cayman) LLP, in each case, dated the Closing Date or each Option Closing Date, as the case may be, addressed to the Representative as
        representative for the several Underwriters, and in substantially the form agreed to by the parties. On the Closing Date and each Option Closing Date, the Representative shall have received the favorable opinion and negative assurance statement of
        DLA Piper, dated the Closing Date, addressed to the Representative as representative for the several Underwriters.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">4.2.2. <u>Reliance</u>. In rendering such opinions, such counsels may rely as to matters of fact, to the extent they deem proper, on certificates or other written statements of officers of the
        Company and officers of departments of various jurisdictions having custody of documents respecting the corporate existence or good standing of the Company, provided that copies of any such statements or certificates shall be delivered to the
        Representative&#8217;s counsel if requested.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">4.3. <font style="font-weight: bold;"><u>Comfort Letters</u></font>. At the time this Agreement is executed, and at the Closing Date and Option Closing Date, if any, the Representative shall have
        received a letter, addressed to the Representative as representative for the several Underwriters and in form and substance satisfactory in all respects (including the non-material nature of the changes or decreases, if any, referred to in <u>Section



          4.3.3</u> below) to the Representative, from Adeptus dated, respectively, as of the date of this Agreement and as of the Closing Date and Option Closing Date, if any:</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">4.3.1. Confirming that they are an independent registered public accounting firm with respect to the Company within the meaning of the Act and the applicable Regulations and that they have not,
        during the periods covered by the financial statements included in the Registration Statement, Preliminary Prospectus, the Sale Preliminary Prospectus and the Prospectus, provided to the Company any non-audit services, as such term is used in
        Section 10A(g) of the Exchange Act;</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">4.3.2. Stating that in their opinion the financial statements of the Company included in the Registration Statement, the Sale Preliminary Prospectus and the Prospectus comply as to form in all
        material respects with the applicable accounting requirements of the Act and the published Regulations thereunder;</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">4.3.3. Stating that, on the basis of their review, which included a reading of the latest available unaudited interim financial statements of the Company (with an indication of the date of the
        latest available unaudited interim financial statements), a reading of the latest available minutes of the shareholders and Board of Directors and the various committees of the Board of Directors, consultations with officers and other employees of
        the Company responsible for financial and accounting matters and other specified procedures and inquiries, nothing has come to their attention that would lead them to believe that (a) the unaudited financial statements of the Company included in
        the Registration Statement, the Sale Preliminary Prospectus and the Prospectus do not comply as to form in all material respects with the applicable accounting requirements of the Act and the Regulations or are not fairly presented in conformity
        with GAAP applied on a basis substantially consistent with that of the audited financial statements of the Company included in the Registration Statement, the Sale Preliminary Prospectus and the Prospectus; or (b) at a date not later than five (5)
        days prior to the Effective Date, Closing Date or Option Closing Date, as the case may be, there was any change in the share capital or long-term debt of the Company, or any decrease in the shareholders&#8217; equity of the Company as compared with
        amounts shown in the most recent balance sheet included in the Registration Statement, the Sale Preliminary Prospectus and the Prospectus, other than as set forth in or contemplated by the Registration Statement, the Sale Preliminary Prospectus and
        the Prospectus or, if there was any decrease, setting forth the amount of such decrease; and (c) during the period from the most recent balance sheet included in the Registration Statement to a specified date not later than five (5) days prior to
        the Effective Date, Closing Date or any Option Closing Date, as the case may be, there was any decrease in revenues, net earnings or net earnings per Ordinary Share, in each case as compared with the corresponding period in the preceding year and
        as compared with the corresponding period in the preceding quarter, other than as set forth in or contemplated by the Registration Statement the Sale Preliminary Prospectus and the Prospectus, or, if there was any such decrease, setting forth the
        amount of such decrease;</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">4.3.4. Stating that they have compared specific dollar amounts, numbers of shares, percentages of revenues and earnings, statements and other financial information pertaining to the Company set
        forth in the Registration Statement, the Sale Preliminary Prospectus and the Prospectus in each case to the extent that such amounts, numbers, percentages, statements and information may be derived from the general accounting records, including
        work sheets, of the Company and excluding any questions requiring an interpretation by legal counsel, with the results obtained from the application of specified readings, inquiries and other appropriate procedures (which procedures do not
        constitute an examination in accordance with generally accepted auditing standards) set forth in the letter and found them to be in agreement;</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">4.3.5. Stating that they have not, since the Company&#8217;s incorporation, brought to the attention of the Company&#8217;s management any reportable condition related to internal structure, design or
        operation as defined in the Statement on Auditing Standards No. 60 &#8220;Communication of Internal Control Structure Related Matters Noted in an Audit,&#8221; in the Company&#8217;s internal controls; and</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">4.3.6. Statements as to such other matters incident to the transaction contemplated hereby as the Representative or DLA Piper may reasonably request, including (i) that Adeptus is registered with
        the PCAOB; (ii) that Adeptus has sufficient assets and insurance to pay for any liability incurred by it relating to providing the letter; and (iii) that Adeptus is not insolvent.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">4.4. <font style="font-weight: bold;"><u>Officers&#8217; Certificates</u></font>.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">4.4.1. <u>Officers&#8217; Certificate</u>. At each of the Closing Date and the Option Closing Date, if any, the Representative shall have received a certificate of the Company signed by the Chairman of
        the Board or the Chief Executive Officer and the Secretary or Assistant Secretary of the Company, or any similar or equivalent officer of the Company (in their capacities as such), dated the Closing Date or the Option Closing Date, as the case may
        be, respectively, to the effect that the Company has performed in all material respects all covenants and complied with all conditions required by this Agreement to be performed or complied with by the Company prior to and as of the Closing Date,
        or the Option Closing Date, as the case may be, and that the conditions set forth in <u>Section 4</u> hereof have been satisfied as of such date and that, as of Closing Date and the Option Closing Date, as the case may be, the representations and
        warranties of the Company set forth in <u>Section 2</u> hereof are true and correct. In addition, the Representative will have received such other and further certificates of officers of the Company (in their capacities as such) as the
        Representative may reasonably request.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">4.4.2. <u>Secretary&#8217;s Certificate</u>. At each of the Closing Date and the Option Closing Date, if any, the Representative shall have received a certificate of the Company signed by the Secretary
        or Assistant Secretary of the Company, or any similar or equivalent officer of the Company, dated the Closing Date or the Option Closing Date, as the case may be, respectively, certifying (i) that the Charter Documents are true and complete, have
        not been modified and are in full force and effect; (ii) that the resolutions of the Company&#8217;s Board of Directors relating to the public offering contemplated by this Agreement are in full force and effect and have not been modified; (iii) as to
        the accuracy and completeness of all correspondence between the Company or its counsel and the Commission; (iv) as to the accuracy and completeness of all correspondence between the Company or its counsel and Nasdaq; and (v) as to the incumbency of
        the officers of the Company. The documents referred to in such certificate shall be attached to such certificate.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">4.5 <font style="font-weight: bold;"><u>No Material Changes</u></font>. Prior to and on each of the Closing Date and the Option Closing Date, if any, (i) there shall have been no material adverse
        change or development involving a prospective material adverse change in the condition or prospects or the business activities, financial or otherwise, of the Company from the latest dates as of which such condition is set forth in the Registration
        Statement and the Prospectus; (ii) no action suit or proceeding, at law or in equity, shall have been pending or threatened against the Company or any Insider before or by any court or federal, foreign or state commission, board or other
        administrative agency wherein an unfavorable decision, ruling or finding may materially adversely affect the business, operations, or financial condition or income of the Company, except as set forth in the Registration Statement and the
        Prospectus; (iii) no stop order shall have been issued under the Act and no proceedings therefor shall have been initiated or, to the Company&#8217;s knowledge, assuming reasonable inquiry, threatened by the Commission; and (iv) the Registration
        Statement, the Sale Preliminary Prospectus and the Prospectus and any amendments or supplements thereto shall contain all material statements which are required to be stated therein in accordance with the Act and the Regulations and shall conform
        in all material respects to the requirements of the Act and the Regulations, and neither the Registration Statement, the Sale Preliminary Prospectus nor the Prospectus nor any amendment or supplement thereto shall contain any untrue statement of a
        material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">4.6. <font style="font-weight: bold;"><u>Delivery of Agreements</u></font>. On the Effective Date, the Company shall have delivered to the Representative executed copies of the Transaction
        Documents.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">4.7. <font style="font-weight: bold;"><u>Private Placement</u></font>. On the Closing Date and the Option Closing Date, if any, the Private Placement shall have been completed in accordance with <u>Section



          3.24</u> and the required proceeds of the Private Placement shall have been wired into the Trust Account one Business Day prior to the Closing Date or Option Closing Date, if any.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">4.8. <font style="font-weight: bold;"><u>Good Standing</u></font>. The Representative shall have received on and as of (i) the Effective Date, and (ii) the Closing Date or the Option Closing Date,
        as the case may be, satisfactory evidence of the good standing of the Company in its jurisdiction of organization in writing or any standard form of telecommunication from the appropriate governmental authorities of such jurisdiction.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">4.9. <font style="font-weight: bold;"><u>Trust Waiver</u></font>. On and as of the Effective Date, the Company shall have received waivers from all vendors and service providers to all claims on
        amounts in the Trust Account which are to be distributed to the Company&#8217;s shareholders in accordance with the terms of the Trust Agreement, except for Adeptus.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div>5. <font style="font-weight: bold;"><u>Indemnification</u></font>.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">5.1. <font style="font-weight: bold;"><u>Indemnification of the Underwriters</u></font>.&#160; The Company agrees to indemnify and hold harmless each Underwriter, its affiliates and their respective
        partners, members, directors, officers, employees and agents, and each person, if any, who controls each Underwriter or any affiliate within the meaning of Section 15 of the Act or Section 20 of the Exchange Act (each, an &#8220;<font style="font-weight: bold;">Indemnified Person</font>&#8221;) as follows:</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 108pt;">(a). against any and all loss, liability, claim, damage and expense whatsoever, as reasonably incurred, joint or several, arising out of or based upon any untrue statement or alleged untrue
        statement of a material fact contained in the Registration Statement (or any amendment thereto), or the omission or alleged omission therefrom of a material fact required to be stated therein or necessary to make the statements therein not
        misleading, or arising out of any untrue statement or alleged untrue statement of a material fact included in any Preliminary Prospectus, the Sale Preliminary Prospectus, any Testing-the-Waters Communication or the Prospectus or, in the event a
        Business Combination Advisor, in its sole judgment, may be deemed to be an underwriter of any Business Combination Securities, any Business Combination Securities Disclosure Document (or any amendment or supplement to the foregoing), or the
        omission or alleged omission therefrom of a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading;</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 108pt;">(b). against any and all loss, liability, claim, damage and expense whatsoever, as reasonably incurred, joint or several, to the extent of the aggregate amount paid in settlement of any
        litigation, or any investigation or proceeding by any governmental authority, commenced or threatened, or of any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or omission; provided that
        (subject to <u>Section 5.4</u>) any such settlement is effected with the written consent of the Company, which consent shall not unreasonably be delayed, conditioned or withheld;</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 108pt;">(c). against any and all claims, actions, suits, proceedings, damages, liabilities and expenses reasonably incurred by any of them (including the reasonable fees and expenses of counsel), as
        incurred, that are related to or arise out of any business combination marketing or capital markets advisory activities by any Underwriter on the Company&#8217;s behalf in connection with a Business Combination, provided that the Company will not,
        however, be responsible to an Indemnified Person for any portion of any such claim, action, suit, proceeding, damage, liability or expense that is finally judicially determined by a court of competent jurisdiction (not subject to further appeal) to
        have resulted primarily and directly from the bad faith or gross negligence of the Indemnified Person seeking such indemnification; and</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 108pt;">(d). against any and all expense whatsoever (including the fees and disbursements of counsel), as reasonably incurred in investigating, preparing, pursuing or defending against any litigation, or
        any investigation or proceeding by any governmental authority, whether or not pending, commenced or threatened, or any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or omission (whether or
        not a party), to the extent that any such expense is not paid under (<u>a</u>), (<u>b</u>) or (<u>c</u>) above;</div>
      <div><br>
      </div>
      <div style="text-align: justify;">provided, however, that the foregoing agreement shall not apply to any loss, liability, claim, damage or expense to the extent arising out of any untrue statement or omission or alleged untrue statement or omission
        made solely in reliance upon and in conformity with the Underwriters&#8217; Information (and, in connection with any Business Combination, similar information provided by or on behalf of the Business Combination Advisors expressly for use in any Business
        Combination Securities Disclosure Document).</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">5.2. <font style="font-weight: bold;"><u>Indemnification of the Company</u></font>. Each Underwriter agrees, severally and not jointly, to indemnify and hold harmless the Company, and its
        directors, each officer of the Company who signed the Registration Statement and each person, if any, who controls the Company within the meaning of Section 15 of the Act or Section 20 of the Exchange Act, against any and all loss, liability,
        claim, damage and expense described in the indemnity contained in <u>Section 5.1</u>, as incurred, but only with respect to untrue statements or omissions, or alleged untrue statements or omissions, made in the Registration Statement, any
        Preliminary Prospectus, the Sale Preliminary Prospectus, any Testing-the-Waters Communication or the Prospectus (or any amendment or supplement to the foregoing), in reliance upon and in conformity with the Underwriters&#8217; Information.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">5.3 <font style="font-weight: bold;"><u>Notifications and Other Indemnification Procedures</u></font>.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">5.3.1. Any party that proposes to assert the right to be indemnified under this <u>Section 5</u> will, promptly after receipt of notice of commencement of any action against such party in respect
        of which a claim is to be made against an indemnifying party or parties under this <u>Section 5.3</u>, notify each such indemnifying party of the commencement of such action, enclosing a copy of all papers served, but the omission so to notify
        such indemnifying party will not relieve the indemnifying party from (i) any liability that it might have to any indemnified party otherwise than under this <u>Section 5</u> and (ii) any liability that it may have to any indemnified party under
        the foregoing provision of this <u>Section 5</u> unless, and only to the extent that, such omission results in the forfeiture of substantive rights or defenses by the indemnifying party. If any such action is brought against any indemnified party
        and it notifies the indemnifying party of its commencement, the indemnifying party will be entitled to participate in and, to the extent that it elects by delivering written notice to the indemnified party promptly of receiving notice of the
        commencement of the action from the indemnified party, jointly with any other indemnifying party similarly notified, to assume the defense of, the action, with counsel reasonably satisfactory to the indemnified party, and after notice from the
        indemnifying party to the indemnified party of its election to assume the defense, the indemnifying party will not be liable to the indemnified party for any other legal expenses except as provided below and except for the reasonable and documented
        out-of-pocket costs of investigation subsequently incurred by the indemnified party in connection with the defense. The indemnified party will have the right to employ its own counsel in any such action, but the fees, expenses and other charges of
        such counsel will be at the expense of such indemnified party unless (A) the employment of counsel by the indemnified party has been authorized in writing by the indemnifying party, (B) the indemnified party has reasonably concluded (based on
        advice of counsel) that there may be legal defenses available to it or other indemnified parties that are different from or in addition to those available to the indemnifying party, (C) a conflict or potential conflict exists (based on advice of
        counsel to the indemnified party) between the indemnified party and the indemnifying party (in which case the indemnifying party will not have the right to direct the defense of such action on behalf of the indemnified party), or (D) the
        indemnifying party has not in fact employed counsel to assume the defense of such action or counsel reasonably satisfactory to the indemnified party, in each case, within a reasonable time after receiving notice of the commencement of the action;
        in each of which cases the reasonable fees, disbursements and other charges of counsel will be at the expense of the indemnifying party or parties. It is understood that the indemnifying party or parties shall not, in connection with any proceeding
        or related proceedings in the same jurisdiction, be liable for the reasonable fees, disbursements and other charges of more than one separate firm admitted to practice in such jurisdiction (plus local counsel) at any one time for all such
        indemnified party or parties. All such fees, disbursements and other charges will be reimbursed by the indemnifying party promptly as they are incurred. An indemnifying party will not, in any event, be liable for any settlement of any action or
        claim effected without its written consent. No indemnifying party shall, without the prior written consent of each indemnified party, settle or compromise or consent to the entry of any judgment in any pending or threatened claim, action or
        proceeding relating to the matters contemplated by this <u>Section 5</u> (whether or not any indemnified party is a party thereto), unless such settlement, compromise or consent (x) includes an express and unconditional release of each indemnified
        party, in form and substance reasonably satisfactory to such indemnified party, from all liability arising out of such litigation, investigation, proceeding or claim and (y) does not include a statement as to or an admission of fault, culpability
        or a failure to act by or on behalf of any indemnified party.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">5.4. <font style="font-weight: bold;"><u>Settlement Without Consent if Failure to Reimburse</u></font>. If an indemnified party shall have requested an indemnifying party to reimburse the
        indemnified party for reasonable fees and expenses of counsel, such indemnifying party agrees that it shall be liable for any settlement of the nature contemplated by <u>Section 5.1(b)</u> effected without its written consent if (i) such
        settlement is entered into more than forty-five (45) days after receipt by such indemnifying party of the aforesaid request, (ii) such indemnifying party shall have received notice of the terms of such settlement at least thirty (30) days prior to
        such settlement being entered into and (iii) such indemnifying party shall not have reimbursed such indemnified party in accordance with such request prior to the date of such settlement.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">5.5.<font style="font-weight: bold;">&#160;<u>Contribution</u></font>.&#160; In order to provide for just and equitable contribution in circumstances in which the indemnification provided for in the
        foregoing paragraphs of <u>Section 5.1</u> is applicable in accordance with its terms but for any reason is held to be unavailable or insufficient from the Company or the Underwriters, the Company and the Underwriters will contribute to the total
        losses, claims, liabilities, expenses and damages (including any investigative, legal and other expenses reasonably incurred in connection with, and any amount paid in settlement of, any action, suit or proceeding or any claim asserted) to which
        any indemnified party may be subject in such proportion as shall be appropriate to reflect the relative benefits received by the Company on the one hand and the Underwriters on the other hand. The relative benefits received by the Company on the
        one hand and the Underwriters on the other hand shall be deemed to be in the same proportion as the total net proceeds from the sale of the Public Securities (before deducting expenses) received by the Company bear to the total compensation
        received by the Underwriters (before deducting expenses) from the sale of the Units on behalf of the Company. If, but only if, the allocation provided by the foregoing sentence is not permitted by applicable law, the allocation of contribution
        shall be made in such proportion as is appropriate to reflect not only the relative benefits referred to in the foregoing sentence but also the relative fault of the Company, on the one hand, and the Underwriters, on the other hand, with respect to
        the statements or omissions that resulted in such loss, claim, liability, expense or damage, or action in respect thereof, as well as any other relevant equitable considerations with respect to such offering. Such relative fault shall be determined
        by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by the Company or the Underwriters, the intent of the
        parties and their relative knowledge, access to information and opportunity to correct or prevent such statement or omission. The Company and the Underwriters agree that it would not be just and equitable if contributions pursuant to this <u>Section



          5.5</u> were to be determined by pro rata allocation or by any other method of allocation that does not take into account the equitable considerations referred to herein. The amount paid or payable by an indemnified party as a result of the loss,
        claim, liability, expense or damage, or action in respect thereof, referred to above in this <u>Section 5.5</u> shall be deemed to include, for the purpose of this <u>Section 5.5</u>, any legal or other expenses reasonably incurred by such
        indemnified party in connection with investigating or defending any such action or claim to the extent consistent with <u>Section 5.3</u>. Notwithstanding the foregoing provisions of <u>Section 5.1</u> and this <u>Section 5.5</u>, each
        Underwriter shall not be required to contribute any amount in excess of the commissions actually received by it under this Agreement and no person found guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Act) will be
        entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. For purposes of this <u>Section 5.5</u>, any person who controls a party to this Agreement within the meaning of the Act, any affiliates of the
        respective Underwriters and any officers, directors, partners, employees or agents of the Underwriters or their respective affiliates, will have the same rights to contribution as that party, and each director of the Company and each officer of the
        Company who signed the Registration Statement will have the same rights to contribution as the Company, subject in each case to the provisions hereof. Any party entitled to contribution, promptly after receipt of notice of commencement of any
        action against such party in respect of which a claim for contribution may be made under this <u>Section 5.5</u>, will notify any such party or parties from whom contribution may be sought, but the omission to so notify will not relieve that party
        or parties from whom contribution may be sought from any other obligation it or they may have under this <u>Section 5.5</u> except to the extent that the failure to so notify such other party materially prejudiced the substantive rights or
        defenses of the party from whom contribution is sought. Except for a settlement entered into pursuant to the last sentence of <u>Section 5.3</u>, no party will be liable for contribution with respect to any action or claim settled without its
        written consent if such consent is required pursuant to <u>Section 5.3</u>.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div>6. <font style="font-weight: bold;"><u>Default by an Underwriter</u></font>.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">6.1. <font style="font-weight: bold;"><u>Default Not Exceeding 10% of Firm Units</u></font>. If any Underwriter or Underwriters shall default in its or their obligations to purchase the Firm Units
        and if the number of the Firm Units with respect to which such default relates does not exceed in the aggregate 10% of the number of Firm Units that all Underwriters have agreed to purchase hereunder, then such Firm Units to which the default
        relates shall be purchased by the non-defaulting Underwriters in proportion to their respective commitments hereunder.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">6.2. <font style="font-weight: bold;"><u>Default Exceeding 10% of Firm Units</u></font>. In the event that the default addressed in <u>Section 6.1</u> above relates to more than 10% of the Firm
        Units, the Representative may, in its discretion, arrange for it or for another party or parties satisfactory to the Company to purchase such Firm Units to which such default relates on the terms contained herein. If within one (1) Business Day
        after such default relating to more than 10% of the Firm Units the Representative does not arrange for the purchase of such Firm Units, then the Company shall be entitled to a further period of one (1) Business Day within which to procure another
        party or parties satisfactory to the Representative to purchase said Firm Units on such terms. In the event that neither the Representative nor the Company arrange for the purchase of the Firm Units to which a default relates as provided in this <u>Section



          6</u>, this Agreement may be terminated by the Representative or the Company without liability on the part of the Company (except as provided in <u>Sections 3.9</u>, <u>5</u>, and <u>9.3</u> hereof) or the several Underwriters (except as
        provided in <u>Section 5</u> hereof); provided that nothing herein shall relieve a defaulting Underwriter of its liability, if any, to the other several Underwriters and to the Company for damages occasioned by its default hereunder.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">6.3. <font style="font-weight: bold;"><u>Postponement of Closing Date</u></font>. In the event that the Firm Units to which the default relates are to be purchased by the non-defaulting
        Underwriters, or are to be purchased by another party or parties as aforesaid, the Representative or the Company shall have the right to postpone the Closing Date for a reasonable period, but not in any event exceeding five (5) Business Days, in
        order to effect whatever changes may thereby be made necessary in the Registration Statement and/or the Prospectus, as the case may be, or in any other documents and arrangements, and the Company agrees to file promptly any amendment to, or to
        supplement, the Registration Statement and/or the Prospectus, as the case may be, that in the reasonable opinion of counsel for the Underwriters may thereby be made necessary. The term &#8220;<font style="font-weight: bold;">Underwriter</font>&#8221; as used
        in this Agreement shall include any party substituted under this <u>Section 6</u> with like effect as if it had originally been a party to this Agreement with respect to such securities.</div>
      <div><br>
      </div>
      <div>7. <font style="font-weight: bold;"><u>Additional Covenants</u></font>.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">7.1. <font style="font-weight: bold;"><u>Additional Shares or Options</u></font>. The Company hereby agrees that, until the consummation of a Business Combination, it shall not issue any Ordinary
        Shares or any options or other securities convertible into Ordinary Shares, or any preferred shares or other securities of the Company that participate in any manner in the Trust Account or that vote as a class with the Ordinary Shares on a
        Business Combination.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">7.2 <font style="font-weight: bold;"><u>Trust Account Waiver Acknowledgments</u></font>. The Company hereby agrees that it will use its reasonable best efforts prior to commencing its due
        diligence investigation of any prospective Target Business or prior to obtaining the services of any vendor to have such Target Business and/or vendor, as applicable, acknowledge in writing whether through a letter of intent, memorandum of
        understanding or other similar document (and subsequently acknowledges the same in any definitive document replacing any of the foregoing), that: (a) it has read the Prospectus and understands that the Company has established the Trust Account,
        initially in an amount of $200,000,000 (without giving effect to any exercise of the Over-allotment Option) for the benefit of the Public Shareholders and that, except for a portion of the interest earned on the amounts held in the Trust Account,
        the Company may disburse monies from the Trust Account only (i) to the Public Shareholders in the event they elect to redeem Public Shares in connection with the consummation of a Business Combination, (ii) to the Public Shareholders in the event
        they elect to redeem Public Shares in connection with a shareholder vote to amend the Charter Documents to modify the substance and timing of the Company&#8217;s obligation to redeem 100% of the Public Shares if the Company does not complete its initial
        Business Combination within the completion window, (iii) to the Public Shareholders if the Company fails to consummate a Business Combination within the time period set forth in the Charter Documents, or (iv) to the Company after or concurrently
        with the consummation of a Business Combination; and (b) for and in consideration of the Company (i) agreeing to evaluate such Target Business for purposes of consummating a Business Combination with it or (ii) agreeing to engage the services of
        the vendor, as the case may be, such Target Business or vendor agrees that it does not have any right, title, interest or claim of any kind in or to any monies in the Trust Account (&#8220;<font style="font-weight: bold;">Claim</font>&#8221;) and waives any
        Claim it may have in the future as a result of, or arising out of, any negotiations, contracts or agreements with the Company and will not seek recourse against the Trust Account for any reason whatsoever. The Company may forego obtaining such
        waivers only if the Company shall have received the approval of its Chief Executive Officer and the approving vote of at least a majority of its Board of Directors.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">7.3 <font style="font-weight: bold;"><u>Insider Letter and Non-Sponsor Investor Letter</u></font>. The Company shall not take any action or omit to take any action which would cause a breach of
        the Insider Letter or the Non-Sponsor Investor Letter and will not allow any amendments to, or waivers of, such Insider Letter and the Non-Sponsor Investor Letter without the prior written consent of the Representative, which consent shall not be
        unreasonably delayed, conditioned or withheld by the Representative.</div>
      <div> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">7.4 <font style="font-weight: bold;"><u>Rule 419</u></font>. The Company agrees that it will use its commercially reasonable efforts to prevent the Company from becoming subject to Rule 419 under
        the Act prior to the consummation of any Business Combination, including but not limited to using its commercially reasonable efforts to prevent any of the Company&#8217;s outstanding securities from being deemed to be a &#8220;penny stock&#8221; as defined in Rule
        3a-51-1 under the Exchange Act during such period.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">7.5 <font style="font-weight: bold;"><u>Tender Offer Documents, Proxy Materials and Other Information</u></font>. The Company shall provide to the Representative or their counsel (if so instructed
        by the Representative) with ten (10) copies of all tender offer documents or proxy information and all related material filed with the Commission in connection with a Business Combination concurrently with such filing with the Commission. Documents
        filed with the Commission pursuant to its EDGAR system shall be deemed to have been provided to the Representative pursuant to this <u>Section 7.5</u>. In addition, the Company shall furnish any other state in which its initial public offering was
        registered, such information as may be requested by such state.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">7.6 <font style="font-weight: bold;"><u>Emerging Growth Company</u></font>. The Company shall promptly notify the Representative if the Company ceases to be an Emerging Growth Company at any time
        prior to the completion of the distribution of the Public Securities within the meaning of the Act.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">7.7 <font style="font-weight: bold;"><u>Target Net Assets</u></font>. The Company agrees that, so long as the Company is listed on a national securities exchange, the Target Business that it
        acquires must have a fair market value equal to at least 80% of the balance in the Trust Account at the time of signing the definitive agreement for the Business Combination with such Target Business (excluding taxes payable). The fair market value
        of such business must be determined by the Board of Directors of the Company based upon standards generally accepted by the financial community, such as actual and potential sales, earnings, cash flow and book value. If the Board of Directors of
        the Company is not able to independently determine that the Target Business meets such fair market value requirement, the Company will obtain an opinion from an independent investment banking firm or another independent entity that commonly renders
        valuation opinions with respect to the satisfaction of such criteria. The Company is not required to obtain an opinion as to the fair market value if the Company&#8217;s Board of Directors independently determines that the Target Business does have
        sufficient fair market value.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">7.8 <font style="font-weight: bold;"><u>Representations and Agreements to Survive Delivery</u></font>. Except as the context otherwise requires, all representations, warranties and agreements
        contained in this Agreement shall be deemed to be representations, warranties and agreements as of the Closing Date or the Option Closing Date, if any, and such representations, warranties and agreements of the Underwriters and the Company,
        including the indemnity agreements contained in <u>Section 5</u> hereof, shall remain operative and in full force and effect regardless of any investigation made by or on behalf of the Underwriters, the Company or any controlling person, and shall
        survive termination of this Agreement or the issuance and/or delivery of the Public Securities to the Underwriters until the earlier of the expiration of any applicable statute of limitations and the seventh (7th) anniversary of the later of the
        Closing Date or the Option Closing Date, if any, at which time the representations, warranties and agreements shall terminate and be of no further force and effect.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div><font style="font-weight: bold;">8. <u>Effective Date of this Agreement and Termination</u></font>.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">8.1. <font style="font-weight: bold;"><u>Effective Date</u></font>. This Agreement shall become effective on the Effective Date at the time the Registration Statement is declared effective by the
        Commission.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">8.2. <font style="font-weight: bold;"><u>Termination</u></font>. The Representative shall have the right to terminate this Agreement at any time prior to the Closing Date by notice given to the
        Company, (i) if any domestic or international event or act or occurrence has materially disrupted, or in the Representative&#8217;s opinion will in the immediate future materially disrupt, general securities markets in the United States; or (ii) if
        trading on the New York Stock Exchange (&#8220;<font style="font-weight: bold;">NYSE</font>&#8221;), the NYSE American, The Nasdaq Global Select Market, The Nasdaq Global Market, or The Nasdaq Capital Market or quotation on the OTCBB shall have been suspended,
        or minimum or maximum prices for trading shall have been fixed, or maximum ranges for prices for securities shall have been fixed, or maximum ranges for prices for securities shall have been required by FINRA or by order of the Commission or any
        other government authority having jurisdiction; or (iii) if the United States shall have become involved in a new war or a significant increase in existing major hostilities; or (iv) if a banking moratorium has been declared by a New York State or
        Federal authority; or (v) if a moratorium on foreign exchange trading has been declared which materially adversely impacts the United States securities market; or (vi) if the Company shall have sustained a material loss by fire, flood, accident,
        hurricane, earthquake, theft, sabotage or other calamity (including, without limitation, a calamity relating to a public health matter or natural disaster) or malicious act which, whether or not such loss shall have been insured, will, in the
        Representative&#8217;s opinion, make it inadvisable to proceed with the delivery of the Units; or (vii) if the Company is in material breach of any of its representations, warranties or covenants hereunder; or (viii) if the Representative shall have
        become aware after the date hereof of such a material adverse change in the conditions of the Company, or such adverse material change in general market conditions, including without limitation, as a result of terrorist activities or any other
        calamity (including, without limitation, a calamity relating to a public health matter or natural disaster) or crisis either within or outside the United States after the date hereof, or a significant increase in any of the foregoing, as in the
        Representative&#8217;s judgment would make it impracticable to proceed with the offering, sale and/or delivery of the Units or to enforce contracts made by the Underwriters for the sale of the Public Securities.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">8.3. <font style="font-weight: bold;"><u>Expenses</u></font>. In the event that this Agreement shall not be carried out for any reason other than solely because of the termination of this
        Agreement pursuant to <u>Section 6</u> hereof, within the time specified herein or any extensions thereof pursuant to the terms herein, (i) the obligations of the Company to pay the out of pocket expenses related to the transactions contemplated
        herein shall be governed by <u>Section 3.9</u> hereof (ii) the Company shall reimburse the Representatives for any reasonable and documented out-of-pocket costs and expenses incurred in connection with enforcing any provisions of this Agreement.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">8.4. <font style="font-weight: bold;"><u>Indemnification</u></font>. Notwithstanding any contrary provision contained in this Agreement, any election hereunder or any termination of this
        Agreement, and whether or not this Agreement is otherwise carried out, the provisions of <u>Section 5</u> shall not be in any way affected by such election or termination or failure to carry out the terms of this Agreement or any part hereof and
        (ii) the Company shall reimburse the Representatives for any reasonable and documented out-of-pocket costs and expenses incurred in connection with enforcing any provisions of this Agreement.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">8.5. <font style="font-weight: bold;"><u>Representations, Warranties, Agreements to Survive</u></font>. All representations, warranties and agreements contained in this Agreement or in
        certificates of officers of the Company submitted pursuant hereto, shall remain operative and in full force and effect regardless of (i) any investigation made by or on behalf of any Underwriter or its affiliates or selling agents, any person
        controlling any Underwriter, its officers or directors or any person controlling the Company or (ii) delivery of and payment for the Public Securities, until the later of the expiration of any applicable statute of limitations and the seventh (7th)
        anniversary of the later of the Closing Date or the Option Closing Date, if any, at which time the representations, warranties and agreements shall terminate and be of no further force and effect.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div>9. <font style="font-weight: bold;"><u>General Provisions</u></font>.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">9.1. <font style="font-weight: bold;"><u>Notices</u></font>. All communications hereunder, except as herein otherwise specifically provided, shall be in writing and shall be mailed (registered or
        certified mail, return receipt requested), personally delivered or sent by facsimile or electronic transmission and confirmed and shall be deemed given when so delivered or emailed and confirmed (which may be by email) or if mailed, two (2) days
        after such mailing.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">If to the Representative:</div>
      <div><br>
      </div>
      <div style="margin-left: 72pt;">D. Boral Capital LLC</div>
      <div style="text-indent: 36pt; margin-left: 36pt;">590 Madison Avenue, 39th Floor</div>
      <div style="text-indent: 36pt; margin-left: 36pt;">New York, NY 10022</div>
      <div style="text-indent: 36pt; margin-left: 36pt;">USA</div>
      <div style="margin-left: 72pt;">Attention:</div>
      <div style="margin-left: 72pt;">Fax No: +1</div>
      <div style="margin-left: 72pt;">E-Mail:</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">with a copy (which shall not constitute notice) to:</div>
      <div><br>
      </div>
      <div style="margin-left: 72pt;">Jeffrey C. Selman, Esq.</div>
      <div style="margin-left: 72pt;">Elena Nrtina, Esq.</div>
      <div style="margin-left: 72pt;">DLA Piper LLP (US)</div>
      <div style="margin-left: 72pt;">555 Mission Street</div>
      <div style="margin-left: 72pt;">Suite 2400</div>
      <div style="margin-left: 72pt;">San Francisco, CA 94105-2933</div>
      <div style="margin-left: 72pt;">Email: Jeffrey.selman@us.dlapiper.com; Elena.Nrtina@us.dlapiper.com</div>
      <div style="margin-left: 72pt;">Tel: (415) 615 6095</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">If to the Company:</div>
      <div><br>
      </div>
      <div style="text-indent: 72pt;">VENDOME ACQUISITION CORPORATION I</div>
      <div style="text-indent: 36pt; margin-left: 36pt;">1090 Center Drive</div>
      <div style="text-indent: 36pt; margin-left: 36pt;">Park City, UT 84098</div>
      <div style="margin-left: 72pt;">Attention: Scott LaPorta</div>
      <div style="margin-left: 72pt;">Tel: (435) 714-7973</div>
      <div style="margin-left: 72pt;">E-Mail: Scott.Laporta@sugarfina.com</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">with copies (which shall not constitute notice) to:</div>
      <div><br>
      </div>
      <div style="margin-left: 72pt;">Gil Savir, Esq.</div>
      <div style="margin-left: 72pt;">Paul Hastings LLP</div>
      <div style="margin-left: 72pt;">200 Park Avenue</div>
      <div style="margin-left: 72pt;">New York, NY 10166</div>
      <div style="margin-left: 72pt;">Email: gilsavir@paulhastings.com</div>
      <div style="margin-left: 72pt;">Tel: (212) 318-6000</div>
      <div><br>
      </div>
      <div style="margin-left: 72pt;">Brandon J. Bortner, Esq.</div>
      <div style="margin-left: 72pt;">Paul Hastings LLP</div>
      <div style="margin-left: 72pt;">2050 M Street NW</div>
      <div style="margin-left: 72pt;">Washington, DC 20036</div>
      <div style="margin-left: 72pt;">Email: brandonbortner@paulhastings.com</div>
      <div style="margin-left: 72pt;">Tel: (202) 551-1700</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">9.2. <font style="font-weight: bold;"><u>Headings</u></font>. The headings contained herein are for the sole purpose of convenience of reference, and shall not in any way limit or affect the
        meaning or interpretation of any of the terms or provisions of this Agreement.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">9.3. <font style="font-weight: bold;"><u>Amendment</u></font>. This Agreement may only be amended by a written instrument executed by each of the parties hereto.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">9.4. <font style="font-weight: bold;"><u>Entire Agreement</u></font>. This Agreement (together with the other agreements and documents being delivered pursuant to or in connection with this
        Agreement) constitutes the entire agreement of the parties hereto with respect to the subject matter hereof and thereof, and supersedes all prior agreements and understandings of the parties, oral and written, with respect to the subject matter
        hereof.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">9.5. <font style="font-weight: bold;"><u>Binding Effect</u></font>. This Agreement shall inure solely to the benefit of and shall be binding upon the Representative, the Underwriters, the Company
        and the controlling persons, directors, agents, partners, members, employees and officers referred to in <u>Section 5</u> hereof, and their respective successors, legal representatives and assigns, and no other person shall have or be construed to
        have any legal or equitable right, remedy or claim under or in respect of or by virtue of this Agreement or any provisions herein contained. The term &#8220;<font style="font-weight: bold;">successors and assigns</font>&#8221; shall not include a purchaser, in
        its capacity as such, of securities from any of the Underwriters.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">9.6. <font style="font-weight: bold;"><u>Waiver of Immunity</u></font>. To the extent that the Company may be entitled in any jurisdiction in which judicial proceedings may at any time be
        commenced hereunder, to claim for itself or its revenues or assets any immunity, including sovereign immunity, from suit, jurisdiction, attachment in aid of execution of a judgment or prior to a judgment, execution of a judgment or any other legal
        process with respect to its obligations hereunder and to the extent that in any such jurisdiction there may be attributed to the Company such an immunity (whether or not claimed), the Company hereby irrevocably agrees not to claim and irrevocably
        waives such immunity to the maximum extent permitted by law.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">9.7. <font style="font-weight: bold;"><u>Submission to Jurisdiction</u></font>. Each of the Company and the Representative irrevocably submits to the non-exclusive jurisdiction of any New York
        State or United States Federal court sitting in the City of New York, Borough of Manhattan, over any suit, action or proceeding arising out of or relating to this Agreement, the Registration Statement, the Sale Preliminary Prospectus and the
        Prospectus or the offering of the Securities. Each of the Company and the Representative irrevocably waives, to the fullest extent permitted by law, any objection that they may now or hereafter have to the laying of venue of any such suit, action
        or proceeding brought in such a court and any claim that any such suit, action or proceeding brought in such a court has been brought in an inconvenient forum. Any such process or summons to be served upon the Company or the Representative may be
        served by transmitting a copy thereof by registered or certified mail, return receipt requested, postage prepaid, addressed to it at the address set forth in <u>Section 9.1</u> hereof. Such mailing shall be deemed personal service and shall be
        legal and binding upon the Company or the Representative in any action, proceeding or claim. Each of the Company and the Representative waives, to the fullest extent permitted by law, any other requirements of or objections to personal jurisdiction
        with respect thereto. Notwithstanding the foregoing, any action based on this Agreement may be instituted by the Underwriters in any competent court. The Company agrees that the Underwriters shall be entitled to recover all of their reasonable
        attorneys&#8217; fees and expenses relating to any action or proceeding and/or incurred in connection with the preparation therefor if any of them are the prevailing party in such action or proceeding. EACH PARTY HEREBY IRREVOCABLY WAIVES, TO THE FULLEST
        EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">9.8. <font style="font-weight: bold;"><u>Governing Law</u></font>. This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of New York, without
        giving effect to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">9.9. <font style="font-weight: bold;"><u>WAIVER OF TRIAL BY JURY</u></font>. The Company (on its behalf and, to the extent permitted by applicable law, on behalf of its shareholders and
        affiliates) and each of the Underwriters hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Agreement or the transactions
        contemplated hereby.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">9.10. <font style="font-weight: bold;"><u>Execution in Counterparts; Electronic Signatures</u></font>. This Agreement may be executed in one or more counterparts, and by the different parties
        hereto in separate counterparts, each of which shall be deemed to be an original, but all of which taken together shall constitute one and the same agreement, and shall become effective when one or more counterparts has been signed by each of the
        parties hereto and delivered to each of the other parties hereto. Delivery of a signed counterpart of this Agreement by facsimile, electronic mail (including pdf or any electronic signature complying with U.S. federal ESIGN Act of 2000, Uniform
        Electronic Transactions Act or other applicable law) or other transmission method and any counterpart so delivered will be deemed to have been duly and validly delivered and valid and effective for all purposes.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">9.11. <font style="font-weight: bold;"><u>Waiver</u></font>. The failure of any of the parties hereto to at any time enforce any of the provisions of this Agreement shall not be deemed or
        construed to be a waiver of any such provision, nor to in any way affect the validity of this Agreement or any provision hereof or the right of any of the parties hereto to thereafter enforce each and every provision of this Agreement. No waiver of
        any breach, non-compliance or non-fulfillment of any of the provisions of this Agreement shall be effective unless set forth in a written instrument executed by the party or parties against whom or which enforcement of such waiver is sought; and no
        waiver of any such breach, non-compliance or non-fulfillment shall be construed or deemed to be a waiver of any other or subsequent breach, non-compliance or non-fulfillment.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">9.12. <font style="font-weight: bold;"><u>No Fiduciary Relationship</u></font>. The Company acknowledges and agrees that (i) the purchase and sale of the Units pursuant to this Agreement is an
        arm&#8217;s-length commercial transaction pursuant to a contractual relationship between the Company and the Underwriters; (ii) in connection therewith and with the process leading to such transaction, each Underwriter is acting solely as a principal and
        not the agent or fiduciary of the Company; (iii) the Underwriters have not assumed an advisory or fiduciary responsibility in favor of the Company with respect to the offering contemplated hereby or the process leading thereto (irrespective of
        whether the Underwriters have advised or are currently advising the Company on other matters) or any other obligation to the Company except the obligations expressly set forth in this Agreement; (iv) in no event do the parties intend that the
        Underwriters act or be responsible as a fiduciary to the Company, its management, shareholders, creditors or any other person in connection with any activity that the Underwriters may undertake or have undertaken in furtherance of the Offering,
        either before or after the date hereof; and (v) the Company has consulted its own legal and financial advisors to the extent it deemed appropriate. The Underwriters hereby expressly disclaim any fiduciary or similar obligations to the Company,
        either in connection with the transactions contemplated by this Agreement or any matters leading up to such transactions, and the Company hereby confirms its understanding and agreement to that effect. The Company agrees that it will not claim that
        the Underwriters have rendered advisory services of any nature or respect, or owe a fiduciary or similar duty to the Company, in connection with such transaction or the process leading thereto. The Company and the Underwriters agree that they are
        each responsible for making their own independent judgment with respect to any such transactions, and that any opinions or views expressed by the Underwriters to the Company regarding such transactions, including but not limited to any opinions or
        views with respect to the price or market for the Company&#8217;s securities, do not constitute advice or recommendations to the Company. The Company hereby waives and releases, to the fullest extent permitted by law, any claims that the Company may have
        against the Underwriters with respect to any breach or alleged breach of any fiduciary or similar duty to the Company in connection with the transactions contemplated by this Agreement or any matters leading up to such transactions.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div>
        <div style="text-align: justify; text-indent: 36pt;">9.13. <font style="font-weight: bold;"><u>Recognition of the U.S. Special Resolution Regimes</u></font>. In the event that any Underwriter that is a Covered Entity (as defined below) becomes
          subject to a proceeding under a U.S. Special Resolution Regime (as defined below), the transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the
          transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt;">In the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate (as defined below) of such Underwriter becomes subject to a proceeding under a U.S. Special Resolution Regime,
          Default Rights (as defined below) under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this
          Agreement were governed by the laws of the United States or a state of the United States.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt;">For purposes of this Agreement, (a) &#8220;<font style="font-weight: bold;">BHC Act Affiliate</font>&#8221; has the meaning assigned to the term &#8220;affiliate&#8221; in, and shall be interpreted in accordance with,
          12 U.S.C. Sec. 1841(k); (b) &#8220;<font style="font-weight: bold;">Covered Entity</font>&#8221; means any of the following: (i) a &#8220;covered entity&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. Sec. 252.82(b); (ii) a &#8220;covered
          bank&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. Sec. 47.3(b); or (iii) a &#8220;covered FSI&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. Sec. 382.2(b); (c) &#8220;<font style="font-weight: bold;">Default


            Right</font>&#8221; has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. Sec.Sec. 252.81, 47.2 or 382.1, as applicable; and (d) &#8220;U.S. Special Resolution Regime&#8221; means each of (i) the Federal Deposit
          Insurance Act and the regulations promulgated thereunder and (ii) Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.</div>
      </div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div style="text-align: center;">[<font style="font-style: italic;">Signature page follows</font>]</div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">If the foregoing correctly sets forth the understanding between the Underwriters and the Company, please so indicate in the space provided below for that purpose, whereupon this letter shall
        constitute a binding agreement between us as of the date first above written.</div>
      <div><br>
      </div>
      <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zbbd538c8c793449c93e258d4c7654251" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: bottom;">
              <div style="color: #000000;">Very truly yours,</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: bottom;">
              <div style="color: #000000; font-weight: bold;">VENDOME ACQUISITION CORPORATION I</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 6%; vertical-align: bottom;">
              <div style="color: #000000;">By:</div>
            </td>
            <td style="width: 44%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 6%; vertical-align: bottom;">
              <div style="color: #000000;">Name:</div>
            </td>
            <td style="width: 44%; vertical-align: bottom;">
              <div style="color: #000000;">Scott LaPorta</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 6%; vertical-align: bottom;">
              <div style="color: #000000;">Title:</div>
            </td>
            <td style="width: 44%; vertical-align: bottom;">
              <div style="color: #000000;">Chief Executive Officer</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="text-align: justify;">Confirmed as of the date first written above on behalf of itself and as Representative of the several Underwriters named on Schedule 1 hereto:</div>
      <div><br>
      </div>
      <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zc185ec506dad4da2b42c231353a04c1c" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td colspan="2" style="vertical-align: bottom;">
              <div style="color: #000000; font-weight: bold;">D. BORAL CAPITAL LLC</div>
            </td>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: bottom; padding-bottom: 2px;">
              <div style="color: #000000;">By:</div>
            </td>
            <td style="width: 44%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: bottom;">
              <div style="color: #000000;">Name:</div>
            </td>
            <td style="width: 44%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: bottom;">
              <div style="color: #000000;">Title:</div>
            </td>
            <td style="width: 44%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <div><br>
      </div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: center; font-weight: bold;"><u>SCHEDULE 1</u></div>
      <div><br>
      </div>
      <table style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z0619bbeaaac541818239b395aa08f7d8" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Underwriter</div>
            </td>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Total Number of</div>
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Firm Units to be</div>
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Purchased</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">D. Boral Capital LLC</div>
            </td>
            <td style="width: 50%; vertical-align: top; text-align: right;">
              <div style="color: rgb(0, 0, 0);"><br>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif; text-indent: 18px;">TOTAL</div>
            </td>
            <td style="width: 50%; vertical-align: top; text-align: right;">
              <div style="color: rgb(0, 0, 0);">20,000,000</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: center; font-weight: bold;"><u>SCHEDULE 2</u></div>
      <div><br>
      </div>
      <div style="text-align: center; font-weight: bold;">Testing-the-Water Communication</div>
      <div><br>
      </div>
      <div style="text-align: center; font-weight: bold;">[_____]</div>
    </div>
    <div><br>
      <br>
    </div>
    <div> <br>
    </div>
    <div>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"> </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.2
<SEQUENCE>3
<FILENAME>ny20046456x10_ex3-2.htm
<DESCRIPTION>EXHIBIT 3.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <div style="text-align: right; font-weight: bold;">
      <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade">Exhibit 3.2</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">THE COMPANIES ACT (AS REVISED)</div>
    <div style="text-align: center; font-weight: bold;">OF THE CAYMAN ISLANDS</div>
    <div style="text-align: center; font-weight: bold;">COMPANY LIMITED BY SHARES</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">AMENDED AND RESTATED</div>
    <div style="text-align: center; font-weight: bold;">MEMORANDUM AND ARTICLES OF ASSOCIATION</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">OF</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">VENDOME ACQUISITION CORPORATION I</div>
    <div style="text-align: center; font-weight: bold;">(ADOPTED BY SPECIAL RESOLUTION DATED [DATE] AND EFFECTIVE ON [DATE])</div>
    <div><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-align: center; font-weight: bold;">THE COMPANIES ACT (AS REVISED)</div>
    <div style="text-align: center; font-weight: bold;">OF THE CAYMAN ISLANDS</div>
    <div style="text-align: center; font-weight: bold;">COMPANY LIMITED BY SHARES</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">AMENDED AND RESTATED</div>
    <div style="text-align: center; font-weight: bold;">MEMORANDUM OF ASSOCIATION</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">OF</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">VENDOME ACQUISITION CORPORATION I</div>
    <div style="text-align: center; font-weight: bold;">(ADOPTED BY SPECIAL RESOLUTION DATED [DATE] AND EFFECTIVE ON [DATE])</div>
    <div style="text-align: center;"> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z93a9607029ff41268997f8b6fcfb67be" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.11%; vertical-align: top;">&#160;</td>
          <td style="width: 3%; vertical-align: top;">
            <div style="color: #000000;">1.</div>
          </td>
          <td style="width: 97%; vertical-align: top;">
            <div style="color: #000000;">The name of the Company is <font style="font-weight: bold;">Vendome Acquisition Corporation I</font>.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z5e6396b397f341f48a274854109a3805" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3%; vertical-align: top;">
            <div style="color: #000000;">2.</div>
          </td>
          <td style="width: 97%; vertical-align: top;">
            <div style="color: #000000;">The Registered Office of the Company shall be at the offices of Maples Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands, or at such other place within the Cayman Islands
              as the Directors may decide.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="ze90a46c5a8c14ead84311680ab6e8397" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3%; vertical-align: top;">
            <div style="color: #000000;">3.</div>
          </td>
          <td style="width: 97%; vertical-align: top;">
            <div style="color: #000000;">The objects for which the Company is established are unrestricted and the Company shall have full power and authority to carry out any object not prohibited by the laws of the Cayman Islands.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z07d69eaa846843189ab4f4deef9f33d2" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.09%; vertical-align: top;">&#160;</td>
          <td style="width: 3%; vertical-align: top;">
            <div style="color: #000000;">4.</div>
          </td>
          <td style="width: 97%; vertical-align: top;">
            <div style="color: #000000;">The liability of each Member is limited to the amount unpaid on such Member&#8217;s shares.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z33cbf3e4c5d24abdbe727b897881290f" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3%; vertical-align: top;">
            <div style="color: #000000;">5.</div>
          </td>
          <td style="width: 97%; vertical-align: top;">
            <div style="color: #000000;">The share capital of the Company is US$22,100 divided into 200,000,000 Class A ordinary shares of a par value of US$0.0001 each, 20,000,000 Class B ordinary shares of a par value of US$0.0001 each and 1,000,000
              preference shares of a par value of US$0.0001 each.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zf287c1e788c844b4ac39046bd7b62cf4" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3%; vertical-align: top;">
            <div style="color: #000000;">6.</div>
          </td>
          <td style="width: 97%; vertical-align: top;">
            <div style="color: #000000;">The Company has power to register by way of continuation as a body corporate limited by shares under the laws of any jurisdiction outside the Cayman Islands and to be deregistered in the Cayman Islands.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z3a0b6a8e58954dd88aab8ee8343d89ba" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3%; vertical-align: top;">
            <div style="color: #000000;">7.</div>
          </td>
          <td style="width: 97%; vertical-align: top;">
            <div style="color: #000000;">Capitalised terms that are not defined in this Amended and Restated Memorandum of Association bear the respective meanings given to them in the Amended and Restated Articles of Association of the Company.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-align: center; font-weight: bold;">THE COMPANIES ACT (AS REVISED)</div>
    <div style="text-align: center; font-weight: bold;">OF THE CAYMAN ISLANDS</div>
    <div style="text-align: center; font-weight: bold;">COMPANY LIMITED BY SHARES</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">AMENDED AND RESTATED</div>
    <div style="text-align: center; font-weight: bold;">ARTICLES OF ASSOCIATION</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">OF</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">VENDOME ACQUISITION CORPORATION I</div>
    <div style="text-align: center; font-weight: bold;">(ADOPTED BY SPECIAL RESOLUTION DATED [DATE] AND EFFECTIVE ON [DATE])</div>
    <div style="text-align: center;"> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="ze908dbc081be4cd19b58058ee82f3676" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.45%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">1</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Interpretation</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z992bd13c6941482491684fbf5b57917f" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">1.1</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">In the Articles Table A in the First Schedule to the Statute does not apply and, unless there is something in the subject or context inconsistent therewith:</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z7caba6b0e4c2475cac64c152d9c34666" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 25%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Affiliate&#8221;</div>
          </td>
          <td style="width: 75%; vertical-align: top;">
            <div style="color: #000000;">in respect of a person, means any other person that, directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with, such person, and (a) in the case of a
              natural person, shall include, without limitation, such person&#8217;s spouse, parents, children, siblings, mother-in-law and father-in-law and brothers and sisters-in-law, whether by blood, marriage or adoption or anyone residing in such person&#8217;s
              home, a trust for the benefit of any of the foregoing, a company, partnership or any natural person or entity wholly or jointly owned by any of the foregoing and (b) in the case of an entity, shall include a partnership, a corporation or any
              natural person or entity which directly, or indirectly through one or more intermediaries, controls, is controlled by, or is under common control with, such entity.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 25%; vertical-align: top;">&#160;</td>
          <td style="width: 75%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 25%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Applicable Law&#8221;</div>
          </td>
          <td style="width: 75%; vertical-align: top;">
            <div style="color: #000000;">means, with respect to any person, all provisions of laws, statutes, ordinances, rules, regulations, permits, certificates, judgments, decisions, decrees or orders of any governmental authority applicable to such
              person.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 25%; vertical-align: top;">&#160;</td>
          <td style="width: 75%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 25%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Articles&#8221;</div>
          </td>
          <td style="width: 75%; vertical-align: top;">
            <div style="color: #000000;">means these amended and restated articles of association of the Company.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 25%; vertical-align: top;">&#160;</td>
          <td style="width: 75%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 25%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Audit Committee&#8221;</div>
          </td>
          <td style="width: 75%; vertical-align: top;">
            <div style="color: #000000;">means the audit committee of the board of directors of the Company established pursuant to the Articles, or any successor committee.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 25%; vertical-align: top;">&#160;</td>
          <td style="width: 75%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 25%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Auditor&#8221;</div>
          </td>
          <td style="width: 75%; vertical-align: top;">
            <div style="color: #000000;">means the person for the time being performing the duties of auditor of the Company (if any).</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 25%; vertical-align: top;">&#160;</td>
          <td style="width: 75%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 25%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Business Combination&#8221;</div>
          </td>
          <td style="width: 75%; vertical-align: top;">
            <div style="color: #000000;">means a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination involving the Company, with one or more businesses or entities (the &#8220;<font style="font-weight: bold;">target business</font>&#8221;), which Business Combination: (a) as long as the securities of the Company are listed on The NASDAQ Global Market, must occur with one or more target businesses that together have an
              aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding any deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time of the signing of the definitive
              agreement to enter into such Business Combination; and (b) must not be solely effectuated with another blank cheque company or a similar company with nominal operations.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;business day&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">means any day other than a Saturday, a Sunday or a legal holiday or a day on which banking institutions or trust companies are authorised or obligated by law to close in New York City.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">&#160;</td>
          <td style="width: 74.56%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Clearing House&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">means a clearing house recognised by the laws of the jurisdiction in which the Shares (or depositary receipts therefor) are listed or quoted on a stock exchange or interdealer quotation system in such jurisdiction.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">&#160;</td>
          <td style="width: 74.56%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Class A Share&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">means a Class A ordinary share of a par value of US$0.0001 in the share capital of the Company.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">&#160;</td>
          <td style="width: 74.56%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Class B Share&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">means a Class B ordinary share of a par value of US$0.0001 in the share capital of the Company.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">&#160;</td>
          <td style="width: 74.56%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Company&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">means the above named company.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">&#160;</td>
          <td style="width: 74.56%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Company&#8217;s Website&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">means the website of the Company and/or its web-address or domain name (if any).</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">&#160;</td>
          <td style="width: 74.56%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Compensation Committee&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">means the compensation committee of the board of directors of the Company established pursuant to the Articles, or any successor committee.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">&#160;</td>
          <td style="width: 74.56%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Designated Stock Exchange&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">means any United States national securities exchange on which the securities of the Company are listed for trading, including The NASDAQ Global Market.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">&#160;</td>
          <td style="width: 74.56%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Directors&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">means the directors for the time being of the Company.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">&#160;</td>
          <td style="width: 74.56%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Dividend&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">means any dividend (whether interim or final) resolved to be paid on Shares pursuant to the Articles.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">&#160;</td>
          <td style="width: 74.56%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Electronic Communication&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">means a communication sent by electronic means, including electronic posting to the Company&#8217;s Website, transmission to any number, address or internet website (including the website of the Securities and Exchange
              Commission) or other electronic delivery methods as otherwise decided and approved by the Directors.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">&#160;</td>
          <td style="width: 74.56%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Electronic Record&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">has the same meaning as in the Electronic Transactions Act.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">&#160;</td>
          <td style="width: 74.56%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Electronic Transactions Act&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">means the Electronic Transactions Act (As Revised) of the Cayman Islands.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">&#160;</td>
          <td style="width: 74.56%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Equity-linked Securities&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">means any debt or equity securities that are convertible, exercisable or exchangeable for Class A Shares issued in a financing transaction in connection with a Business Combination, including but not limited to a
              private placement of equity or debt.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">&#160;</td>
          <td style="width: 74.56%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Exchange Act&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">means the United States Securities Exchange Act of 1934, as amended, or any similar United States federal statute and the rules and regulations of the Securities and Exchange Commission thereunder, all as the same
              shall be in effect at the time.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">&#160;</td>
          <td style="width: 74.56%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Founders&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">means all Members immediately prior to the consummation of the IPO.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">&#160;</td>
          <td style="width: 74.56%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Independent Director&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">has the same meaning as in the rules and regulations of the Designated Stock Exchange or in Rule 10A-3 under the Exchange Act, as the case may be.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">&#160;</td>
          <td style="width: 74.56%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;IPO&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">means the Company&#8217;s initial public offering of securities.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">&#160;</td>
          <td style="width: 74.56%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Member&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">has the same meaning as in the Statute.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Memorandum&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">means the amended and restated memorandum of association of the Company.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">&#160;</td>
          <td style="width: 74.56%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Nominating and Corporate Governance Committee&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">means the nominating and corporate governance committee of the board of directors of the Company established pursuant to the Articles, or any successor committee.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">&#160;</td>
          <td style="width: 74.56%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Officer&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">means a person appointed to hold an office in the Company.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">&#160;</td>
          <td style="width: 74.56%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Ordinary Resolution&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">means a resolution passed by a simple majority of the Members as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at a general meeting, and includes a unanimous written resolution. In
              computing the majority when a poll is demanded regard shall be had to the number of votes to which each Member is entitled by the Articles.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">&#160;</td>
          <td style="width: 74.56%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Over-Allotment Option&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">means the option of the Underwriters to purchase up to an additional 15% of the firm units (as described in the Articles) issued in the IPO at a price equal to US$10 per unit, less underwriting discounts and
              commissions.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">&#160;</td>
          <td style="width: 74.56%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Preference Share&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">means a preference share of a par value of US$0.0001 in the share capital of the Company.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">&#160;</td>
          <td style="width: 74.56%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Public Share&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">means a Class A Share issued as part of the units (as described in the Articles) issued in the IPO.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">&#160;</td>
          <td style="width: 74.56%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Redemption Notice&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">means a notice in a form approved by the Company by which a holder of Public Shares is entitled to require the Company to redeem its Public Shares, subject to any conditions contained therein.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">&#160;</td>
          <td style="width: 74.56%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Register of Members&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">means the register of Members maintained in accordance with the Statute and includes (except where otherwise stated) any branch or duplicate register of Members.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">&#160;</td>
          <td style="width: 74.56%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Registered Office&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">means the registered office for the time being of the Company.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">&#160;</td>
          <td style="width: 74.56%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Representative&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">means a representative of the Underwriters.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">&#160;</td>
          <td style="width: 74.56%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Seal&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">means the common seal of the Company and includes every duplicate seal.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">&#160;</td>
          <td style="width: 74.56%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Securities and Exchange Commission&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">means the United States Securities and Exchange Commission.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">&#160;</td>
          <td style="width: 74.56%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Share&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">means a Class A Share, a Class B Share or a Preference Share and includes any class or series, and a fraction, of a share in the Company.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">&#160;</td>
          <td style="width: 74.56%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Special Resolution&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">subject to Articles 29.4 and 47.2, has the same meaning as in the Statute, and includes a unanimous written resolution.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">&#160;</td>
          <td style="width: 74.56%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Sponsor&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">means Vendome Acquisition Sponsor I LLC, a Cayman Islands limited liability company, and its successors or assigns.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">&#160;</td>
          <td style="width: 74.56%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Statute&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">means the Companies Act (As Revised) of the Cayman Islands.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">&#160;</td>
          <td style="width: 74.56%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Tax Filing Authorised Person&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">means such person as any Director shall designate from time to time, acting severally.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">&#160;</td>
          <td style="width: 74.56%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Treasury Share&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">means a Share held in the name of the Company as a treasury share in accordance with the Statute.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Trust Account&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">means the trust account established by the Company upon the consummation of the IPO and into which a certain amount of the net proceeds of the IPO, together with a certain amount of the proceeds of a private
              placement of securities simultaneously with the closing date of the IPO or otherwise, will be deposited.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">&#160;</td>
          <td style="width: 74.56%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 24.89%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">&#8220;Underwriter&#8221;</div>
          </td>
          <td style="width: 74.56%; vertical-align: top;">
            <div style="color: #000000;">means an underwriter of the IPO from time to time and any successor underwriter.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
  </div>
  <div>
    <table id="zd74aa4d01eb04da1840111b783f0f254" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0%;">
            <div>&#160;</div>
          </td>
          <td style="width: 4%;">1.2</td>
          <td style="width: 96%;">In the Articles: </td>
        </tr>

    </table>
  </div>
  <div>&#160; <br>
    <div style="text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;words importing the singular number include the plural number and vice versa;</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;words importing the masculine gender include the feminine gender;</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;words importing persons include corporations as well as any other legal or natural person;</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;written&#8221; and &#8220;in writing&#8221; include all modes of representing or reproducing words in visible form, including in the form of an Electronic Record;</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;shall&#8221; shall be construed as imperative and &#8220;may&#8221; shall be construed as permissive;</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;references to provisions of any law or regulation shall be construed as references to those provisions as amended, modified, re-enacted or replaced;</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any phrase introduced by the terms &#8220;including&#8221;, &#8220;include&#8221;, &#8220;in particular&#8221; or any similar expression shall be construed as illustrative and shall not limit the sense of the words preceding those terms;</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the term &#8220;and/or&#8221; is used to mean both &#8220;and&#8221; as well as &#8220;or.&#8221; The use of &#8220;and/or&#8221; in certain contexts in no respects qualifies or modifies the use of the terms &#8220;and&#8221; or &#8220;or&#8221; in others. The term &#8220;or&#8221; shall
      not be interpreted to be exclusive and the term &#8220;and&#8221; shall not be interpreted to require the conjunctive (in each case, unless the context otherwise requires);</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;headings are inserted for reference only and shall be ignored in construing the Articles;</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any requirements as to delivery under the Articles include delivery in the form of an Electronic Record;</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; any requirements as to execution or signature under the Articles including the execution of the Articles themselves can be satisfied in the form of an electronic signature as defined in the Electronic
      Transactions Act;</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">(l)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;sections 8 and 19(3) of the Electronic Transactions Act shall not apply;</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">(m)&#160;&#160;&#160;&#160;&#160;&#160;&#160; the term &#8220;clear days&#8221; in relation to the period of a notice means that period excluding the day when the notice is received or deemed to be received and the day for which it is given or on which it is to take
      effect; and</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">(n)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the term &#8220;holder&#8221; in relation to a Share means a person whose name is entered in the Register of Members as the holder of such Share.</div>
    <div> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z88e07bc548d0457f8c0755662e75ec4d" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">2</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Commencement of Business</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z51a087e0fcb84a4a993f7c6dc28e9c2c" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">2.1</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">The business of the Company may be commenced as soon after incorporation of the Company as the Directors shall see fit.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z02b539b5457e4b489c51a04d8e2b0636" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">2.2</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">The Directors may pay, out of the capital or any other monies of the Company, all expenses incurred in or about the formation and establishment of the Company, including the expenses of registration.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z4c8cec7e90174237a546fe158e1b037e" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.18%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">3</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Issue of Shares and other Securities</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zb02257eeb0f840d8a550ba33ab8d83ed" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">3.1</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">Subject to the provisions, if any, in the Memorandum (and to any direction that may be given by the Company in general meeting) and, where applicable, the rules and regulations of the Designated Stock Exchange, the
              Securities and Exchange Commission and/or any other competent regulatory authority or otherwise under Applicable Law, and without prejudice to any rights attached to any existing Shares, the Directors may allot, issue, grant options over or
              otherwise dispose of Shares in separate classes and/or series (including fractions of a Share) with or without preferred, deferred or other rights or restrictions, whether in regard to Dividends or other distributions, voting, return of
              capital or otherwise and to such persons, at such times and on such other terms as they think proper, and may also (subject to the Statute and the Articles) vary such rights, save that the Directors shall not allot, issue, grant options over
              or otherwise dispose of Shares (including fractions of a Share) to the extent that it may affect the ability of the Company to carry out a Class B Ordinary Share Conversion set out in the Articles.</div>
          </td>
        </tr>

    </table>
    <div style="margin-left: 36pt;"> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z4ad1e60e77f748cfb01dbae5623517b2" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">3.2</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">The Company may issue rights, options, warrants or convertible securities or securities of similar nature conferring the right upon the holders thereof to subscribe for, purchase or receive any class or series of
              Shares or other securities in the Company on such terms as the Directors may from time to time determine.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z87f87da35e114f5ba1ebc461e0966943" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">3.3</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">The Company may issue units of securities in the Company, which may be comprised of whole or fractional Shares, rights, options, warrants or convertible securities or securities of similar nature conferring the
              right upon the holders thereof to subscribe for, purchase or receive any class or series of Shares or other securities in the Company, upon such terms as the Directors may from time to time determine. The securities comprising any such units
              which are issued pursuant to the IPO can only be traded separately from one another on the 52nd day following the date of the prospectus relating to the IPO unless the Representative(s) determines that an earlier date is acceptable, subject
              to the Company having filed a current report on Form 8-K with the Securities and Exchange Commission and a press release announcing when such separate trading will begin. Prior to such date, the units can be traded, but the securities
              comprising such units cannot be traded separately from one another.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zecbe0ca923c94a86b24148993bd3aa4f" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.15%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">3.4</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">The Company shall not issue Shares to bearer.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z824d8326de9f4955aa5f4afdf63f9f0e" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">3.5</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">On or before the allotment of any Share, the Directors shall resolve the class and/or series to which such Share shall be classified and may, prior to the issue of any Share, reclassify such Share. Each class and/or
              series shall be specifically identified. Subject to the Statute and the Articles, the Directors may at any time re-name any Share.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z4f93788a0dac496c9d379df19d64d185" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.32%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">4</div>
          </td>
          <td style="width: 94.4%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Register of Members</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z82ee396542284c0aa25b814b44530f84" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">4.1</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">The Company shall maintain or cause to be maintained the Register of Members in accordance with the Statute.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zc4b3e99700b5456da2ceacc247bf0601" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">4.2</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">The Directors may determine that the Company shall maintain one or more branch registers of Members in accordance with the Statute. The Directors may also determine which register of Members shall constitute the
              principal register and which shall constitute the branch register or registers, and to vary such determination from time to time.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z5d509ac3e6ec4c878f4484e933a28f17" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.13%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">5</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Closing Register of Members or Fixing Record Date</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z87a8409914274bdb971f550961b34077" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">5.1</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">For the purpose of determining Members entitled to notice of, or to vote at any meeting of Members or any adjournment thereof, or Members entitled to receive payment of any Dividend or other distribution, or in
              order to make a determination of Members for any other purpose, the Directors may, after notice has been given by advertisement in an appointed newspaper or any other newspaper or by any other means in accordance with the rules and
              regulations of the Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory authority or otherwise under Applicable Law, provide that the Register of Members shall be closed for transfers for a
              stated period which shall not in any case exceed forty days.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z29651838631a4fbdb1d00ef533ef2057" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">5.2</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">In lieu of, or apart from, closing the Register of Members, the Directors may fix in advance or arrears a date as the record date for any such determination of Members entitled to notice of, or to vote at any
              meeting of the Members or any adjournment thereof, or for the purpose of determining the Members entitled to receive payment of any Dividend or other distribution, or in order to make a determination of Members for any other purpose.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z8d0473fbc7bc4549bef76f05cabaf721" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">5.3</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">If the Register of Members is not so closed and no record date is fixed for the determination of Members entitled to notice of, or to vote at, a meeting of Members or Members entitled to receive payment of a
              Dividend or other distribution, the date on which notice of the meeting is sent or the date on which the resolution of the Directors resolving to pay such Dividend or other distribution is passed, as the case may be, shall be the record date
              for such determination of Members. When a determination of Members entitled to vote at any meeting of Members has been made as provided in this Article, such determination shall apply to any adjournment thereof.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z27e7217de4074dd09f8dead6d1d2768c" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.29%; vertical-align: top;">&#160;</td>
          <td style="width: 4.94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">6</div>
          </td>
          <td style="width: 94.78%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Certificates for Shares</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z500aecaa658e4510a978feb31aed4f4d" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">6.1</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">A Member shall only be entitled to a share certificate if the Directors resolve that share certificates shall be issued. Share certificates representing Shares, if any, shall be in such form as the Directors may
              determine. Share certificates shall be signed by one or more Directors or other person authorised by the Directors. The Directors may authorise certificates to be issued with the authorised signature(s) affixed by mechanical process. All
              certificates for Shares shall be consecutively numbered or otherwise identified and shall specify the Shares to which they relate. All certificates surrendered to the Company for transfer shall be cancelled and, subject to the Articles, no
              new certificate shall be issued until the former certificate representing a like number of relevant Shares shall have been surrendered and cancelled.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zdb604c8bbd424b60834c732f5c878af6" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">6.2</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">The Company shall not be bound to issue more than one certificate for Shares held jointly by more than one person and delivery of a certificate to one joint holder shall be a sufficient delivery to all of them.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z17369662f56c444b997545b28731c305" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">6.3</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">If a share certificate is defaced, worn out, lost or destroyed, it may be renewed on such terms (if any) as to evidence and indemnity and on the payment of such expenses reasonably incurred by the Company in
              investigating evidence, as the Directors may prescribe, and (in the case of defacement or wearing out) upon delivery of the old certificate.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z318bf0f1bab94d57a9c454fe5c2da0c8" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">6.4</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">Every share certificate sent in accordance with the Articles will be sent at the risk of the Member or other person entitled to the certificate. The Company will not be responsible for any share certificate lost or
              delayed in the course of delivery.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z93cbd4ae7c4f4b8ca5a48436340a7ff6" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">6.5</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">Share certificates shall be issued within the relevant time limit as prescribed by the Statute, if applicable, or as the rules and regulations of the Designated Stock Exchange, the Securities and Exchange Commission
              and/or any other competent regulatory authority or otherwise under Applicable Law may from time to time determine, whichever is shorter, after the allotment or, except in the case of a Share transfer which the Company is for the time being
              entitled to refuse to register and does not register, after lodgement of a Share transfer with the Company.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z9e60646f77d64dbba9da67f0c800c4e8" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.35%; vertical-align: top;">&#160;</td>
          <td style="width: 5.87%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">7</div>
          </td>
          <td style="width: 93.78%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Transfer of Shares</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z6f73e2084bcc401e8e31a724a07c95a4" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">7.1</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">Subject to the terms of the Articles, any Member may transfer all or any of their Shares by an instrument of transfer provided that such transfer complies with the rules and regulations of the Designated Stock
              Exchange, the Securities and Exchange Commission and/or any other competent regulatory authority or otherwise under Applicable Law. If the Shares in question were issued in conjunction with rights, options, warrants or units issued pursuant
              to the Articles on terms that one cannot be transferred without the other, the Directors shall refuse to register the transfer of any such Share without evidence satisfactory to them of the like transfer of such right, option, warrant or
              unit.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z8b716b8d29874a0380d6da866c91aa81" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">7.2</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">The instrument of transfer of any Share shall be in writing in the usual or common form or in a form prescribed by the rules and regulations of the Designated Stock Exchange, the Securities and Exchange Commission
              and/or any other competent regulatory authority or otherwise under Applicable Law or in any other form approved by the Directors and shall be executed by or on behalf of the transferor (and if the Directors so require, signed by or on behalf
              of the transferee) and may be under hand or, if the transferor or transferee is a Clearing House or its nominee(s), by hand or by machine imprinted signature or by such other manner of execution as the Directors may approve from time to time.
              The transferor shall be deemed to remain the holder of a Share until the name of the transferee is entered in the Register of Members.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zdbd2a113790c4c6db91fb2cfba1dddd4" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.14%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">8</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Redemption, Repurchase and Surrender of Shares</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z9e6c8e6dda0d421e9c618288562b6fbc" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">8.1</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">Subject to the provisions of the Statute, and, where applicable, the rules and regulations of the Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory authority or
              otherwise under Applicable Law, the Company may issue Shares that are to be redeemed or are liable to be redeemed at the option of the Member or the Company. The redemption of such Shares, except Public Shares, shall be effected in such
              manner and upon such other terms as the Company may, by Special Resolution, determine before the issue of such Shares. With respect to redeeming or repurchasing the Shares:</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z47a3cbd39f01479d929ee0b79b8ac258" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">(a)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">Members who hold Public Shares are entitled to request the redemption of such Shares in the circumstances described in the Business Combination Article hereof;</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zf11bb6cff6e34a1e8909952ca1b86f05" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">(b)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">Class B Shares held by the Sponsor shall be surrendered by the Sponsor for no consideration to the extent that the Over-Allotment Option is not exercised in full so that the Sponsor, together with any Independent
              Directors to whom the Sponsor transfers or has previously transferred any Class B Shares, will own 25% of the Company&#8217;s issued Shares after the IPO (exclusive of any securities purchased in a private placement simultaneously with the IPO);
              and</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z71cbcbc432f4474d9fe3c10d4cd7d13b" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">(c)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">Public Shares shall be repurchased by way of tender offer in the circumstances set out in the Business Combination Article hereof.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zf128d25af845473b8e4c1ea0ad24e5dd" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">8.2</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">Subject to the provisions of the Statute, and, where applicable, the rules and regulations of the Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory authority or
              otherwise under Applicable Law, the Company may purchase its own Shares (including any redeemable Shares) in such manner and on such other terms as the Directors may agree with the relevant Member. For the avoidance of doubt, redemptions,
              repurchases and surrenders of Shares in the circumstances described in the Article above shall not require further approval of the Members.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z00795263801e4d6c891186c691c4f5e9" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">8.3</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">The Company may make a payment in respect of the redemption or purchase of its own Shares in any manner permitted by the Statute, including out of capital.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zea6789a4da51447ea481209ffd17dd13" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.09%; vertical-align: top;">&#160;</td>
          <td style="width: 3.57%; vertical-align: top;">
            <div style="color: #000000;">8.4</div>
          </td>
          <td style="width: 96.35%; vertical-align: top;">
            <div style="color: #000000;">The Directors may accept the surrender for no consideration of any fully paid Share.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z4c7ab6c81ca445568d9577cc0ec3cb0f" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.38%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">9</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Treasury Shares</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z1c47466111094ba4b0b2c5c5292877cf" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">9.1</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">The Directors may, prior to the purchase, redemption or surrender of any Share, determine that such Share shall be held as a Treasury Share.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z04c4bbce6d70488aad51f107b4625d5b" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">9.2</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">The Directors may determine to cancel a Treasury Share or transfer a Treasury Share on such terms as they think proper (including, without limitation, for nil consideration).</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zf8d44d1c1e954e47b6949492cd2e72ba" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.21%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">10</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Variation of Rights of Shares</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z5149b9f7fdea445dbf54a949141ada51" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">10.1</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">Subject to Article 3.1, if at any time the share capital of the Company is divided into different classes or series of Shares, all or any of the rights attached to any class (unless otherwise provided by the terms
              of issue of the Shares of that class) may, whether or not the Company is being wound up, be varied without the consent of the holders of the issued Shares of that class where such variation is considered by the Directors not to have a
              material adverse effect upon such rights; otherwise, any such variation shall be made only with the consent in writing of the holders of not less than two-thirds of the issued Shares of that class (other than with respect to a waiver of the
              provisions of the Class B Ordinary Share Conversion Article hereof, which as stated therein shall only require the consent in writing of the holders of a majority of the issued Shares of that class), or with the approval of a resolution
              passed by a majority of not less than two-thirds of the votes cast at a separate meeting of the holders of the Shares of that class. For the avoidance of doubt, the Directors reserve the right, notwithstanding that any such variation may not
              have a material adverse effect, to obtain consent from the holders of Shares of the relevant class. To any such meeting all the provisions of the Articles relating to general meetings shall apply <font style="font-style: italic;">mutatis
                mutandis</font>, except that the necessary quorum shall be one person holding or representing by proxy at least one-third of the issued Shares of the class and that any holder of Shares of the class present in person or by proxy may demand
              a poll.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z1ff007268a5e45538e4de7add87acb8e" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">10.2</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">For the purposes of a separate class meeting, the Directors may treat two or more or all the classes or series of Shares as forming one class or series of Shares if the Directors consider that such class or series
              of Shares would be affected in the same way by the proposals under consideration, but in any other case shall treat them as separate classes or series of Shares.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zdf8aac8d7d52472ca4557e1f92c57d49" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">10.3</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div><font style="color: #000000;">The rights conferred upon the holders of the Shares of any class issued with preferred or other rights shall not, unless otherwise expressly provided by the terms of issue of the Shares of that class, be
                deemed to be varied by: (i) the creation or issue of further Shares ranking pari passu therewith or Shares issued with preferred or other rights; (ii) where the constitutional documents of the Company are amended or new constitutional
                documents of the Company are adopted, in each case, as a result of the Company undertaking a transfer </font>by way of continuation as a body corporate under the laws of any jurisdiction outside the Cayman Islands and the de-registration
              in the Cayman Islands<font style="color: #000000;">; or (iii) the conversion of any Class B Shares pursuant to the Class B Ordinary Share Conversion Article.</font></div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z494674985d874d1d974aec78d43aedce" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.21%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">11</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Commission on Sale of Shares</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="margin: 0px 0px 0px 48pt;">The Company may, in so far as the Statute permits, pay a commission to any person in consideration of that person subscribing or agreeing to subscribe (whether absolutely or conditionally) or procuring or agreeing
      to procure subscriptions (whether absolutely or conditionally) for any Shares. Such commissions may be satisfied by the payment of cash and/or the issue of fully or partly paid-up Shares. The Company may also on any issue of Shares pay such brokerage
      as may be lawful.</div>
    <div style="margin-left: 36pt;"> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z28a818ab572342798a2327dd44e31f4c" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.25%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">12</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Non Recognition of Trusts</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="margin: 0px 0px 0px 48pt;">The Company shall not be bound by or compelled to recognise in any way (even when notified) any equitable, contingent, future or partial interest in any Share, or (except only as is otherwise provided by the
      Articles or the Statute) any other rights in respect of any Share other than an absolute right to the entirety thereof in the holder.</div>
    <div style="margin-left: 36pt;"> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z2f1f4a55778c42e28f76114bee6f5648" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.41%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">13</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Lien on Shares</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z9ce100bfd36d40b9b36fab24c2a339ad" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">13.1</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The Company shall have a first and paramount lien on all Shares (whether fully paid-up or not) registered in the name of a Member (whether solely or jointly with others) for all debts, liabilities or engagements to
              or with the Company (whether presently payable or not) by such Member or their estate, either alone or jointly with any other person, whether a Member or not, but the Directors may at any time declare any Share to be wholly or in part exempt
              from the provisions of this Article. The registration of a transfer of any such Share shall operate as a waiver of the Company&#8217;s lien thereon. The Company&#8217;s lien on a Share shall also extend to any amount payable in respect of that Share.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z848bf4f4360441ceba715695e2d8f19f" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">13.2</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The Company may sell, in such manner as the Directors think fit, any Shares on which the Company has a lien, if a sum in respect of which the lien exists is presently payable, and is not paid within 14 clear days
              after notice has been received or deemed to have been received by the holder of the Shares, or to the person entitled to it in consequence of the death or bankruptcy of the holder, demanding payment and stating that if the notice is not
              complied with the Shares may be sold.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z341facade4e346a6a99af354d987e501" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">13.3</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">To give effect to any such sale the Directors may authorise any person to execute an instrument of transfer of the Shares sold to, or in accordance with the directions of, the purchaser. The purchaser or their
              nominee shall be registered as the holder of the Shares comprised in any such transfer, and they shall not be bound to see to the application of the purchase money, nor shall their title to the Shares be affected by any irregularity or
              invalidity in the sale or the exercise of the Company&#8217;s power of sale under the Articles.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z5c584ff6068c4edea26682d8f3527757" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">13.4</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The net proceeds of such sale after payment of costs, shall be applied in payment of such part of the amount in respect of which the lien exists as is presently payable and any balance shall (subject to a like lien
              for sums not presently payable as existed upon the Shares before the sale) be paid to the person entitled to the Shares at the date of the sale.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z6a00f6182cb94a0181d1df4916ae9b9c" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.43%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">14</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Call on Shares</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zb80bd152a30149a887d54e631a982ba7" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">14.1</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">Subject to the terms of the allotment and issue of any Shares, the Directors may make calls upon the Members in respect of any monies unpaid on their Shares (whether in respect of par value or premium), and each
              Member shall (subject to receiving at least 14 clear days&#8217; notice specifying the time or times of payment) pay to the Company at the time or times so specified the amount called on the Shares. A call may be revoked or postponed, in whole or
              in part, as the Directors may determine. A call may be required to be paid by instalments. A person upon whom a call is made shall remain liable for calls made upon them notwithstanding the subsequent transfer of the Shares in respect of
              which the call was made.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="ze2378bec68b346d3820b542f266890b5" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">14.2</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">A call shall be deemed to have been made at the time when the resolution of the Directors authorising such call was passed.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zc670c4245f584a3eb439d49a61a42ea6" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.07%; vertical-align: top;">&#160;</td>
          <td style="width: 4.31%; vertical-align: top;">
            <div style="color: #000000;">14.3</div>
          </td>
          <td style="width: 95.62%; vertical-align: top;">
            <div style="color: #000000;">The joint holders of a Share shall be jointly and severally liable to pay all calls in respect thereof.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zbe464a4cceff4a838ee3f45d480d725e" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">14.4</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">If a call remains unpaid after it has become due and payable, the person from whom it is due shall pay interest on the amount unpaid from the day it became due and payable until it is paid at such rate as the
              Directors may determine (and in addition all expenses that have been incurred by the Company by reason of such non-payment), but the Directors may waive payment of the interest or expenses wholly or in part.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zc704a5231c164d3cbf47b1b24d29d794" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">14.5</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">An amount payable in respect of a Share on issue or allotment or at any fixed date, whether on account of the par value of the Share or premium or otherwise, shall be deemed to be a call and if it is not paid all
              the provisions of the Articles shall apply as if that amount had become due and payable by virtue of a call.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="za4492aa3c02e48b48345b04f13d2f2ab" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">14.6</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The Directors may issue Shares with different terms as to the amount and times of payment of calls, or the interest to be paid.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z3dfddf2b3a5544e6ab21b1c936c3e8ca" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">14.7</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The Directors may, if they think fit, receive an amount from any Member willing to advance all or any part of the monies uncalled and unpaid upon any Shares held by that Member, and may (until the amount would
              otherwise become payable) pay interest at such rate as may be agreed upon between the Directors and the Member paying such amount in advance.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zc17d430b5e5949acb39c9e7be40201b0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">14.8</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">No such amount paid in advance of calls shall entitle the Member paying such amount to any portion of a Dividend or other distribution payable in respect of any period prior to the date upon which such amount would,
              but for such payment, become payable.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zc33510a06e254c248f239c0dad8a5503" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.31%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">15</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Forfeiture of Shares</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z461d7fa7a1fa47eb972cb8537610a1ef" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">15.1</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">If a call or instalment of a call remains unpaid after it has become due and payable the Directors may give to the person from whom it is due not less than 14 clear days&#8217; notice requiring payment of the amount
              unpaid together with any interest which may have accrued and any expenses incurred by the Company by reason of such non-payment. The notice shall specify where payment is to be made and shall state that if the notice is not complied with the
              Shares in respect of which the call was made will be liable to be forfeited.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="za44a4dd063154926986ac23e47a9f409" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">15.2</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">If the notice is not complied with, any Share in respect of which it was given may, before the payment required by the notice has been made, be forfeited by a resolution of the Directors. Such forfeiture shall
              include all Dividends, other distributions or other monies payable in respect of the forfeited Share and not paid before the forfeiture.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z543a5ef4cd1d4f81998ab0492a8699c6" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">15.3</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">A forfeited Share may be sold, re-allotted or otherwise disposed of on such terms and in such manner as the Directors think fit and at any time before a sale, re-allotment or disposition the forfeiture may be
              cancelled on such terms as the Directors think fit. Where for the purposes of its disposal a forfeited Share is to be transferred to any person the Directors may authorise some person to execute an instrument of transfer of the Share in
              favour of that person.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z6c2e97e7ab2541eb9d1302fb082b0a40" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">15.4</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">A person any of whose Shares have been forfeited shall cease to be a Member in respect of them and shall surrender to the Company for cancellation the certificate for the Shares forfeited and shall remain liable to
              pay to the Company all monies which at the date of forfeiture were payable by that person to the Company in respect of those Shares together with interest at such rate as the Directors may determine, but that person&#8217;s liability shall cease if
              and when the Company shall have received payment in full of all monies due and payable by them in respect of those Shares.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zeb7c2c018f564996bcf42c0ce95db894" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">15.5</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">A certificate in writing under the hand of one Director or Officer that a Share has been forfeited on a specified date shall be conclusive evidence of the facts stated in it as against all persons claiming to be
              entitled to the Share. The certificate shall (subject to the execution of an instrument of transfer) constitute a good title to the Share and the person to whom the Share is sold or otherwise disposed of shall not be bound to see to the
              application of the purchase money, if any, nor shall their title to the Share be affected by any irregularity or invalidity in the proceedings in reference to the forfeiture, sale or disposal of the Share.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z69cd079421ff417e8734adc36c3ea013" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">15.6</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The provisions of the Articles as to forfeiture shall apply in the case of non payment of any sum which, by the terms of issue of a Share, becomes payable at a fixed time, whether on account of the par value of the
              Share or by way of premium as if it had been payable by virtue of a call duly made and notified.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z546beeeb4cad4d6c9b7a544771dc28e9" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.28%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">16</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Transmission of Shares</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z76b9d6c6441d49dc975e8835126139a9" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">16.1</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">If a Member dies, the survivor or survivors (where they were a joint holder), or their legal personal representatives (where they were a sole holder), shall be the only persons recognised by the Company as having
              any title to the deceased Member&#8217;s Shares. The estate of a deceased Member is not thereby released from any liability in respect of any Share, for which the Member was a joint or sole holder.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zafff4a091cf749e994243dc06cd29736" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">16.2</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">Any person becoming entitled to a Share in consequence of the death or bankruptcy or liquidation or dissolution of a Member (or in any other way than by transfer) may, upon such evidence being produced as may be
              required by the Directors, elect, by a notice in writing sent by that person to the Company, either to become the holder of such Share or to have some person nominated by them registered as the holder of such Share. If they elect to have
              another person registered as the holder of such Share they shall sign an instrument of transfer of that Share to that person. The Directors shall, in either case, have the same right to decline or suspend registration as they would have had
              in the case of a transfer of the Share by the relevant Member before their death or bankruptcy or liquidation or dissolution, as the case may be.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z4df371f051974352a8ed528d564026d4" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">16.3</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">A person becoming entitled to a Share by reason of the death or bankruptcy or liquidation or dissolution of a Member (or in any other case than by transfer) shall be entitled to the same Dividends, other
              distributions and other advantages to which they would be entitled if they were the holder of such Share. However, they shall not, before becoming a Member in respect of a Share, be entitled in respect of it to exercise any right conferred by
              membership in relation to general meetings of the Company and the Directors may at any time give notice requiring any such person to elect either to be registered or to have some person nominated by them registered as the holder of the Share
              (but the Directors shall, in either case, have the same right to decline or suspend registration as they would have had in the case of a transfer of the Share by the relevant Member before their death or bankruptcy or liquidation or
              dissolution or any other case than by transfer, as the case may be). If the notice is not complied with within 90 days of being received or deemed to be received (as determined pursuant to the Articles), the Directors may thereafter withhold
              payment of all Dividends, other distributions, bonuses or other monies payable in respect of the Share until the requirements of the notice have been complied with.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zaac95afe4a154542bf900e385cc3e882" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.18%; vertical-align: top;">&#160;</td>
          <td style="width: 6.09%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">17</div>
          </td>
          <td style="width: 93.73%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Class B Ordinary Share Conversion</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z5cb56e651b564b628c23a8443500ec52" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">17.1</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The rights attaching to the Class A Shares and Class B Shares shall rank <font style="font-style: italic;">pari passu</font> in all respects, and the Class A Shares and Class B Shares shall vote together as a
              single class on all matters (subject to the Variation of Rights of Shares Article and the Appointment and Removal of Directors Article hereof) with the exception that the holder of a Class B Share shall have the conversion rights referred to
              in this Article.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="za26bf544fd51480d88a5a5601ff27dbf" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">17.2</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">Class B Shares shall automatically convert into Class A Shares on a one-for-one basis (the &#8220;<font style="font-weight: bold;">Initial Conversion Ratio</font>&#8221;): (a) at any time and from time to time at the option of
              the holders thereof; or (b) in connection with the consummation of a Business Combination.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z94f988b9cb2b438ba62817adc5fae9ae" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">17.3</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">Notwithstanding the Initial Conversion Ratio, in the case that additional Class A Shares or any other Equity-linked Securities, are issued, or deemed issued, by the Company in excess of the amounts offered in the
              IPO and in connection with the consummation of a Business Combination, all Class B Shares in issue shall automatically convert into Class A Shares in connection with the consummation of a Business Combination at a ratio for which the Class B
              Shares shall convert into Class A Shares will be adjusted (unless the holders of a majority of the Class B Shares in issue agree to waive such anti-dilution adjustment with respect to any such issuance or deemed issuance) so that the number
              of Class A Shares issuable upon conversion of all Class B Shares will equal, on an as-converted basis, in the aggregate, 20% of the sum of all Class A Shares and Class B Shares in issue upon completion of the IPO plus all Class A Shares and
              Equity-linked Securities issued or deemed issued in connection with a Business Combination, exclusive of (i) any Class A Shares, subject to vesting and any other restrictions, issued or deemed issued to Sponsor in connection with the
              consummation of the IPO and (ii) any Class A Shares underlying any private placement warrants issued by the Company simultaneously with the IPO or upon conversion of working capital loans made to the Company.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z38269581193e4ec78b55c805a0aad1d0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">17.4</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">Notwithstanding anything to the contrary contained herein, the foregoing adjustment to the Initial Conversion Ratio may be waived as to any particular issuance or deemed issuance of additional Class A Shares or
              Equity-linked Securities by the written consent or agreement of holders of a majority of the Class B Shares then in issue consenting or agreeing separately as a separate class in the manner provided in the Variation of Rights of Shares
              Article hereof.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z73719199302c4a4dbf6867b900e239c1" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">17.5</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The foregoing conversion ratio shall also be adjusted to account for any subdivision (by share subdivision, exchange, capitalisation, rights issue, reclassification, recapitalisation or otherwise) or combination (by
              share consolidation, exchange, reclassification, recapitalisation or otherwise) or similar reclassification or recapitalisation of the Class A Shares in issue into a greater or lesser number of shares occurring after the original filing of
              the Articles without a proportionate and corresponding subdivision, combination or similar reclassification or recapitalisation of the Class B Shares in issue.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z73a362019ebe4eb582bf68bad7145c5a" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">17.6</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">Each Class B Share shall convert into its pro rata number of Class A Shares pursuant to this Article. The pro rata share for each holder of Class B Shares will be determined as follows: each Class B Share shall
              convert into such number of Class A Shares as is equal to the product of 1 multiplied by a fraction, the numerator of which shall be the total number of Class A Shares into which all of the Class B Shares in issue shall be converted pursuant
              to this Article and the denominator of which shall be the total number of Class B Shares in issue at the time of conversion.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zf9995f32bb3b485f8dd4395a56a6e579" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">17.7</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">References in this Article to &#8220;converted&#8221;, &#8220;conversion&#8221; or &#8220;exchange&#8221; shall mean the compulsory redemption without notice of Class B Shares of any Member and, on behalf of such Members, automatic application of such
              redemption proceeds in paying for such new Class A Shares into which the Class B Shares have been converted or exchanged at a price per Class B Share necessary to give effect to a conversion or exchange calculated on the basis that the Class
              A Shares to be issued as part of the conversion or exchange will be issued at par. The Class A Shares to be issued on an exchange or conversion shall be registered in the name of such Member or in such name as the Member may direct.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z7ae7c2de271d45a9aaa6611737891ab3" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">17.8</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">Notwithstanding anything to the contrary in this Article, in no event may any Class B Share convert into Class A Shares at a ratio that is less than one-for-one.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zc420828fe9554002a9b0210155f6d9a3" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.09%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">18</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Amendments of Memorandum and Articles of Association and Alteration of Capital</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z0bbc1fbbd25a455999a7d5236d12215b" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.16%; vertical-align: top;">&#160;</td>
          <td style="width: 3.76%; vertical-align: top;">
            <div style="color: #000000;">18.1</div>
          </td>
          <td style="width: 96.08%; vertical-align: top;">
            <div style="color: #000000;">The Company may by Ordinary Resolution:</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z9462dccc6ae344498592b54b004861be" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">(a)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">increase its share capital by such sum as the Ordinary Resolution shall prescribe and with such rights, priorities and privileges annexed thereto, as the Company in general meeting may determine;</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="ze3594760f7aa49dbadf85ff74d924f4d" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.07%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">(b)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">consolidate and divide all or any of its share capital into Shares of larger amount than its existing Shares;</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z177da0b73b244fe6b52c1da62b2be112" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">(c)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">convert all or any of its paid-up Shares into stock, and reconvert that stock into paid-up Shares of any denomination;</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z88fbdd6f578b401cb0712cd13133cb69" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">(d)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">by subdivision of its existing Shares or any of them divide the whole or any part of its share capital into Shares of smaller amount than is fixed by the Memorandum or into Shares without par value; and</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zb7f41f6b9f3b4c8099e40ee425c4ce15" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">(e)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">cancel any Shares that at the date of the passing of the Ordinary Resolution have not been taken or agreed to be taken by any person and diminish the amount of its share capital by the amount of the Shares so
              cancelled.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zf91e64bfae684bc4ada0747570e14786" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">18.2</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">All new Shares created in accordance with the provisions of the preceding Article shall be subject to the same provisions of the Articles with reference to the payment of calls, liens, transfer, transmission,
              forfeiture and otherwise as the Shares in the original share capital.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z85511f14cd43418f9f63c7eef5ef37c4" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">18.3</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">&#160;Subject to the provisions of the Statute, the provisions of the Articles as regards the matters to be dealt with by Ordinary Resolution and Articles 29.4 and 47.2, the Company may by Special Resolution:</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z9027e4a2c6ed4b5b889eb4f4b45f8fdb" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.37%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">(a)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">change its name;</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z510a0c17f78c4dca998a6388ce110550" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.24%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">(b)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">alter or add to the Articles;</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zb82ebe948c844a1388f389a2529e3136" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">(c)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">alter or add to the Memorandum with respect to any objects, powers or other matters specified therein; and</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z4ceb9b141ea3476eab13ab7d267afd7d" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.12%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">(d)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">reduce its share capital or any capital redemption reserve fund.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z9a4cb4823ebd48b6ba72b176033d87b6" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.21%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">19</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Offices and Places of Business</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="margin: 0px 0px 0px 48pt;">Subject to the provisions of the Statute, the Company may by resolution of the Directors change the location of its Registered Office. The Company may, in addition to its Registered Office, maintain such other
      offices or places of business as the Directors determine.</div>
    <div style="margin-left: 36pt;"> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zef1e3b06e2884f9cbb5f6ef46631d293" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.36%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">20</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">General Meetings</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z4e32594010e64cc7a1358298acb516e1" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4.05%; vertical-align: top;">
            <div style="color: #000000;">20.1</div>
          </td>
          <td style="width: 95.89%; vertical-align: top;">
            <div style="color: #000000;">All general meetings other than annual general meetings shall be called extraordinary general meetings.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z21a08a75f89141f887d751b9cd92c20b" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">20.2</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The Company may, but shall not (unless required by the Statute) be obliged to, in each year hold a general meeting as its annual general meeting, and shall specify the meeting as such in the notices calling it. Any
              annual general meeting shall be held at such time and place as the Directors shall appoint. At these meetings the report of the Directors (if any) shall be presented.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zb1eacec534c14086ba0014b25943c003" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">20.3</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The Directors, the chief executive officer or the chairperson of the board of Directors may call general meetings, and, for the avoidance of doubt, the Members shall not have the ability to call general meetings.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zebfb155abd874b0ab4050b1b8c45b53c" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">20.4</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">Members seeking to bring business before the annual general meeting must deliver notice to the principal executive offices of the Company not less than 120 calendar days before the date of the Company&#8217;s proxy
              statement released to Members in connection with the previous year&#8217;s annual general meeting or, if the Company did not hold an annual general meeting the previous year, or if the date of the current year&#8217;s annual general meeting has been
              changed by more than 30 days from the date of the previous year&#8217;s annual general meeting, then the deadline shall be set by the board of Directors with such deadline being a reasonable time before the Company begins to print and send its
              related proxy materials.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="za50ad4cf384945c692e7a61ef07e3a81" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.24%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">21</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Notice of General Meetings</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z023629614337444884b9e0070dd25afd" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">21.1</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">At least five clear days&#8217; notice shall be given of any general meeting. Every notice shall specify the place, the day and the hour of the meeting and the general nature of the business to be conducted at the general
              meeting and shall be given in the manner hereinafter mentioned or in such other manner if any as may be prescribed by the Company, provided that a general meeting of the Company shall, whether or not the notice specified in this Article has
              been given and whether or not the provisions of the Articles regarding general meetings have been complied with, be deemed to have been duly convened if it is so agreed:</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zc0d267aabe69469cad46ed359a7df47e" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">(a)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">in the case of an annual general meeting, by all of the Members entitled to attend and vote at the meeting; and</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zd51872fb314d49fd91c23e33b6b78fad" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">(b)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">in the case of an extraordinary general meeting, by a majority in number of the Members having a right to attend and vote at the meeting, together holding not less than 95% in par value of the Shares giving that
              right.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z034f871fed074e4084dc263a976f1f2f" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">21.2</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The accidental omission to give notice of a general meeting to, or the non receipt of notice of a general meeting by, any person entitled to receive such notice shall not invalidate the proceedings of that general
              meeting.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z640fe5883ec74e3fabc32a3f6ebdbbcf" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.2%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">22</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Proceedings at General Meetings</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z2b76bd68438744e9be5b246509705ca5" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">22.1</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">No business shall be transacted at any general meeting unless a quorum is present. The holders of one-third of the Shares being individuals present in person or by proxy or if a corporation or other non-natural
              person by its duly authorised representative or proxy shall be a quorum.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zbc4f921db73b4fc99c4c7aa35ac9cff3" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">22.2</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">A person may participate at a general meeting by conference telephone or other communications equipment by means of which all the persons participating in the meeting can communicate with each other. Participation
              by a person in a general meeting in this manner is treated as presence in person at that meeting.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z4ad5c3ca178f404e98acaaa26ae3f6dc" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">22.3</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">A resolution (including a Special Resolution) in writing (in one or more counterparts) signed by or on behalf of all of the Members for the time being entitled to receive notice of and to attend and vote at general
              meetings (or, being corporations or other non-natural persons, signed by their duly authorised representatives) shall be as valid and effective as if the resolution had been passed at a general meeting of the Company duly convened and held.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="ze380fa898520405c86c35eadfe727ac4" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">22.4</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">If a quorum is not present within half an hour from the time appointed for the meeting to commence, the meeting shall stand adjourned to the same day in the next week at the same time and/or place or to such other
              day, time and/or place as the Directors may determine, and if at the adjourned meeting a quorum is not present within half an hour from the time appointed for the meeting to commence, the Members present shall be a quorum.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z6db3a62aa46b4656ad19c1e1ccb9a2e3" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">22.5</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The Directors may, at any time prior to the time appointed for the meeting to commence, appoint any person to act as chairperson of a general meeting of the Company or, if the Directors do not make any such
              appointment, the chairperson, if any, of the board of Directors shall preside as chairperson at such general meeting. If there is no such chairperson, or if the person shall not be present within 15 minutes after the time appointed for the
              meeting to commence, or is unwilling to act, the Directors present shall elect one of their number to be chairperson of the meeting.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zf079df60e1af416aba7e009094db06b8" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">22.6</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">If no Director is willing to act as chairperson or if no Director is present within 15 minutes after the time appointed for the meeting to commence, the Members present shall choose one of their number to be
              chairperson of the meeting.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z411fd1d2dc4d4bc7bcea717edf6053f0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">22.7</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The chairperson may, with the consent of a meeting at which a quorum is present (and shall if so directed by the meeting) adjourn the meeting from time to time and from place to place, but no business shall be
              transacted at any adjourned meeting other than the business left unfinished at the meeting from which the adjournment took place.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zc2bf1813e2fa45efafa45a1fbc980831" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">22.8</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">When a general meeting is adjourned for 30 days or more, notice of the adjourned meeting shall be given as in the case of an original meeting. Otherwise it shall not be necessary to give any such notice of an
              adjourned meeting.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z86a2fdbbf9e44c0788814aa3f39cc84c" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">22.9</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">If, prior to a Business Combination, a notice is issued in respect of a general meeting and the Directors, in their absolute discretion, consider that it is impractical or undesirable for any reason to hold that
              general meeting at the place, the day and the hour specified in the notice calling such general meeting, the Directors may postpone the general meeting to another place, day and/or hour provided that notice of the place, the day and the hour
              of the rearranged general meeting is promptly given to all Members. No business shall be transacted at any postponed meeting other than the business specified in the notice of the original meeting.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z669271188b1543daa7c3aec5b3dae5f8" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">22.10</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">When a general meeting is postponed for 30 days or more, notice of the postponed meeting shall be given as in the case of an original meeting. Otherwise it shall not be necessary to give any such notice of a
              postponed meeting. All proxy forms submitted for the original general meeting shall remain valid for the postponed meeting. The Directors may postpone a general meeting which has already been postponed.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z87208a2739ef4b11903efb9755775ba8" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.07%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">22.11</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">A resolution put to the vote of the meeting shall be decided on a poll.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z8f70d4994ab4476f86e9a7605b31ac22" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">22.12</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">A poll shall be taken as the chairperson directs, and the result of the poll shall be deemed to be the resolution of the general meeting at which the poll was demanded.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zd2ea86ea50b44123b98cccc6d778608e" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">22.13</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">A poll demanded on the election of a chairperson or on a question of adjournment shall be taken forthwith. A poll demanded on any other question shall be taken at such date, time and place as the chairperson of the
              general meeting directs, and any business other than that upon which a poll has been demanded or is contingent thereon may proceed pending the taking of the poll.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zd147130f34f74dc5b1b24ae35fcb64d8" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.07%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">22.14</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">In the case of an equality of votes the chairperson shall be entitled to a second or casting vote.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zf06a63393e834851a33b3b09dbfae9e0" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.34%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">23</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Votes of Members</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z0044f46d2df14922ba1b6b0f55d742a0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">23.1</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">Subject to any rights or restrictions attached to any Shares, including as set out at Articles 29.4 and 47.2, every Member present in any such manner shall have one vote for every Share of which they are the holder.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z54c85c01e5164ee2b2e33a3b50518334" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">23.2</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">In the case of joint holders the vote of the senior holder who tenders a vote, whether in person or by proxy (or, in the case of a corporation or other non-natural person, by its duly authorised representative or
              proxy), shall be accepted to the exclusion of the votes of the other joint holders, and seniority shall be determined by the order in which the names of the holders stand in the Register of Members.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z814662001e30440ab4e1839ba5e7bb28" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">23.3</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">A Member of unsound mind, or in respect of whom an order has been made by any court, having jurisdiction in lunacy, may vote by their committee, receiver, curator bonis, or other person on such Member&#8217;s behalf
              appointed by that court, and any such committee, receiver, curator bonis or other person may vote by proxy.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z80a0f707cf85427995df48820ec08f89" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">23.4</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">No person shall be entitled to vote at any general meeting unless they are registered as a Member on the record date for such meeting nor unless all calls or other monies then payable by them in respect of Shares
              have been paid.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z7d2cdaada60b4b5e95c8f4a820fe38f2" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">23.5</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">No objection shall be raised as to the qualification of any voter except at the general meeting or adjourned general meeting at which the vote objected to is given or tendered and every vote not disallowed at the
              meeting shall be valid. Any objection made in due time in accordance with this Article shall be referred to the chairperson whose decision shall be final and conclusive.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z88b76d7d50584afca99cce47bc6247a8" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">23.6</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">Votes may be cast either personally or by proxy (or in the case of a corporation or other non-natural person by its duly authorised representative or proxy). A Member may appoint more than one proxy or the same
              proxy under one or more instruments to attend and vote at a meeting. Where a Member appoints more than one proxy the instrument of proxy shall specify the number of Shares in respect of which each proxy is entitled to exercise the related
              votes.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z5d6c8ba056b84d6c9b4d764e0288f6e0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">23.7</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">A Member holding more than one Share need not cast the votes in respect of their Shares in the same way on any resolution and therefore may vote a Share or some or all such Shares either for or against a resolution
              and/or abstain from voting a Share or some or all of the Shares and, subject to the terms of the instrument appointing the proxy, a proxy appointed under one or more instruments may vote a Share or some or all of the Shares in respect of
              which they are appointed either for or against a resolution and/or abstain from voting a Share or some or all of the Shares in respect of which they are appointed.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z546b897e05d44c9bbebf9d2e5ae4e8a1" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">24</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Proxies</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="za4a7e0e46cc847fa87dd0f685e5deb29" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">24.1</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The instrument appointing a proxy shall be in writing and shall be executed under the hand of the appointor or of their attorney duly authorised in writing, or, if the appointor is a corporation or other non natural
              person, under the hand of its duly authorised representative. A proxy need not be a Member.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z2c81e2fcace9431495c6a66fbee81961" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">24.2</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The Directors may, in the notice convening any meeting or adjourned meeting, or in an instrument of proxy sent out by the Company, specify the manner by which the instrument appointing a proxy shall be deposited and
              the place and the time (being not later than the time appointed for the commencement of the meeting or adjourned meeting to which the proxy relates) at which the instrument appointing a proxy shall be deposited. In the absence of any such
              direction from the Directors in the notice convening any meeting or adjourned meeting or in an instrument of proxy sent out by the Company, the instrument appointing a proxy shall be deposited physically at the Registered Office not less than
              48 hours before the time appointed for the meeting or adjourned meeting to commence at which the person named in the instrument proposes to vote.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z1eb5c9cfb4fa4a36b1e1f3ca3e318210" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">24.3</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The chairperson may in any event at their discretion declare that an instrument of proxy shall be deemed to have been duly deposited. An instrument of proxy that is not deposited in the manner permitted, or which
              has not been declared to have been duly deposited by the chairperson, shall be invalid.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zee31cd6a2a0b4ae0b35351988a62fbb2" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">24.4</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The instrument appointing a proxy may be in any usual or common form (or such other form as the Directors may approve) and may be expressed to be for a particular meeting or any adjournment thereof or generally
              until revoked. An instrument appointing a proxy shall be deemed to include the power to demand or join or concur in demanding a poll.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z83be25b7d1cc497d98ed90a2541ed2bd" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">24.5</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">Votes given in accordance with the terms of an instrument of proxy shall be valid notwithstanding the previous death or insanity of the principal or revocation of the proxy or of the authority under which the proxy
              was executed, or the transfer of the Share in respect of which the proxy is given unless notice in writing of such death, insanity, revocation or transfer was received by the Company at the Registered Office before the commencement of the
              general meeting, or adjourned meeting at which it is sought to use the proxy.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zee6193e4b8c24cb2859868951860ace4" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.31%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">25</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Corporate Members</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z5f1fb358970140299e6207c8d1465ce9" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">25.1</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">Any corporation or other non-natural person which is a Member may in accordance with its constitutional documents, or in the absence of such provision by resolution of its directors or other governing body,
              authorise such person as it thinks fit to act as its representative at any meeting of the Company or of any class of Members, and the person so authorised shall be entitled to exercise the same powers on behalf of the corporation which they
              represent as the corporation could exercise if it were an individual Member.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z15983c2161c34c36a4aeb7b9f1e714e4" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">25.2</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">If a Clearing House (or its nominee(s)), being a corporation, is a Member, it may authorise such persons as it sees fit to act as its representative at any meeting of the Company or at any meeting of any class of
              Members provided that the authorisation shall specify the number and class or series of Shares in respect of which each such representative is so authorised. Each person so authorised under the provisions of this Article shall be deemed to
              have been duly authorised without further evidence of the facts and be entitled to exercise the same rights and powers on behalf of the Clearing House (or its nominee(s)) as if such person was the registered holder of such Shares held by the
              Clearing House (or its nominee(s)).</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z1f436c71b177473b9a516a400d2a695f" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.21%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">26</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Shares that May Not be Voted</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="margin: 0px 0px 0px 48pt;">Shares in the Company that are beneficially owned by the Company shall not be voted, directly or indirectly, at any meeting and shall not be counted in determining the total number of outstanding Shares at any
      given time.</div>
    <div style="margin-left: 36pt;"> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z51df5b7a422847a09fdabc71e802de1a" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">27</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Directors</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="margin: 0px 0px 0px 48pt;">There shall be a board of Directors consisting of not less than one person provided however that the Company may by Ordinary Resolution increase or reduce the limits in the number of Directors.</div>
    <div style="margin-left: 36pt;"> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z9cd07e3348b84dfc9d946331f28a7bb2" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.32%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">28</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Powers of Directors</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z87afb6bd281342549840830cb823b003" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">28.1</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">Subject to the provisions of the Statute, the Memorandum and the Articles and to any directions given by Special Resolution, the business of the Company shall be managed by the Directors who may exercise all the
              powers of the Company. No alteration of the Memorandum or Articles and no such direction shall invalidate any prior act of the Directors which would have been valid if that alteration had not been made or that direction had not been given. A
              duly convened meeting of Directors at which a quorum is present may exercise all powers exercisable by the Directors.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zc6a76d87e7164f50afb7d0528b3c5963" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">28.2</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">All cheques, promissory notes, drafts, bills of exchange and other negotiable or transferable instruments and all receipts for monies paid to the Company shall be signed, drawn, accepted, endorsed or otherwise
              executed as the case may be in such manner as the Directors shall determine by resolution.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zb2af42bd503840d2a9b356e6c5d5b4c3" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">28.3</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The Directors on behalf of the Company may pay a gratuity or pension or allowance on retirement to any Director who has held any other salaried office or place of profit with the Company or to their surviving
              spouse, civil partner or dependants and may make contributions to any fund and pay premiums for the purchase or provision of any such gratuity, pension or allowance.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z34432138c07549e88d2585038788e091" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">28.4</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The Directors may exercise all the powers of the Company to borrow money and to mortgage or charge its undertaking, property and assets (present and future) and uncalled capital or any part thereof and to issue
              debentures, debenture stock, mortgages, bonds and other such securities whether outright or as security for any debt, liability or obligation of the Company or of any third party.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z96748730d056429abcf217e26d203cbf" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.17%; vertical-align: top;">&#160;</td>
          <td style="width: 5.58%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">29</div>
          </td>
          <td style="width: 94.25%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Appointment and Removal of Directors</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zb31a55ce0e5c47d79042163c8778fc56" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">29.1</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The Company may by Ordinary Resolution appoint any person to be a Director or may by Ordinary Resolution remove any Director, provided that prior to the consummation of a Business Combination and for so long as
              there are Class B Shares in issue, only the holders of the Class B Shares shall be entitled to vote on any such Ordinary Resolution. For the avoidance of doubt, prior to the consummation of a Business Combination, if there are any Class B
              Shares in issue, holders of Class A Shares shall have no right to vote on the appointment or removal of any Director.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z0c8ec03fa6c548278e4ec65b5200a31e" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">29.2</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The Directors may appoint any person to be a Director, either to fill a vacancy or as an additional Director provided that the appointment does not cause the number of Directors to exceed any number fixed by or in
              accordance with the Articles as the maximum number of Directors.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="za7aefd749e8a4829904c3dfa27c8b3a4" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">29.3</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">After the consummation of a Business Combination, the Company may by Ordinary Resolution appoint any person to be a Director or may by Ordinary Resolution remove any Director.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z02f2381a147d43baa3a87f75dc8f9e36" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">29.4</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">Prior to the consummation of a Business Combination, Article 29.1 may only be amended by a Special Resolution passed by at least 90% of such Members as, being entitled to do so, vote in person or, where proxies are
              allowed, by proxy at a general meeting of which notice specifying the intention to propose the resolution as a special resolution has been given, or by way of unanimous written resolution.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z16f3514d90db4cfe8316d78230367847" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.21%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">30</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Vacation of Office of Director</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="margin: 0px 0px 0px 48pt;">The office of a Director shall be vacated if:</div>
    <div style="margin-left: 36pt;"> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z7fa26b76a24e408cb922555d8e2cf384" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.09%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">(a)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">the Director gives notice in writing to the Company that they resign the office of Director; or</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z60e7c5d57e6644a388b534028c382ee1" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">(b)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">the Director is absent (for the avoidance of doubt, without being represented by proxy) from three consecutive meetings of the board of Directors without special leave of absence from the Directors, and the
              Directors pass a resolution that they have by reason of such absence vacated office; or</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zaceb138da1544aee85af43bd67cd608b" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">(c)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">the Director dies, becomes bankrupt or makes any arrangement or composition with their creditors generally; or</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z9987fe01a9334a5796cd84d049f26548" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.13%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">(d)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">the Director is found to be or becomes of unsound mind; or</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z4ba7b3ae5d9643e48e90b538d68ee2c6" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">(e)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">all of the other Directors (being not less than two in number) determine that the Director should be removed as a Director, either by a resolution passed by all of the other Directors at a meeting of the Directors
              duly convened and held in accordance with the Articles or by a resolution in writing signed by all of the other Directors.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z9a583c35798244418aed3ea027ffe2dc" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.26%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">31</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Proceedings of Directors</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zdcfc06d143a74b5e9fb80482be3633b4" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">31.1</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The quorum for the transaction of the business of the Directors may be fixed by the Directors, and unless so fixed shall be a majority of the Directors then in office.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zd022c163e37e4f49b10e6cde128acfab" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">31.2</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">Subject to the provisions of the Articles, the Directors may regulate their proceedings as they think fit. Questions arising at any meeting shall be decided by a majority of votes. In the case of an equality of
              votes, the chairperson shall have a second or casting vote.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="ze45057f1a589480e92c6668a63267ba1" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">31.3</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">A person may participate in a meeting of the Directors or any committee of Directors by conference telephone or other communications equipment by means of which all the persons participating in the meeting can
              communicate with each other at the same time. Participation by a person in a meeting in this manner is treated as presence in person at that meeting. Unless otherwise determined by the Directors, the meeting shall be deemed to be held at the
              place where the chairperson is located at the start of the meeting.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zf837814f0d454cfdb1628e39ebb4c078" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">31.4</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">A resolution in writing (in one or more counterparts) signed by all the Directors or all the members of a committee of the Directors or, in the case of a resolution in writing relating to the removal of any Director
              or the vacation of office by any Director, all of the Directors other than the Director who is the subject of such resolution shall be as valid and effectual as if it had been passed at a meeting of the Directors, or committee of Directors as
              the case may be, duly convened and held.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z8ab757df62254383ab221fc3977e7eb0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">31.5</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">A Director may, or other Officer on the direction of a Director shall, call a meeting of the Directors by at least two days&#8217; notice in writing to every Director which notice shall set forth the general nature of the
              business to be considered unless notice is waived by all the Directors either at, before or after the meeting is held. To any such notice of a meeting of the Directors all the provisions of the Articles relating to the giving of notices by
              the Company to the Members shall apply <font style="font-style: italic;">mutatis mutandis.</font></div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z2e4cfcd568554d468d8e54ac252bd405" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">31.6</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The continuing Directors (or a sole continuing Director, as the case may be) may act notwithstanding any vacancy in their body, but if and so long as their number is reduced below the number fixed by or pursuant to
              the Articles as the necessary quorum of Directors the continuing Directors or Director may act for the purpose of increasing the number of Directors to be equal to such fixed number, or of summoning a general meeting of the Company, but for
              no other purpose.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z4aba1dd8abd841d5b8745432778ed679" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">31.7</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The Directors may elect a chairperson of their board and determine the period for which they are to hold office; but if no such chairperson is elected, or if at any meeting the chairperson is not present within five
              minutes after the time appointed for the meeting to commence, the Directors present may choose one of their number to be chairperson of the meeting.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zaf50b845c92c4630a829ec0c59b80a84" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">31.8</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">All acts done by any meeting of the Directors or of a committee of the Directors shall, notwithstanding that it is afterwards discovered that there was some defect in the appointment of any Director, and/or that
              they or any of them were disqualified, and/or had vacated their office and/or were not entitled to vote, be as valid as if every such person had been duly appointed and/or not disqualified to be a Director and/or had not vacated their office
              and/or had been entitled to vote, as the case may be.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z3802e6ebedff402bbbd0dfdc359a4d45" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">31.9</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">A Director may be represented at any meetings of the board of Directors by a proxy appointed in writing by that Director. The proxy shall count towards the quorum and the vote of the proxy shall for all purposes be
              deemed to be that of the appointing Director.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zd1d2111e2aaf48e095b0e3e7b6f43247" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.28%; vertical-align: top;">&#160;</td>
          <td style="width: 6.46%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">32</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Presumption of Assent</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="margin: 0px 0px 0px 48pt;">A Director who is present at a meeting of the board of Directors at which action on any Company matter is taken shall be presumed to have assented to the action taken unless their dissent shall be entered in the
      minutes of the meeting or unless they shall file their written dissent from such action with the person acting as the chairperson or secretary of the meeting before the adjournment thereof or shall forward such dissent by registered post to such
      person immediately after the adjournment of the meeting. Such right to dissent shall not apply to a Director who voted in favour of such action.</div>
    <div style="margin-left: 36pt;"> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z75ec8808c3d74e1eabeeaaf100f9f526" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.32%; vertical-align: top;">&#160;</td>
          <td style="width: 6.42%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">33</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Directors&#8217; Interests</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z31903d142f48488bbd561c5c15a9b29d" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">33.1</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">A Director may hold any other office or place of profit under the Company (other than the office of Auditor) in conjunction with their office of Director for such period and on such terms as to remuneration and
              otherwise as the Directors may determine.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z6c34744948b54e43b97f86a0302ad9ed" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">33.2</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">A Director may act on their own or by, through or on behalf of their firm in a professional capacity for the Company and they or their firm shall be entitled to remuneration for professional services as if they were
              not a Director.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zd58122b2b0bf4dfb8626040c32e8875c" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">33.3</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">A Director may be or become a director or other officer of or otherwise interested in any company promoted by the Company or in which the Company may be interested as a shareholder, a contracting party or otherwise,
              and no such Director shall be accountable to the Company for any remuneration or other benefits received by them as a director or officer of, or from their interest in, such other company.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zaa7fe70b19a64cd3aa90480c926958df" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">33.4</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">No person shall be disqualified from the office of Director or prevented by such office from contracting with the Company, either as vendor, purchaser or otherwise, nor shall any such contract or any contract or
              transaction entered into by or on behalf of the Company in which any Director shall be in any way interested be or be liable to be avoided, nor shall any Director so contracting or being so interested be liable to account to the Company for
              any profit realised by or arising in connection with any such contract or transaction by reason of such Director holding office or of the fiduciary relationship thereby established. A Director shall be at liberty to vote in respect of any
              contract or transaction in which they are interested provided that the nature of the interest of any Director in any such contract or transaction shall be disclosed by them at or prior to its consideration and any vote thereon.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="ze05b5869da70443f841f91a6f34bf017" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">33.5</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">A general notice that a Director is a shareholder, director, officer or employee of any specified firm or company and is to be regarded as interested in any transaction with such firm or company shall be sufficient
              disclosure for the purposes of voting on a resolution in respect of a contract or transaction in which they have an interest, and after such general notice it shall not be necessary to give special notice relating to any particular
              transaction.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zfb735a8c0dd84060b7151e953bb58de1" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">34</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Minutes</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="margin: 0px 0px 0px 48pt;">The Directors shall cause minutes to be made in books kept for the purpose of recording all appointments of Officers made by the Directors, all proceedings at meetings of the Company or the holders of any class or
      series of Shares and of the Directors, and of committees of the Directors, including the names of the Directors present at each meeting.</div>
    <div style="margin-left: 36pt;"> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zb3ea5c20d1a74e50914bc1ff28b0286e" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.2%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">35</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Delegation of Directors&#8217; Powers</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z79db2a8cc8884a56b72b7fb7bfeb3efb" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">35.1</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The Directors may delegate any of their powers, authorities and discretions, including the power to sub-delegate, to any committee consisting of one or more Directors (including, without limitation, the Audit
              Committee, the Compensation Committee and the Nominating and Corporate Governance Committee). Any such delegation may be made subject to any conditions the Directors may impose and either collaterally with or to the exclusion of their own
              powers and any such delegation may be revoked or altered by the Directors. Subject to any such conditions, the proceedings of a committee of Directors shall be governed by the Articles regulating the proceedings of Directors, so far as they
              are capable of applying.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="ze271dc4cc42243ccb257b45150f4e328" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">35.2</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The Directors may establish any committees, local boards or agencies or appoint any person to be a manager or agent for managing the affairs of the Company and may appoint any person to be a member of such
              committees, local boards or agencies. Any such appointment may be made subject to any conditions the Directors may impose, and either collaterally with or to the exclusion of their own powers and any such appointment may be revoked or altered
              by the Directors. Subject to any such conditions, the proceedings of any such committee, local board or agency shall be governed by the Articles regulating the proceedings of Directors, so far as they are capable of applying.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.44%; vertical-align: top;">&#160;</td>
          <td style="width: 3.78%; vertical-align: top;">
            <div style="color: #000000;">35.3</div>
          </td>
          <td style="width: 95.67%; vertical-align: top;">
            <div style="color: #000000;">The Directors may adopt formal written charters for committees and, if so adopted, shall review and assess the adequacy of such formal written charters on an annual basis as may be required from time to time by the
              rules and regulations of the Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory authority or otherwise under Applicable Law. Each of these committees shall be empowered to do all things
              necessary to exercise the rights of such committee set forth in the Articles and shall have such powers as the Directors may delegate pursuant to the Articles and as required by the rules and regulations of the Designated Stock Exchange, the
              Securities and Exchange Commission and/or any other competent regulatory authority or otherwise under Applicable Law. Each of the Audit Committee, the Compensation Committee and the Nominating and Corporate Governance Committee, if
              established, shall consist of such number of Directors as the Directors shall from time to time determine (or such minimum number as may be required from time to time by the rules and regulations of the Designated Stock Exchange, the
              Securities and Exchange Commission and/or any other competent regulatory authority or otherwise under Applicable Law). For so long as any class or series of Shares is listed on the Designated Stock Exchange, the Audit Committee, the
              Compensation Committee and the Nominating and Corporate Governance Committee shall be made up of such number of Independent Directors as is required from time to time by the rules and regulations of the Designated Stock Exchange, the
              Securities and Exchange Commission and/or any other competent regulatory authority or otherwise under Applicable Law.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z1ee43da800754b9591ea45b4bbda0f18" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">35.4</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The Directors may by power of attorney or otherwise appoint any person to be the agent of the Company on such conditions as the Directors may determine, provided that the delegation is not to the exclusion of their
              own powers and may be revoked by the Directors at any time.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z41d8594bcd4b4f458b43e5b8742febc3" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">35.5</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The Directors may by power of attorney or otherwise appoint any company, firm, person or body of persons, whether nominated directly or indirectly by the Directors, to be the attorney or authorised signatory of the
              Company for such purpose and with such powers, authorities and discretions (not exceeding those vested in or exercisable by the Directors under the Articles) and for such period and subject to such conditions as they may think fit, and any
              such powers of attorney or other appointment may contain such provisions for the protection and convenience of persons dealing with any such attorneys or authorised signatories as the Directors may think fit and may also authorise any such
              attorney or authorised signatory to delegate all or any of the powers, authorities and discretions vested in them.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z542dc5fda6f9406da3daa5146bed0dd8" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">35.6</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The Directors may appoint such Officers as they consider necessary on such terms, at such remuneration and to perform such duties, and subject to such provisions as to disqualification and removal as the Directors
              may think fit. Unless otherwise specified in the terms of their appointment an Officer may be removed by resolution of the Directors or Members. An Officer may vacate their office at any time if they give notice in writing to the Company that
              they resign their office.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z4260cbff6467482bb71279536cf099b6" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.24%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">36</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">No Minimum Shareholding</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="margin: 0px 0px 0px 48pt;">The Company in general meeting may fix a minimum shareholding required to be held by a Director, but unless and until such a shareholding qualification is fixed a Director is not required to hold Shares.</div>
    <div style="margin-left: 36pt;"> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z43b3368e32614f1db5d30b8b48423f7c" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.24%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">37</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Remuneration of Directors</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zff4ff96a50ac40028e2c03fb7d4d5f1e" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">37.1</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The remuneration to be paid to the Directors, if any, shall be such remuneration as the Directors shall determine, provided that no cash remuneration shall be paid to any Director by the Company prior to the
              consummation of a Business Combination. The Directors shall also, whether prior to or after the consummation of a Business Combination, be entitled to be paid all travelling, hotel and other expenses properly incurred by them in connection
              with their attendance at meetings of Directors or committees of Directors, or general meetings of the Company, or separate meetings of the holders of any class or series of Shares or debentures of the Company, or otherwise in connection with
              the business of the Company or the discharge of their duties as a Director, or to receive a fixed allowance in respect thereof as may be determined by the Directors, or a combination partly of one such method and partly the other.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zdc3562b43d8e4b72a6a8cd5fc576fc80" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">37.2</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The Directors may by resolution approve additional remuneration to any Director for any services which in the opinion of the Directors go beyond that Director&#8217;s ordinary routine work as a Director. Any fees paid to
              a Director who is also counsel, attorney or solicitor to the Company, or otherwise serves it in a professional capacity shall be in addition to their remuneration as a Director.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z5f6e063c12714b29b02002f65aa09e41" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">38</div>
          </td>
          <td style="width: 94.24%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Seal</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zb3c16882254b4d949bff9eef4641a5b7" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">38.1</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The Company may, if the Directors so determine, have a Seal. The Seal shall only be used by the authority of the Directors or of a committee of the Directors authorised by the Directors. Every instrument to which
              the Seal has been affixed shall be signed by at least one person who shall be either a Director or some Officer or other person appointed by the Directors for the purpose.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zc7767dffb0524a62b3da27cbd782d2cb" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">38.2</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The Company may have for use in any place or places outside the Cayman Islands a duplicate Seal or Seals each of which shall be a facsimile of the common Seal of the Company and, if the Directors so determine, with
              the addition on its face of the name of every place where it is to be used.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z1ccf04b190e64edd8450f0e54ff5992c" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">38.3</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">A Director or Officer, representative or attorney of the Company may without further authority of the Directors affix the Seal over their signature alone to any document of the Company required to be authenticated
              by them under seal or to be filed with the Registrar of Companies in the Cayman Islands or elsewhere wheresoever.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z0700b2ee8e794f28bbf71fa2f0125041" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.18%; vertical-align: top;">&#160;</td>
          <td style="width: 5.91%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">39</div>
          </td>
          <td style="width: 93.91%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Dividends, Distributions and Reserve</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zdd15ffdeebac4dbda820e5a71193172f" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">39.1</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">Subject to the Statute and this Article and except as otherwise provided by the rights attached to any Shares, the Directors may resolve to pay Dividends and other distributions on Shares in issue and authorise
              payment of the Dividends or other distributions out of the funds of the Company lawfully available therefor. A Dividend shall be deemed to be an interim Dividend unless the terms of the resolution pursuant to which the Directors resolve to
              pay such Dividend specifically state that such Dividend shall be a final Dividend. No Dividend or other distribution shall be paid except out of the realised or unrealised profits of the Company, out of the share premium account or as
              otherwise permitted by law.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z302a7fe7e7fb4b20a687d11b4c4d62bf" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">39.2</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">Except as otherwise provided by the rights attached to any Shares, all Dividends and other distributions shall be paid according to the par value of the Shares that a Member holds. If any Share is issued on terms
              providing that it shall rank for Dividend as from a particular date, that Share shall rank for Dividend accordingly.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z6513aa56ac984a7d891cdd9e7517ee91" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">39.3</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The Directors may deduct from any Dividend or other distribution payable to any Member all sums of money (if any) then payable by the Member to the Company on account of calls or otherwise.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="ze29083464ddb45808498aa0e99524aa4" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">39.4</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The Directors may resolve that any Dividend or other distribution be paid wholly or partly by the distribution of specific assets and in particular (but without limitation) by the distribution of shares, debentures,
              or securities of any other company or in any one or more of such ways and where any difficulty arises in regard to such distribution, the Directors may settle the same as they think expedient and in particular may issue fractional Shares and
              may fix the value for distribution of such specific assets or any part thereof and may determine that cash payments shall be made to any Members upon the basis of the value so fixed in order to adjust the rights of all Members and may vest
              any such specific assets in trustees in such manner as may seem expedient to the Directors.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z2b30b43fd7774ae5862b6b44acad76c9" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">39.5</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">Except as otherwise provided by the rights attached to any Shares, Dividends and other distributions may be paid in any currency. The Directors may determine the basis of conversion for any currency conversions that
              may be required and how any costs involved are to be met.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zef06557b56c443e39bb42e3d69577e15" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">39.6</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The Directors may, before resolving to pay any Dividend or other distribution, set aside such sums as they think proper as a reserve or reserves which shall, at the discretion of the Directors, be applicable for any
              purpose of the Company and pending such application may, at the discretion of the Directors, be employed in the business of the Company.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z30263563a04d45fea8f0e5ef91cb645b" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">39.7</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">Any Dividend, other distribution, interest or other monies payable in cash in respect of Shares may be paid by wire transfer to the holder or by cheque or warrant sent through the post directed to the registered
              address of the holder or, in the case of joint holders, to the registered address of the holder who is first named on the Register of Members or to such person and to such address as such holder or joint holders may in writing direct. Every
              such cheque or warrant shall be made payable to the order of the person to whom it is sent. Any one of two or more joint holders may give effectual receipts for any Dividends, other distributions, bonuses, or other monies payable in respect
              of the Share held by them as joint holders.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z9d29626540314026aa5cedcb8cf0e0e8" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.1%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">39.8</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">No Dividend or other distribution shall bear interest against the Company.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z04fd2a1ddd544cfbb45d6a3b22017c33" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">39.9</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">Any Dividend or other distribution which cannot be paid to a Member and/or which remains unclaimed after six months from the date on which such Dividend or other distribution becomes payable may, in the discretion
              of the Directors, be paid into a separate account in the Company&#8217;s name, provided that the Company shall not be constituted as a trustee in respect of that account and the Dividend or other distribution shall remain as a debt due to the
              Member. Any Dividend or other distribution which remains unclaimed after a period of six years from the date on which such Dividend or other distribution becomes payable shall be forfeited and shall revert to the Company.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z6402ef70d6884e5ab6cecdd4337dbd73" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">39.10</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">Prior to the Deadline Date, the Directors may not resolve to pay Dividends and other distributions on Shares in issue and authorise payment of the Dividends or other distributions out of the funds of the Company
              lawfully available therefor.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zab2c8149f84d4f04aee9f756281be810" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">39.11</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">Other than with respect to payments or distributions from the Trust Account, no Dividends or other distributions shall be payable on the Class A Shares.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z924fb4bb4ba44278b2e3ed884c74f0ce" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.45%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">40</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Capitalisation</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="margin: 0px 0px 0px 48pt;">The Directors may at any time capitalise any sum standing to the credit of any of the Company&#8217;s reserve accounts or funds (including the share premium account and capital redemption reserve fund) or any sum
      standing to the credit of the profit and loss account or otherwise available for distribution; appropriate such sum to Members in the proportions in which such sum would have been divisible amongst such Members had the same been a distribution of
      profits by way of Dividend or other distribution; and apply such sum on their behalf in paying up in full unissued Shares for allotment and distribution credited as fully paid-up to and amongst them in the proportion aforesaid. In such event the
      Directors shall do all acts and things required to give effect to such capitalisation, with full power given to the Directors to make such provisions as they think fit in the case of Shares becoming distributable in fractions (including provisions
      whereby the benefit of fractional entitlements accrue to the Company rather than to the Members concerned). The Directors may authorise any person to enter on behalf of all of the Members interested into an agreement with the Company providing for
      such capitalisation and matters incidental or relating thereto and any agreement made under such authority shall be effective and binding on all such Members and the Company.</div>
    <div style="margin-left: 36pt;"> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zf440f51442374226917bf0675e4413c1" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.35%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">41</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Books of Account</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="ze989d4cc830d49f19ab3a57b0bd1bf01" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">41.1</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The Directors shall cause proper books of account (including, where applicable, material underlying documentation including contracts and invoices) to be kept with respect to all sums of money received and expended
              by the Company and the matters in respect of which the receipt or expenditure takes place, all sales and purchases of goods by the Company and the assets and liabilities of the Company. Such books of account must be retained for a minimum
              period of five years from the date on which they are prepared. Proper books shall not be deemed to be kept if there are not kept such books of account as are necessary to give a true and fair view of the state of the Company&#8217;s affairs and to
              explain its transactions.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z25085eb2fe5748488f3e1969f2fd696a" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">41.2</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The Directors shall determine whether and to what extent and at what times and places and under what conditions or regulations the accounts and books of the Company or any of them shall be open to the inspection of
              Members not being Directors and no Member (not being a Director) shall have any right of inspecting any account or book or document of the Company except as conferred by Statute or authorised by the Directors or by the Company in general
              meeting.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z412121ba52d94e62a0992acef70b464a" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">41.3</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The Directors may cause to be prepared and to be laid before the Company in general meeting profit and loss accounts, balance sheets, group accounts (if any) and such other reports and accounts as may be required by
              law.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z0c3b6ff4f2144382b1cc6fde52e1dd4b" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">42</div>
          </td>
          <td style="width: 94.24%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Audit</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z0fa7183f61e64495bc77478862bede10" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">42.1</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The Directors may appoint an Auditor of the Company who shall hold office on such terms as the Directors determine.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z4c218ca5f70040cd8ca2e51cd46c7974" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">42.2</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">Without prejudice to the freedom of the Directors to establish any other committee, if the Shares (or depositary receipts therefor) are listed or quoted on the Designated Stock Exchange, and if required by the rules
              and regulations of the Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory authority or otherwise under Applicable Law, the Directors shall establish and maintain an Audit Committee as a
              committee of the Directors and shall adopt a formal written Audit Committee charter and review and assess the adequacy of the formal written charter on an annual basis. The composition and responsibilities of the Audit Committee shall comply
              with the rules and regulations of the Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory authority or otherwise under Applicable Law. The Audit Committee shall meet at least once every
              financial quarter, or more frequently as circumstances dictate.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="za266a366a73e41e8a0b931facff1252f" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">42.3</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">If the Shares (or depositary receipts therefor) are listed or quoted on the Designated Stock Exchange, the Company shall conduct an appropriate review of all related party transactions on an ongoing basis and shall
              utilise the Audit Committee for the review and approval of potential conflicts of interest.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zd9ce899734704a18a2478acd52fa9137" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.09%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">42.4</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">The remuneration of the Auditor shall be fixed by the Audit Committee (if one exists).</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z02f6be3cad1c4377af8e0ba666ee68fd" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">42.5</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">If the office of Auditor becomes vacant by resignation or death of the Auditor, or by their becoming incapable of acting by reason of illness or other disability at a time when their services are required, the
              Directors shall fill the vacancy and determine the remuneration of such Auditor.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z1f25326d1be4462dbfd0e7d8026cd8e8" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">42.6</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">Every Auditor of the Company shall have a right of access at all times to the books and accounts and vouchers of the Company and shall be entitled to require from the Directors and Officers such information and
              explanation as may be necessary for the performance of the duties of the Auditor.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="ze8dafc740ba847a48d293c99ec657cd9" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">42.7</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">Auditors shall, if so required by the Directors, make a report on the accounts of the Company during their tenure of office at the next annual general meeting following their appointment in the case of a company
              which is registered with the Registrar of Companies as an ordinary company, and at the next extraordinary general meeting following their appointment in the case of a company which is registered with the Registrar of Companies as an exempted
              company, and at any other time during their term of office, upon request of the Directors or any general meeting of the Members.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z7cde874c20fc436a9fac3ea7723c2280" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">42.8</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">Any payment made to members of the Audit Committee (if one exists) shall require the review and approval of the Directors, with any Director interested in such payment abstaining from such review and approval.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z29d558f23efb420da848b8fa5c045ec4" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">42.9</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The Audit Committee shall monitor compliance with the terms of the IPO and, if any non-compliance is identified, the Audit Committee shall be charged with the responsibility to take all action necessary to rectify
              such non-compliance or otherwise cause compliance with the terms of the IPO.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z5bd4f27a2456450aaf554d2708a7bdee" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">42.10</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">At least one member of the Audit Committee shall be an &#8220;audit committee financial expert&#8221; as determined by the rules and regulations of the Designated Stock Exchange, the Securities and Exchange Commission and/or
              any other competent regulatory authority or otherwise under Applicable Law. The &#8220;audit committee financial expert&#8221; shall have such past employment experience in finance or accounting, requisite professional certification in accounting, or any
              other comparable experience or background which results in the individual&#8217;s financial sophistication.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z6af06ac0a76742e690f8a758ebf98db7" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">43</div>
          </td>
          <td style="width: 94.24%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Notices</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zbf69bb90a7de4f8bbb909e862d6da519" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">43.1</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">Notices shall be in writing and may be given by the Company to any Member either personally or by sending it by courier, post, telex, fax or email to such Member or to such Member&#8217;s address as shown in the Register
              of Members (or where the notice is given by email by sending it to the email address provided by such Member). Notice may also be served by Electronic Communication in accordance with the rules and regulations of the Designated Stock
              Exchange, the Securities and Exchange Commission and/or any other competent regulatory authority or by placing it on the Company&#8217;s Website.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z5e2f97db45c04fce9c4ac6f26fda26aa" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.24%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">43.2</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">Where a notice is sent by:</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z8757ff46de1945a09a7fd697f537f016" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">(a)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">&#160;courier; service of the notice shall be deemed to be effected by delivery of the notice to a courier company, and shall be deemed to have been received on the third day (not including Saturdays or Sundays or public
              holidays) following the day on which the notice was delivered to the courier;</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="ze7512327dcfd4f9a84289353a38fa114" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">(b)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">post; service of the notice shall be deemed to be effected by properly addressing, pre paying and posting a letter containing the notice, and shall be deemed to have been received on the fifth day (not including
              Saturdays or Sundays or public holidays in the Cayman Islands) following the day on which the notice was posted;</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z9df36365d6684c62ada3d30027bddad7" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">(c)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">telex or fax; service of the notice shall be deemed to be effected by properly addressing and sending such notice and shall be deemed to have been received on the same day that it was transmitted;</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zacaf86a6c43e406db0946140d6544bb6" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">(d)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">email or other Electronic Communication; service of the notice shall be deemed to be effected by transmitting the email to the email address provided by the intended recipient and shall be deemed to have been
              received on the same day that it was sent, and it shall not be necessary for the receipt of the email to be acknowledged by the recipient; and</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z3fec0d739d384195859e3597b92723c6" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">(e)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">placing it on the Company&#8217;s Website; service of the notice shall be deemed to have been effected one hour after the notice or document was placed on the Company&#8217;s Website.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z7415ad8725f34e7e93a0eb27f43e9b6b" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">43.3</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">A notice may be given by the Company to the person or persons which the Company has been advised are entitled to a Share or Shares in consequence of the death or bankruptcy of a Member in the same manner as other
              notices which are required to be given under the Articles and shall be addressed to them by name, or by the title of representatives of the deceased, or trustee of the bankrupt, or by any like description at the address supplied for that
              purpose by the persons claiming to be so entitled, or at the option of the Company by giving the notice in any manner in which the same might have been given if the death or bankruptcy had not occurred.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z34679bebf74c46f7bf560ec8163114f7" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">43.4</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">Notice of every general meeting shall be given in any manner authorised by the Articles to every holder of Shares carrying an entitlement to receive such notice on the record date for such meeting except that in the
              case of joint holders the notice shall be sufficient if given to the joint holder first named in the Register of Members and every person upon whom the ownership of a Share devolves because they are a legal personal representative or a
              trustee in bankruptcy of a Member where the Member but for their death or bankruptcy would be entitled to receive notice of the meeting, and no other person shall be entitled to receive notices of general meetings.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z54f59b0232a74dadb2629dc3df5f5abd" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.48%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">44</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Winding Up</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zd00b70b0cadc4caf82620131e41449d3" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">44.1</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">If the Company shall be wound up, the liquidator shall apply the assets of the Company in satisfaction of creditors&#8217; claims in such manner and order as such liquidator thinks fit. Subject to the rights attaching to
              any Shares, in a winding up:</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z447cf73c28044910b810f0ca187e1369" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">(a)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">&#160;if the assets available for distribution amongst the Members shall be insufficient to repay the whole of the Company&#8217;s issued share capital, such assets shall be distributed so that, as nearly as may be, the losses
              shall be borne by the Members in proportion to the par value of the Shares held by them; or</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z7c9d26bc51944095b7a4d81fce36c860" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">(b)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">&#160;if the assets available for distribution amongst the Members shall be more than sufficient to repay the whole of the Company&#8217;s issued share capital at the commencement of the winding up, the surplus shall be
              distributed amongst the Members in proportion to the par value of the Shares held by them at the commencement of the winding up subject to a deduction from those Shares in respect of which there are monies due, of all monies payable to the
              Company for unpaid calls or otherwise.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zaa15e29396954940a6d7d1118103f7cf" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">44.2</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">&#160;If the Company shall be wound up the liquidator may, subject to the rights attaching to any Shares and with the approval of a Special Resolution of the Company and any other approval required by the Statute, divide
              amongst the Members in kind the whole or any part of the assets of the Company (whether such assets shall consist of property of the same kind or not) and may for that purpose value any assets and determine how the division shall be carried
              out as between the Members or different classes of Members. The liquidator may, with the like approval, vest the whole or any part of such assets in trustees upon such trusts for the benefit of the Members as the liquidator, with the like
              approval, shall think fit, but so that no Member shall be compelled to accept any asset upon which there is a liability.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zbeeec6bc7c964cff87648986b7742357" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.25%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">45</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Indemnity and Insurance</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z9d44fc03eb7a424b959f52798538d228" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">45.1</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">&#160;Every Director and Officer (which for the avoidance of doubt, shall not include auditors of the Company), together with every former Director and former Officer (each an &#8220;<font style="font-weight: bold;">Indemnified






                Person</font>&#8221;) shall be indemnified out of the assets of the Company against any liability, action, proceeding, claim, demand, costs, damages or expenses, including legal expenses, whatsoever which they or any of them may incur as a result
              of any act or failure to act in carrying out their functions other than such liability (if any) that they may incur by reason of their own actual fraud, wilful neglect or wilful default. No Indemnified Person shall be liable to the Company
              for any loss or damage incurred by the Company as a result (whether direct or indirect) of the carrying out of their functions unless that liability arises through the actual fraud, wilful neglect or wilful default of such Indemnified Person.
              No person shall be found to have committed actual fraud, wilful neglect or wilful default under this Article unless or until a court of competent jurisdiction shall have made a finding to that effect.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z740ebc1817a0442bb6f9efc2c0b47eac" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">45.2</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The Company shall advance to each Indemnified Person reasonable attorneys&#8217; fees and other costs and expenses incurred in connection with the defence of any action, suit, proceeding or investigation involving such
              Indemnified Person for which indemnity will or could be sought. In connection with any advance of any expenses hereunder, the Indemnified Person shall execute an undertaking to repay the advanced amount to the Company if it shall be
              determined by final judgment or other final adjudication that such Indemnified Person was not entitled to indemnification pursuant to this Article. If it shall be determined by a final judgment or other final adjudication that such
              Indemnified Person was not entitled to indemnification with respect to such judgment, costs or expenses, then such party shall not be indemnified with respect to such judgment, costs or expenses and any advancement shall be returned to the
              Company (without interest) by the Indemnified Person.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z17e97ba862f2455886e1b59f8e63865e" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">45.3</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">The Directors, on behalf of the Company, may purchase and maintain insurance for the benefit of any Director or Officer against any liability which, by virtue of any rule of law, would otherwise attach to such
              person in respect of any negligence, default, breach of duty or breach of trust of which such person may be guilty in relation to the Company.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z5b877ece3779435e9055e39654a31d13" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.41%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">46</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Financial Year</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="margin: 0px 0px 0px 48pt;">Unless the Directors otherwise prescribe, the financial year of the Company shall end on 31st December in each year and, following the year of incorporation, shall begin on 1st January in each year.</div>
    <div style="margin-left: 36pt;"> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="ze74dcf104f7c488db50d5dadc52501a5" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.19%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">47</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Transfer by Way of Continuation</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div>
      <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 0.06%; vertical-align: top;">&#160;</td>
            <td style="width: 3.74%; vertical-align: top;">
              <div style="color: #000000;">47.1</div>
            </td>
            <td style="width: 96.2%; vertical-align: top;">If the Company is exempted as defined in the Statute, it shall, subject to the provisions of the Statute and with the approval of a Special Resolution passed in accordance with this Article 47,
              have the power to register by way of continuation as a body corporate under the laws of any jurisdiction outside the Cayman Islands and to be deregistered in the Cayman Islands.</td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 0.09%; vertical-align: top;">&#160;</td>
            <td style="width: 4%; vertical-align: top;">
              <div style="color: #000000;">47.2</div>
            </td>
            <td style="width: 96%; vertical-align: top;">
              <div style="color: #000000;">Prior to the closing of a Business Combination:</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 7%; vertical-align: top;">&#160;</td>
            <td style="width: 4%; vertical-align: top;">
              <div style="color: #000000;">(a)<br>
              </div>
            </td>
            <td style="width: 89%; vertical-align: top;">
              <div>only the Class B Shares shall carry the right to vote on any resolution of the shareholders to approve any transfer by way of continuation pursuant to this Article (including any Special Resolution required to amend the constitutional
                documents of the Company or to adopt new constitutional documents of the Company, in each case, as a result of the Company approving a transfer by way of continuation in a jurisdiction outside the Cayman Islands); and</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 7%; vertical-align: top;">&#160;</td>
            <td style="width: 4%; vertical-align: top;">
              <div style="color: #000000;">(b)<br>
              </div>
            </td>
            <td style="width: 89%; vertical-align: top;">
              <div>this Article 47.2 may only be amended by a Special Resolution passed by at least 90% (or, where such amendment is proposed in respect of the consummation of a Business Combination, at least two-thirds) of such Members as, being entitled
                to do so, vote in person or, where proxies are allowed, by proxy at a general meeting of which notice specifying the intention to propose the resolution as a special resolution has been given, or by way of unanimous written resolution.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="margin-left: 36pt;"> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zcacbf17eaf66452bb398e40092f10fff" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.24%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">48</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Mergers and Consolidations</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="margin: 0px 0px 0px 48pt;">The Company shall have the power to merge or consolidate with one or more other constituent companies (as defined in the Statute) upon such terms as the Directors may determine and (to the extent required by the
      Statute) with the approval of a Special Resolution.</div>
    <div style="margin-left: 36pt;"> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z850bbc8fd0a840e2885bab2e57d5172d" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.29%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">49</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Business Combination</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z79f89b49f2a24c829a8716ba4bc919e1" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">49.1</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">Notwithstanding any other provision of the Articles, this Article shall apply during the period commencing upon the adoption of the Articles and terminating upon the first to occur of the consummation of a Business
              Combination and the full distribution of the Trust Account pursuant to this Article. In the event of a conflict between this Article and any other Articles, the provisions of this Article shall prevail.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zcb14743dade3483f89ee10433610e791" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.09%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">49.2</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">Prior to the consummation of a Business Combination, the Company shall either:</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z1ec97be4b79d4d96b82b555b7b707253" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.11%; vertical-align: top;">&#160;</td>
          <td style="width: 3.96%; vertical-align: top;">
            <div style="color: #000000;">(a)</div>
          </td>
          <td style="width: 95.93%; vertical-align: top;">
            <div style="color: #000000;">submit such Business Combination to its Members for approval; or</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zeca297287f9744468089f43328704b8a" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">(b)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">provide Members with the opportunity to have their Shares repurchased by means of a tender offer for a per-Share repurchase price payable in cash, equal to the aggregate amount then on deposit in the Trust Account,
              calculated as of two business days prior to the consummation of such Business Combination, including interest earned on the Trust Account (net of taxes paid or payable, if any), divided by the number of then issued Public Shares. Such
              obligation to repurchase Shares is subject to the completion of the proposed Business Combination to which it relates.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z6f06716d2adc4eb8a8296c6358943e42" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">49.3</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">If the Company initiates any tender offer in accordance with Rule 13e-4 and Regulation 14E of the Exchange Act in connection with a proposed Business Combination, it shall file tender offer documents with the
              Securities and Exchange Commission prior to completing such Business Combination which contain substantially the same financial and other information about such Business Combination and the redemption rights as is required under Regulation
              14A of the Exchange Act. If, alternatively, the Company holds a general meeting to approve a proposed Business Combination, the Company will conduct any redemptions in conjunction with a proxy solicitation pursuant to Regulation 14A of the
              Exchange Act, and not pursuant to the tender offer rules, and file proxy materials with the Securities and Exchange Commission.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z4320457dfaef43249bc8cca5803a7e16" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">49.4</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">At a general meeting called for the purposes of approving a Business Combination pursuant to this Article, in the event that such Business Combination is approved by Ordinary Resolution, the Company shall be
              authorised to consummate such Business Combination, provided that the Company shall not consummate such Business Combination unless the Company meets the net tangible asset or cash requirement that may be contained in the agreement relating
              to, such Business Combination.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zd353e32b81e7465f87d43ec901c1b5a8" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">49.5</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">Any Member holding Public Shares who is not the Sponsor, a Founder, Officer or Director may, at least two business days&#8217; prior to any vote on a Business Combination, elect to have their Public Shares redeemed for
              cash, in accordance with any applicable requirements provided for in the related proxy materials (the &#8220;<font style="font-weight: bold;">Business Combination Redemption</font>&#8221;), provided that no such Member acting together with any Affiliate
              of their or any other person with whom they are acting in concert or as a partnership, limited partnership, syndicate, or other group (including, for the avoidance of doubt, a &#8220;group&#8221; (as defined under Section 13 of the Exchange Act) for the
              purposes of acquiring, holding, or disposing of Shares may exercise this redemption right with respect to more than 15% of the Public Shares in the aggregate without the prior consent of the Company and provided further that any beneficial
              holder of Public Shares on whose behalf a redemption right is being exercised must identify itself to the Company in connection with any redemption election in order to validly redeem such Public Shares. If so demanded, the Company shall pay
              any such redeeming Member, regardless of whether they are voting for or against such proposed Business Combination, a per-Share redemption price payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as
              of two business days prior to the consummation of the Business Combination, including interest earned on the Trust Account (such interest shall be net of taxes payable) and not previously released to the Company to pay its taxes, divided by
              the number of then issued Public Shares (such redemption price being referred to herein as the &#8220;<font style="font-weight: bold;">Redemption Price</font>&#8221;), but only in the event that the applicable proposed Business Combination is approved
              and in connection with its consummation.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z78aa7a06828849e7aa673f905a04c1b3" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">49.6</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">A Member may not withdraw a Redemption Notice once submitted to the Company unless the Directors determine (in their sole discretion) to permit the withdrawal of such redemption request (which they may do in whole
              or in part). The Directors (in their sole discretion) shall determine the timing of such Business Combination Redemption of Public Shares in order to facilitate the consummation and/or closing of a Business Combination.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z083c70dcae0849b592216ce7ea70d44d" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.34%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">49.7</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">In the event that:</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z6234ed96785849bb9042f72e4f475bed" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">(a)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">the Company does not consummate a Business Combination within 24 months from the consummation of the IPO (the &#8220;<font style="font-weight: bold;">Deadline Date</font>&#8221;), or such later time as the Members may approve
              by Special Resolution in accordance with the Articles; or</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z8f32db64087e43ffb97bd78b41e0f3a5" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">(b)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">if the Directors, acting in good faith, determine by resolution, and provide notice in writing to the Members, that the Company is unable to consummate a Business Combination by the Deadline Date,</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="margin: 0px 0px 0px 48pt;">the Company shall:</div>
    <div style="text-indent: 36pt; margin-left: 36pt;"> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zd295771dfb474d8ebba6cebb65575458" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.13%; vertical-align: top;">&#160;</td>
          <td style="width: 3.92%; vertical-align: top;">
            <div style="color: #000000;">(i)</div>
          </td>
          <td style="width: 95.95%; vertical-align: top;">
            <div style="color: #000000;">cease all operations except for the purpose of winding up;</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z768e1fe2613344eab6342e89caff2418" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">(ii)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-Share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account,
              including interest earned on the funds held in the Trust Account and not previously released to the Company (less taxes payable and up to US$100,000 of interest to pay dissolution expenses), divided by the number of then Public Shares in
              issue, which redemption will completely extinguish public Members&#8217; rights as Members (including the right to receive further liquidation distributions, if any); and</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zc6867b21c879470ab220777b3973449e" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">(iii)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">as promptly as reasonably possible following such redemption, subject to the approval of the Company&#8217;s remaining Members and the Directors, liquidate and dissolve,</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="margin: 0px 0px 0px 48pt;">subject in each case to its obligations under Cayman Islands law to provide for claims of creditors and other requirements of Applicable Law.</div>
    <div style="margin-left: 72pt;"> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zacedbc025dbc407b8e0208e08ec05818" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.09%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">49.8</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">In the event that any amendment is made to the Articles (an &#8220;<font style="font-weight: bold;">Amendment</font>&#8221;):</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zcafad02c82d34d9682358f257ee564e4" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">(a)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">to modify the substance or timing of the Company&#8217;s obligation to allow redemption in connection with a Business Combination or redeem 100% of the Public Shares if the Company does not consummate a Business
              Combination by the Deadline Date, or such later time as the Members may approve by Special Resolution in accordance with the Articles; or</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zb9e2555d8c4046e68f658d59fe6694cd" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.07%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">(b)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">with respect to any other provision relating to Members&#8217; rights or pre-Business Combination activity,</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="margin: 0px 0px 0px 48pt;">any Member holding Public Shares who is not the Sponsor, a Founder, Officer or Director may, at least two business days&#8217; prior to any vote on an Amendment, elect to have their Public Shares redeemed for cash, in
      accordance with any applicable requirements provided for in the related proxy materials (the &#8220;<font style="font-weight: bold;">Amendment Redemption</font>&#8221;), provided that no such Member acting together with any Affiliate of their or any other person
      with whom they are acting in concert or as a partnership, limited partnership, syndicate, or other group (including, for the avoidance of doubt, a &#8220;group&#8221; (as defined under Section 13 of the Exchange Act) for the purposes of acquiring, holding, or
      disposing of Shares may exercise this redemption right with respect to more than 15% of the Public Shares in the aggregate without the prior consent of the Company and provided further that any beneficial holder of Public Shares on whose behalf a
      redemption right is being exercised must identify itself to the Company in connection with any redemption election in order to validly redeem such Public Shares. If so demanded, the Company shall pay any such redeeming Member, regardless of whether
      they are voting for or against such proposed Amendment, the Redemption Price, but only in the event that the applicable proposed Amendment is approved. The Directors (in their sole discretion) shall determine the timing of any such Amendment
      Redemption.</div>
    <div style="margin-left: 36pt;"> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zadc4789415f14b3eb2739cdcf6f5b16e" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">49.9</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">A holder of Public Shares shall be entitled to receive distributions from the Trust Account only in the event of a Business Combination Redemption, an Amendment Redemption, a repurchase of Shares by means of a
              tender offer pursuant to this Article, or a distribution of the Trust Account pursuant to this Article. In no other circumstance shall a holder of Public Shares have any right or interest of any kind in the Trust Account.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zbf8d5c40abd94415b9eca28bafadc420" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">49.10</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">Except in connection with the conversion of Class B Shares into Class A Shares pursuant to the Class B Ordinary Share Conversion Article hereof where the holders of such Shares have waived any right to receive funds
              from the Trust Fund, after the issue of Public Shares, and prior to the consummation of a Business Combination, the Company shall not issue additional Shares or any other securities that would entitle the holders thereof to:</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z2e9c33e86c2545389870ac0d4c287706" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.17%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">(a)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">receive funds from the Trust Account; or</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z271f6010475e49f6b54e3e7a2a99097b" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.12%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">(b)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">vote as a class with Public Shares on a Business Combination.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z31d3d4103fa64e9d9f11fffc42734c82" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">49.11</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">The uninterested Independent Directors shall approve any transaction or transactions between the Company and any of the following parties:</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zb361933a21354ea7b73914f36aa41646" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">(a)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">any Member owning an interest in the voting power of the Company that gives such Member a significant influence over the Company; and</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z473ee92c2cf24fea9e98950bcfe2a6b5" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.1%; vertical-align: top;">&#160;</td>
          <td style="width: 4.08%; vertical-align: top;">
            <div style="color: #000000;">(b)</div>
          </td>
          <td style="width: 95.82%; vertical-align: top;">
            <div style="color: #000000;">any Director or Officer and any Affiliate of such Director or Officer.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z64d4ba97f8f44bb5a12e54199e4737cb" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">49.12</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">A Director may vote in respect of a Business Combination in which such Director has a conflict of interest with respect to the evaluation of such Business Combination. Such Director must disclose such interest or
              conflict to the other Directors.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zc8b507ddd6024e3e926dbd2a58a7781b" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">49.13</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">As long as the securities of the Company are listed on The NASDAQ Global Market, the Company must complete one or more Business Combinations having an aggregate fair market value of at least 80% of the assets held
              in the Trust Account (excluding any deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time of the Company&#8217;s signing a definitive agreement in connection with a Business Combination. A
              Business Combination must not be solely effectuated with another blank cheque company or a similar company with nominal operations.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zbf11ddc908dd4800a8fa1035a6bf334a" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">49.14</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">The Company may enter into a Business Combination with a target business that is Affiliated with the Sponsor, a Founder, a Director or an Officer. In the event the Company seeks to consummate a Business Combination
              with a target that is Affiliated with the Sponsor, a Founder, a Director or an Officer, the Company, or a committee of Independent Directors, will obtain an opinion from an independent investment banking firm or another valuation or appraisal
              firm that regularly renders fairness opinions on the type of target business the Company is seeking to acquire that is a member of the United States Financial Industry Regulatory Authority or an independent accounting firm that such a
              Business Combination is fair to the Company from a financial point of view.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zcb2f99bb2b2e4cf4a566aac55204ed71" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.32%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">50</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Certain Tax Filings</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="margin: 0px 0px 0px 48pt;">Each Tax Filing Authorised Person and any such other person, acting alone, as any Director shall designate from time to time, are authorised to file or execute and provide United States Internal Revenue Service
      tax forms SS-4, W-8 BEN, W-8 IMY, W-9, 8832 and 2553 and such other similar tax forms as are customary to file with any United States state or federal governmental authorities or foreign governmental authorities, or provide to withholding agents in
      connection with the formation, activities and/or elections of the Company and such other tax forms as may be approved from time to time by any Director or Officer. The Company further ratifies and approves any such filing made by any Tax Filing
      Authorised Person or such other person prior to the date of the Articles.</div>
    <div style="margin-left: 36pt;"> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zcd50638c815247ee9ea413ba6089a2ea" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.27%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">51</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Business Opportunities</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zcf4dc1d1c5d744bd9eda6bdab3c93dde" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">51.1</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">To the fullest extent permitted by Applicable Law, no individual serving as a Director or an Officer (&#8220;<font style="font-weight: bold;">Management</font>&#8221;) shall have any duty, except and to the extent expressly
              assumed by contract, to refrain from engaging directly or indirectly in the same or similar business activities or lines of business as the Company. To the fullest extent permitted by Applicable Law, the Company renounces any interest or
              expectancy of the Company in, or in being offered an opportunity to participate in, any potential transaction or matter which may be a corporate opportunity for Management, on the one hand, and the Company, on the other. Except to the extent
              expressly assumed by contract, to the fullest extent permitted by Applicable Law, Management shall have no duty to communicate or offer any such corporate opportunity to the Company and shall not be liable to the Company or its Members for
              breach of any fiduciary duty as a Member, Director and/or Officer solely by reason of the fact that such party pursues or acquires such corporate opportunity for itself, directs such corporate opportunity to another person, or does not
              communicate information regarding such corporate opportunity to the Company.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="za3445ed6d20d4d3b98a234f30fffee64" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">51.2</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">Except as provided elsewhere in this Article, the Company hereby renounces any interest or expectancy of the Company in, or in being offered an opportunity to participate in, any potential transaction or matter
              which may be a corporate opportunity for both the Company and Management, about which a Director and/or Officer who is also a member of Management acquires knowledge.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z6f5066be155442bc896ae4cff55bb648" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">51.3</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">To the extent a court might hold that the conduct of any activity related to a corporate opportunity that is renounced in this Article to be a breach of duty to the Company or its Members, the Company hereby waives,
              to the fullest extent permitted by Applicable Law, any and all claims and causes of action that the Company may have for such activities. To the fullest extent permitted by Applicable Law, the provisions of this Article apply equally to
              activities conducted in the future and that have been conducted in the past.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="za2caf477110c415ab2c391818155534b" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.19%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">52</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Exclusive Jurisdiction and Forum</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z031455c6808342b68372f0c73be2eb9e" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">52.1</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">Unless the Company consents in writing to the selection of an alternative forum, the courts of the Cayman Islands shall have exclusive jurisdiction over any claim or dispute arising out of or in connection with the
              Memorandum, the Articles or otherwise related in any way to each Member&#8217;s shareholding in the Company, including but not limited to:</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zec6d6526b381457fb7dd166096ea2085" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.1%; vertical-align: top;">&#160;</td>
          <td style="width: 3.75%; vertical-align: top;">
            <div style="color: #000000;">(a)</div>
          </td>
          <td style="width: 96.15%; vertical-align: top;">
            <div style="color: #000000;">any derivative action or proceeding brought on behalf of the Company;</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="za23f70ab5a684ef7a4f47388b61f3592" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">(b)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">any action asserting a claim of breach of any fiduciary or other duty owed by any current or former Director, Officer or other employee of the Company to the Company or the Members;</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z69fe1feea5f8488aa2b8a54293c57afb" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">(c)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">any action asserting a claim arising pursuant to any provision of the Statute, the Memorandum or the Articles; or</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zb4ae54fd31064c63a77a0fb36f5248d4" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="color: #000000;">(d)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="color: #000000;">any action asserting a claim against the Company governed by the &#8220;Internal Affairs Doctrine&#8221; (as such concept is recognised under the laws of the United States of America).</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z034dc98327a043889b612ee2538f3193" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">52.2</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">Each Member irrevocably submits to the exclusive jurisdiction of the courts of the Cayman Islands over all such claims or disputes.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z893fbf9b966148e898cbf38e5e766f14" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">52.3</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">Without prejudice to any other rights or remedies that the Company may have, each Member acknowledges that damages alone would not be an adequate remedy for any breach of the selection of the courts of the Cayman
              Islands as exclusive forum and that accordingly the Company shall be entitled, without proof of special damages, to the remedies of injunction, specific performance or other equitable relief for any threatened or actual breach of the
              selection of the courts of the Cayman Islands as exclusive forum.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z4c1083d1aaf549e098b009247055e0a0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.74%; vertical-align: top;">
            <div style="color: #000000;">52.4</div>
          </td>
          <td style="width: 96.2%; vertical-align: top;">
            <div style="color: #000000;">This Article 52 shall not apply to any action or suits brought to enforce any liability or duty created by the United States Securities Act of 1933, as amended, the Exchange Act, or any claim for which the federal
              district courts of the United States of America are, as a matter of the laws of the United States, the sole and exclusive forum for determination of such a claim.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"> </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>ny20046456x10_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade">
    <div>
      <div> </div>
      <div style="text-align: right;"> <font style="font-weight: bold;">Exhibit 5.1</font></div>
      <div style="text-align: right;"><font style="font-weight: bold;"> <br>
        </font></div>
    </div>
    <div><img src="ny20046456x10_ex5-1image01.jpg"><font style="font-weight: bold;"> </font></div>
    <div><font style="font-weight: bold;"> </font></div>
    <div><font style="font-weight: bold;"><br>
      </font>
      <div>
        <div>&#160;June 25, 2025</div>
      </div>
      <div><br>
      </div>
      <div>Vendome Acquisition Corporation I</div>
      <div>1090 Center Drive Park City, UT 84098</div>
      <div><br>
      </div>
      <table id="z61c9c93584f34115a19e3316e6cfb7ba" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt; vertical-align: top;">Re:</td>
            <td style="width: auto; vertical-align: top;">
              <div>Vendome Acquisition Corporation I Registration Statement on Form S-1</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div>Ladies and Gentlemen:</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: #000000;">We have acted as United States counsel to</font> Vendome Acquisition Corporation I<font style="color: #000000;">, a Cayman Islands exempted company (the &#8220;</font><font style="font-weight: bold; font-style: italic; color: #000000;">Company</font><font style="color: #000000;">&#8221;), in connection with the preparation and filing with the U.S. Securities and Exchange Commission (the &#8220;</font><font style="font-weight: bold; font-style: italic; color: #000000;">Commission</font><font style="color: #000000;">&#8221;), pursuant to the Securities Act of 1933, as amended (the &#8220;</font><font style="font-weight: bold; font-style: italic; color: #000000;">Securities Act</font><font style="color: #000000;">&#8221;), of the Registration Statement on Form S-1 (File No. 333-286534) of the Company, initially filed with the Commission on April 15, 2025 (as amended through the date hereof, the &#8220;</font><font style="font-weight: bold; font-style: italic; color: #000000;">Registration Statement</font><font style="color: #000000;">&#8221;), including a related prospectus filed with the Registration Statement (the &#8220;</font><font style="font-weight: bold; font-style: italic; color: #000000;">Prospectus</font><font style="color: #000000;">&#8221;) relating to the proposed underwritten public offering of up to 23,000,000</font>&#160;<font style="color: #000000;">units of the Company (the &#8220;</font><font style="font-weight: bold; font-style: italic; color: #000000;">Units</font><font style="color: #000000;">&#8221;) (which includes up to 3,000,000 Units that may be issued and sold pursuant to the exercise of an over-allotment option described in the Registration Statement),
          with each Unit consisting of:</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #000000;">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: #000000;">one Class A ordinary share of the Company, par value $0.0001 per share (each, a &#8220;<font style="font-weight: bold; font-style: italic;">Class A Ordinary Share</font>,&#8221; and the Class A Ordinary Shares underlying the Units, the &#8220;<font style="font-weight: bold; font-style: italic;">Shares</font>&#8221;); and</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #000000;">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="color: #000000;">one-half of one redeemable warrant of the Company (each whole warrant, a &#8220;<font style="font-weight: bold; font-style: italic;">Warrant</font>&#8221;), with each whole Warrant entitling the holder to purchase one Class A Ordinary Share, to be issued under a Warrant Agreement (the &#8220;<font style="font-weight: bold; font-style: italic;">Warrant Agreement</font>&#8221;)







          to be entered into by the Company and Odyssey Trust Company, as warrant agent (in such capacity, the &#8220;<font style="font-weight: bold; font-style: italic;">Warrant Agent</font>&#8221;),</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; color: #000000;">pursuant to the terms of an underwriting agreement (the &#8220;<font style="font-weight: bold; font-style: italic;">Underwriting Agreement</font>&#8221;) to be executed by the Company and D
        Boral Capital LLC as representative of the several underwriters named therein (collectively the &#8220;<font style="font-weight: bold; font-style: italic;">Underwriters</font>&#8221;).</div>
      <div>&#160;</div>
      <div style="text-align: justify; color: #000000;">This opinion letter is being furnished in accordance with the requirements of Item 601(b)(5) of Regulation S-K under the Securities Act.</div>
      <div>&#160;</div>
      <div style="text-align: justify;">In connection with this opinion letter, we have examined and relied upon the Registration Statement, the Prospectus, the form of <font style="color: #000000;">Underwriting Agreement, the form of Warrant Agreement</font>,
        the form of Unit Certificate, filed as Exhibit 4.1 to the Registration Statement (the &#8220;<font style="font-weight: bold; font-style: italic;">Unit Certificate</font>&#8221;), and the originals or copies certified to our satisfaction of such records,
        documents, certificates, memoranda and other instruments as in our judgment are necessary or appropriate to enable us to render the opinions expressed below. In addition to the foregoing, we have examined and relied upon the accuracy of the opinion
        letter of Maples and Calder (Cayman) LLP, Cayman Islands counsel for the Company, dated the date hereof and filed as Exhibit 5.2 to the Registration Statement (the &#8220;Maples Opinion&#8221;) and made such investigations of law as we have deemed necessary or
        appropriate as a basis for the opinions set forth herein.</div>
      <div style="text-align: right;">&#160;
        <div><img src="ny20046456x10_ex5-1image02.jpg"></div>
        <div><br>
        </div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" border="0" cellpadding="0" cellspacing="0">

              <tr>
                <td rowspan="1"><img src="ny20046456x10_ex5-1image01.jpg"></td>
              </tr>
              <tr>
                <td style="width: 100%;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 100%;">
                  <div style="text-align: left;">Vendome Acquisition Corporation I</div>
                </td>
              </tr>
              <tr>
                <td style="width: 100%;">
                  <div style="text-align: left;">June 25, 2025</div>
                </td>
              </tr>
              <tr>
                <td style="width: 100%;">Page <font class="BRPFPageNumber">2</font></td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: justify;">In such examination and in rendering the opinions expressed below, we have assumed, without independent investigation or verification: (i) the genuineness of all signatures on all agreements, instruments, corporate
        records, certificates and other documents submitted to us; (ii) the legal capacity, competency and authority of all persons or entities executing all agreements, instruments, corporate records, certificates and other documents submitted to us;
        (iii) the authenticity and completeness of all agreements, instruments, corporate records, certificates and other documents submitted to us as originals; (iv) that all agreements, instruments, corporate records, certificates and other documents
        submitted to us as certified, electronic, facsimile, conformed, photostatic or other copies conform to the originals thereof, and that such originals are authentic and complete; (v) the due authorization, execution and delivery of all agreements,
        instruments, corporate records, certificates and other documents by all parties thereto; (vi) that no documents submitted to us have been amended or terminated orally or in writing; (vii) that the statements contained in the certificates and
        comparable documents of public officials, officers and representatives of the Company and other persons on which we have relied for the purposes of this opinion letter are true and correct on and as of the date hereof; (viii) that the Company is a
        validly existing entity in the jurisdiction of its organization, in good standing in each applicable jurisdiction and has the power and authority to execute and deliver, and to perform its obligations under, the Underwriting Agreement and the
        Warrant Agreement and that such execution, delivery and performance does not violate any provision of the certificate of incorporation (or equivalent formation document) of the Company; (ix) that the Underwriting Agreement is the valid and binding
        obligation of each of the parties thereto, enforceable against such parties in accordance with its terms; (x) all documents filed as exhibits to the Registration Statement that have not been executed will conform to the forms thereof; (xi) that at
        or prior to the time of the delivery of any Units, the Board of Directors of the Company shall have duly established the terms of the Units and the Shares and the Warrants included therein and duly authorized the issuance and sale of the Units and
        such authorization shall not have been modified or rescinded; (xii) the Registration Statement shall have been declared effective and such effectiveness shall not have been terminated or rescinded; (xiii) the Warrant Agreement to be entered into in
        connection with the Warrants has been duly authorized, executed and delivered by the Warrant Agent and the Company, and is a valid, binding and enforceable agreement of each party thereto; and (xiv) the Warrant Agreement will be governed by the
        laws of the State of New York. We have also assumed, in reliance on the Maples Opinion, that (i) the Company is incorporated and validly existing under the laws of the Cayman Islands; (ii) the Company has all requisite power and authority to
        execute and deliver, and to perform its obligations under the certificates evidencing the Units and under the Warrants; (iii) the certificates evidencing the Units and the Warrants to which the Company is a party have been duly authorized, executed
        and delivered by the Company under the laws of the Cayman Islands; and (iv) the offering of the Units and the Warrants and the issuance of the Securities are being conducted in accordance with all applicable Cayman Islands, rules and regulations.
        As to all questions of fact material to this opinion letter and as to the materiality of any fact or other matter referred to herein, we have relied (without independent investigation or verification) upon representations and certificates or
        comparable documents of officers and representatives of the Company.</div>
      <div><br>
      </div>
      <div style="text-align: justify;">Based upon the foregoing, and in reliance thereon, and subject to the assumptions, exceptions, qualifications and limitations set forth herein, we are of the opinion that:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; When the Underwriting Agreement has been duly executed and delivered by the respective parties thereto and the Units have been duly issued by the Company and executed by Odyssey Trust
        Company, as transfer agent, as contemplated by the Registration Statement and delivered to and paid for by the Underwriters pursuant to the terms of the Underwriting Agreement, the Units will constitute valid and binding obligations of the Company,
        enforceable against the Company in accordance with their terms <font style="color: #000000;">under the laws of the State of New York</font>, except as such enforceability may be limited by (i) any applicable bankruptcy, insolvency, reorganization,
        moratorium or similar laws affecting creditors&#8217; rights generally including, without limitation, fraudulent transfer or fraudulent conveyance laws; (ii) public policy considerations, statutes or court decisions that may limit rights to obtain
        exculpation, indemnification or contribution (including, without limitation, indemnification regarding violations of the securities laws and indemnification for losses resulting from a judgment for the payment of any amount other than in United
        States dollars); and (iii) general principles of equity (including, without limitation, concepts of materiality, reasonableness, good faith and fair dealing) and the availability of equitable remedies (including, without limitation, specific
        performance and equitable relief), regardless of whether considered in a proceeding in equity or at law.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageFooter" style="width: 100%;"></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" border="0" cellpadding="0" cellspacing="0">

              <tr>
                <td rowspan="1"><img src="ny20046456x10_ex5-1image01.jpg"></td>
              </tr>
              <tr>
                <td style="width: 100%;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 100%;">
                  <div style="text-align: left;">Vendome Acquisition Corporation I</div>
                </td>
              </tr>
              <tr>
                <td style="width: 100%;">
                  <div style="text-align: left;">June 25, 2025</div>
                </td>
              </tr>
              <tr>
                <td style="width: 100%;">Page <font class="BRPFPageNumber">3</font></td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; When the Underwriting Agreement and the Warrant Agreement have been duly executed and delivered by the respective parties thereto, the Units have been validly issued, paid for and
        delivered in accordance with the terms of the Underwriting Agreement, and the Warrants have been duly executed by the Company and duly countersigned by the Warrant Agent in accordance with the terms of the Warrant Agreement and delivered to and
        paid for by the Underwriters pursuant to the terms of the Underwriting Agreement, the Warrants will constitute valid and binding obligations of the Company, enforceable against the Company in accordance with their terms under the laws of the State
        of New York, except as such enforceability may be limited by (i) any applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors&#8217; rights generally including, without limitation, fraudulent transfer or
        fraudulent conveyance laws; (ii) public policy considerations, statutes or court decisions that may limit rights to obtain exculpation, indemnification or contribution (including, without limitation, indemnification regarding violations of the
        securities laws and indemnification for losses resulting from a judgment for the payment of any amount other than in United States dollars); and (iii) general principles of equity (including, without limitation, concepts of materiality,
        reasonableness, good faith and fair dealing) and the availability of equitable remedies (including, without limitation, specific performance and equitable relief), regardless of whether considered in a proceeding in equity or at law.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: rgb(0, 0, 0);">Without limiting any of the other limitations, exceptions, assumptions and qualifications stated elsewhere herein, we express no opinion with regard to the applicability or effect
          of the laws of any jurisdiction other than the laws of</font> the State of New York as in effect on the date hereof. We are not rendering any opinion as to compliance with any federal or state antifraud law, rule or regulation relating to
        securities, or to the sale or issuance thereof. For the avoidance of doubt, we express no opinion herein as to any federal laws of the United States of America, as to any foreign law or regulation, as to the effect or lack of effect of any foreign
        law or regulation on any opinion expressed herein or as to the validity or enforceability of the certificates evidencing the Units or the Warrants under (including, without limitation, the exercise of remedies thereunder) the laws of any foreign
        jurisdiction. We have not acted as counsel for the Company with respect to matters of Cayman Islands law, or other applicable foreign law. For the avoidance of doubt, we express no opinion herein as to any foreign law or regulation or as to the
        effect or lack of effect of any foreign law or regulation on any opinion expressed herein. </div>
      <div>&#160;</div>
      <div style="text-align: justify; color: #000000;">This opinion letter deals only with the specified legal issues expressly addressed herein, and you should not infer any opinion that is not explicitly stated herein from any matter addressed in this
        opinion letter. This opinion letter is rendered solely in connection with the offering of the Units. This opinion letter is rendered as of the date hereof, and we assume no obligation to advise you or any other person with regard to any change
        after the date hereof in the circumstances or the law that may bear on the matters set forth herein even if the change may affect the legal analysis or a legal conclusion or other matters in this opinion letter.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: #000000;">We hereby consent to the filing of this opinion letter as Exhibit 5.1 to the Registration Statement and to the reference to our firm in the Prospectus under the heading &#8220;Legal Matters.&#8221;
          In giving such consent, we do not hereby admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act or the rules or regulations of the Commission thereunder</font>.</div>
      <div>&#160;</div>
      <div>Very truly yours,</div>
      <div>&#160;</div>
      <div>/s/ Paul Hastings LLP</div>
      <div><br>
        <div><br>
        </div>
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
    </div>
  </div>
  <div class="BRPFPageFooter" style="width: 100%;"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.2
<SEQUENCE>5
<FILENAME>ny20046456x10_ex5-2.htm
<DESCRIPTION>EXHIBIT 5.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade">
  <div>
    <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 5.2</font><br>
    </div>
    <div> <br>
    </div>
    <div style="text-align: justify;"><img src="ny20046456x10_ex5-2image01.jpg">
      <div><br>
      </div>
    </div>
    <div>
      <table id="z78de50ab58934edaac90bfb68c2bb070" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 10%;">Our ref</td>
            <td style="width: 60%;">ADN/852570-000001/83042781v2 <br>
            </td>
            <td style="width: 30%;"></td>
          </tr>

      </table>
    </div>
    <div>&#160;</div>
    <div style="text-align: justify;">Vendome Acquisition Corporation I</div>
    <div style="text-align: justify;">PO Box 309, Ugland House</div>
    <div style="text-align: justify;">Grand Cayman</div>
    <div style="text-align: justify;">KY1-1104</div>
    <div style="text-align: justify;">Cayman Islands</div>
    <div>&#160;</div>
    <div style="text-align: justify;">25 June 2025</div>
    <div>&#160;</div>
    <div style="text-align: justify; font-weight: bold;">Vendome Acquisition Corporation I</div>
    <div>&#160;</div>
    <div style="text-align: justify;">We have acted as counsel as to Cayman Islands law to Vendome Acquisition Corporation I (the "<font style="font-weight: bold;">Company</font>") in connection with the Company's registration statement on Form S-1,
      including all amendments or supplements thereto, filed with the United States Securities and Exchange Commission (the "<font style="font-weight: bold;">Commission</font>") under the United States Securities Act of 1933, as amended (the "<font style="font-weight: bold;">Act</font>") (including its exhibits, the "<font style="font-weight: bold;">Registration Statement</font>") for the purposes of, registering with the Commission under the Act, the offering and sale to the public of:</div>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za3710435eef849098dc01f911ad71d5d" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt; vertical-align: top;">(a)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>up to 23,000,000 units (including 3,000,000 units, which D. Boral Capital LLC (the "<font style="font-weight: bold;">Underwriter</font>"), will have a 45-day option to purchase from the Company to cover over-allotments, if any) ("<font style="font-weight: bold;">Units</font>") at an offering price of US$10 per Unit, each Unit consisting of:</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z41b83c7787d94324946ca4dcdeaf7c5d" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(i)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>one Class A ordinary share of a par value of US$0.0001 of the Company ("<font style="font-weight: bold;">Class A Ordinary Shares</font>"); and</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za1f4ea39eaa945f4b6b9cc948c56768c" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(ii)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>one-half of one redeemable warrant, each whole warrant exercisable to purchase one Class A Ordinary Share at a price of US$11.50 per Class A Ordinary Share ("<font style="font-weight: bold;">Warrants</font>");</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze677465e68fb49839e7750bf60064a47" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt; vertical-align: top;">(b)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>all Class A Ordinary Shares and Warrants issued as part of the Units; and</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4044c7ec419a48048437d78ea1cec6a4" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt; vertical-align: top;">(c)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>all Class A Ordinary Shares that may be issued upon exercise of the Warrants included in the Units.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-align: justify;">This opinion letter is given in accordance with the terms of the Legal Matters section of the Registration Statement.</div>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze21aa73e5a6f4c568fa2361fd629203d" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt; vertical-align: top; font-weight: bold;">1</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-weight: bold;">Documents Reviewed</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-align: justify;">We have reviewed originals, copies, drafts or conformed copies of the following documents:</div>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z99fd2c1727db4a3f8549c7542480fe5d" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt; vertical-align: top;">1.1</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>The certificate of incorporation dated 28 January 2025 and the memorandum and articles of association of the Company as registered or adopted on 28 January 2025 (the "<font style="font-weight: bold;">Memorandum and</font>&#160;<font style="font-weight: bold;">Articles</font>").</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div> <img src="ny20046456x10_ex5-2image02.jpg"></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0955b9b582ba479aba938cde07070729" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt; vertical-align: top;">1.2</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>The written resolutions of the board of directors of the Company dated 21 February 2025, the written resolutions of the board of directors of the Company dated 3 April 2025 and the written resolutions of the board of directors of the
              Company dated 23 May 2025 (the "<font style="font-weight: bold;">Resolutions</font>").</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z187b7b205b72431e835afecdfeb611b5" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt; vertical-align: top;">1.3</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>The following corporate records of the Company maintained at its registered office in the Cayman Islands, each as at the date of this opinion letter:</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z66c7508e8576451bbd0867149f4cba28" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(a)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Register of Members;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za7a2c0afbdb8426ba3c98320b17c1f01" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(b)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Register of Directors and Officers; and</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4a7509a82e184b7c9b89ddfe0c83bf15" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(c)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Register of Mortgages and Charges.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4e4774f2c81742e7898bd620ce5f4a58" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt; vertical-align: top;">1.4</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>A certificate of good standing with respect to the Company issued by the Registrar of Companies (the "<font style="font-weight: bold;">Certificate of Good Standing</font>").</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze49848ccfdc445949570255416037b96" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt; vertical-align: top;">1.5</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>A certificate from a director of the Company a copy of which is attached to this opinion letter (the "<font style="font-weight: bold;">Director's Certificate</font>").</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zff86c45c2e3743f7b625e923f56ee831" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt; vertical-align: top;">1.6</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>The Registration Statement.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zec79d26f1b39491aaa213fbb5327b61f" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt; vertical-align: top;">1.7</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>A draft of the form of the unit certificate representing the Units (the "<font style="font-weight: bold;">Unit Certificate</font>").</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4aac45cc9d9d4b979866b4b945a9f279" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt; vertical-align: top;">1.8</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>A draft of the form of the warrant agreement and the warrant certificate constituting the Warrants (the "<font style="font-weight: bold;">Warrant Documents</font>").</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zca76b148405c4f148da78cc40a1a2b02" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt; vertical-align: top;">1.9</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>A draft of the underwriting agreement between the Company and the Underwriter.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-align: justify;">The documents listed in paragraphs 1.6 to 1.9 inclusive above shall be referred to collectively herein as the "<font style="font-weight: bold;">Documents</font>".</div>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9d83da3d39ea4954a1d3e80f47a35efa" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt; vertical-align: top; font-weight: bold;">2</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-weight: bold;">Assumptions</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-align: justify;">The following opinions are given only as to, and based on, circumstances and matters of fact existing and known to us on the date of this opinion letter. These opinions only relate to the laws of the Cayman Islands
      which are in force on the date of this opinion letter. In giving the following opinions, we have relied (without further verification) upon the completeness and accuracy, as at the date of this opinion letter, of the Director's Certificate and the
      Certificate of Good Standing. We have also relied upon the following assumptions, which we have not independently verified:</div>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb9ad55d60a8942148e1ca5975ca4b673" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt; vertical-align: top;">2.1</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>The Documents have been or will be authorised and duly executed and unconditionally delivered by or on behalf of all relevant parties in accordance with all relevant laws (other than, with respect to the Company, the laws of the Cayman
              Islands).</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4c967c6132c84a65ad4248dc18fe4840" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt; vertical-align: top;">2.2</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>The Documents are, or will be, legal, valid, binding and enforceable against all relevant parties in accordance with their terms under the laws of the State of New York (the "<font style="font-weight: bold;">Relevant Law</font>") and all
              other relevant laws (other than, with respect to the Company, the laws of the Cayman Islands).</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z69bf8405f9284a7ea39e71d9688365e4" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt; vertical-align: top;">2.3</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>The choice of the Relevant Law as the governing law of the Documents has been made in good faith and would be regarded as a valid and binding selection which will be upheld by the courts of the State of New York and any other relevant
              jurisdiction (other than the Cayman Islands) as a matter of the Relevant Law and all other relevant laws (other than the laws of the Cayman Islands).</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7bb8480c6ac9411ab9eb3eb50d862815" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt; vertical-align: top;">2.4</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Copies of documents, conformed copies or drafts of documents provided to us are true and complete copies of, or in the final forms of, the originals.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z393c713ea3fb4f50a600e4ed3c2b1615" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt; vertical-align: top;">2.5</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>All signatures, initials and seals are genuine.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4e136f98978b4af4a3f623b1f491e66a" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt; vertical-align: top;">2.6</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>The capacity, power, authority and legal right of all parties under all relevant laws and regulations (other than, with respect to the Company, the laws and regulations of the Cayman Islands) to enter into, execute, unconditionally deliver
              and perform their respective obligations under the Documents.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd54680316fac463982bec498249ffe66" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt; vertical-align: top;">2.7</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>No invitation has been or will be made by or on behalf of the Company to the public in the Cayman Islands to subscribe for any of the Units, the Warrants or the Class A Ordinary Shares.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf365fce2a1964670ae9774939e572c42" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt; vertical-align: top;">2.8</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>There is no contractual or other prohibition or restriction (other than as arising under Cayman Islands law) binding on the Company prohibiting or restricting it from entering into and performing its obligations under the Documents.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za742992c33de4c099e09bf387c94b14a" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt; vertical-align: top;">2.9</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>No monies paid to or for the account of any party under the Documents or any property received or disposed of by any party to the Documents in each case in connection with the Documents or the consummation of the transactions contemplated
              thereby&#160;represent or will represent proceeds of criminal conduct or criminal property or terrorist property (as defined in the Proceeds of Crime Act (As Revised) and the Terrorism Act (As Revised), respectively).</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z702913e43a8049bb82676e002c970f3f" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt; vertical-align: top;">2.10</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>There is nothing contained in the minute book or corporate records of the Company (which, other than the records set out in paragraph 1.3 of this opinion letter, we have not inspected) which would or might affect the opinions set out
              below.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z27050e73d5464338a16526011d741694" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt; vertical-align: top;">2.11</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>There is nothing under any law (other than the laws of the Cayman Islands) which would or might affect the opinions set out below. Specifically, we have made no independent investigation of the Relevant Law.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4fcef30beb0d4fdbac8f41a29143cb71" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt; vertical-align: top;">2.12</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>The Company will receive money or money's worth in consideration for the issue of the Class A Ordinary Shares and none of the Class A Ordinary Shares were or will be issued for less than par value.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-align: justify;">Save as aforesaid we have not been instructed to undertake and have not undertaken any further enquiry or due diligence in relation to the transaction the subject of this opinion letter.</div>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z55a8308a160f42a093d3d0e77f8d10ec" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt; vertical-align: top; font-weight: bold;">3</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-weight: bold;">Opinions</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-align: justify;">Based upon, and subject to, the foregoing assumptions and the qualifications set out below, and having regard to such legal considerations as we deem relevant, we are of the opinion that:</div>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z96b3eb5901a140b6a48cb05cf9d41298" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt; vertical-align: top;">3.1</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>The Company has been duly incorporated as an exempted company with limited liability and is validly existing and in good standing with the Registrar of Companies under the laws of the Cayman Islands.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z54716292881b41959a8b6f7c7f1ba4ec" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt; vertical-align: top;">3.2</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>The Class A Ordinary Shares to be offered and issued by the Company as contemplated by the Registration Statement (including the issuance of Class A Ordinary Shares upon the exercise of the Warrants in accordance with the Warrant
              Documents) have been duly authorised for issue, and when issued <font style="color: #000000;">by the Company against payment in full of the consideration as set out in the Registration Statement and </font>in accordance with the terms set
              out in the Registration Statement (including the issuance of Class A Ordinary Shares upon the exercise of the Warrants in accordance with the Warrant Documents), such Class A Ordinary Shares will be validly issued, fully paid and
              non-assessable. As a matter of Cayman Islands law, a share is only issued when it has been entered in the register of members (shareholders).</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3dcc208209a04730b1b32d10faefa4a8" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt; vertical-align: top;">3.3</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>The execution, delivery and performance of the Unit Certificate and the Warrant Documents have been authorised by and on behalf of the Company and, once the Unit Certificate and the Warrant Documents have been executed and delivered by any
              director or officer of the Company, the Unit Certificate and the Warrant Documents will be duly executed and delivered on behalf of the Company and will constitute the legal, valid and binding obligations of the Company enforceable in
              accordance with their terms.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5e15e54847454daa97ee60575d6bb132" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt; vertical-align: top; font-weight: bold;">4</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-weight: bold;">Qualifications</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-align: justify;">The opinions expressed above are subject to the following qualifications:</div>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z802810411c6a45cba278eb48abc45c0e" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt; vertical-align: top;">4.1</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>The obligations assumed by the Company under the Documents will not necessarily be enforceable in all circumstances in accordance with their terms.&#160; In particular:</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z343159c1ac094761943cceadb29a2fa8" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(a)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>enforcement may be limited by bankruptcy, insolvency, liquidation, reorganisation, readjustment of debts or moratorium or other laws of general application relating to protecting or affecting the rights of creditors and/or contributories;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z85d19141f4014fef97eeb962dffecd5f" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(b)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>enforcement may be limited by general principles of equity. For example, equitable remedies such as specific performance may not be available, <font style="font-style: italic;">inter alia</font>, where damages are considered to be an
              adequate remedy;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbc4eca0d2195414ab970ecb158cb1788" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(c)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>where obligations are to be performed in a jurisdiction outside the Cayman Islands, they may not be enforceable in the Cayman Islands to the extent that performance would be illegal under the laws of that jurisdiction; and</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6bf87d185bf0450b9efc574d9d63c994" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(d)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>some claims may become barred under relevant statutes of limitation or may be or become subject to defences of set off, counterclaim, estoppel and similar defences.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4031805ce93f4a079782f2b117af599d" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt; vertical-align: top;">4.2</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>To maintain the Company in good standing with the Registrar of Companies under the laws of the Cayman Islands, annual filing fees must be paid and returns made to the Registrar of Companies within the time frame prescribed by law.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd9e207aac106419eada8d8b9b8e524c1" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt; vertical-align: top;">4.3</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Under Cayman Islands law, the register of members (shareholders) is <font style="font-style: italic;">prima facie</font> evidence of title to shares and this register would not record a third party interest in such shares. However, there
              are certain limited circumstances where an application may be made to a Cayman Islands court for a determination on whether the register of members reflects the correct legal position. Further, the Cayman Islands court has the power to order
              that the register of members maintained by a company should be rectified where it considers that the register of members does not reflect the correct legal position. As far as we are aware, such applications are rarely made in the Cayman
              Islands and for the purposes of the opinion given in paragraph 3.2, there are no circumstances or matters of fact known to us on the date of this opinion letter which would properly form the basis for an application for an order for
              rectification of the register of members of the Company, but if such an application were made in respect of the Class A Ordinary Shares, then the validity of such shares may be subject to re-examination by a Cayman Islands court.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z129a58d2d0b0457f9db4c75205748daf" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt; vertical-align: top;">4.4</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>In this opinion letter the phrase "non-assessable" means, with respect to the issuance of shares, that a shareholder shall not, in respect of the relevant shares and in the absence of a contractual arrangement, or an obligation pursuant to
              the memorandum and articles of association, to the contrary, have any obligation to make further contributions to the Company's assets (except in exceptional circumstances, such as involving fraud, the establishment of an agency relationship
              or an illegal or improper purpose or other circumstances in which a court may be prepared to pierce or lift the corporate veil).</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-align: justify;">We hereby consent to the filing of this opinion letter as an exhibit to the Registration Statement and to the references to our firm under the headings "Legal Matters", "Risk Factors", "Shareholders' Suits" and
      "Enforcement of Civil Liabilities" in the prospectus included in the Registration Statement. In providing our consent, we do not thereby admit that we are in the category of persons whose consent is required under section 7 of the Act or the Rules
      and Regulations of the Commission thereunder.</div>
    <div>&#160;</div>
    <div style="text-align: justify;">We express no view as to the commercial terms of the Documents or whether such terms represent the intentions of the parties and make no comment with regard to warranties or representations that may be made by the
      Company.</div>
    <div>&#160;</div>
    <div style="text-align: justify;">The opinions in this opinion letter are strictly limited to the matters contained in the opinions section above and do not extend to any other matters.&#160; We have not been asked to review and we therefore have not
      reviewed any of the ancillary documents relating to the Documents and express no opinion or observation upon the terms of any such document.</div>
    <div>&#160;</div>
    <div style="text-align: justify;">This opinion letter is addressed to you and may be relied upon by you, your counsel and purchasers of Units pursuant to the Registration Statement. This opinion letter is limited to the matters detailed herein and is
      not to be read as an opinion with respect to any other matter.</div>
    <div>&#160;</div>
    <div style="text-align: justify;">Yours faithfully</div>
    <div>&#160;</div>
    <div style="text-align: justify;">/s/ Maples and Calder (Cayman) LLP </div>
    <div style="text-align: justify;">Maples and Calder (Cayman) LLP</div>
    <div><br>
    </div>
    <div> </div>
    <div>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.7
<SEQUENCE>6
<FILENAME>ny20046456x10_ex10-7.htm
<DESCRIPTION>EXHIBIT 10.7
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade">
    <div>
      <div style="text-align: right; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt;"> Exhibit 10.7<br>
        </font> </div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-weight: bold;">INDEMNITY AGREEMENT</div>
      <div>&#160;</div>
      <div style="text-indent: 72pt; font-size: 12pt;"><font style="font-weight: bold; font-size: 10pt;">THIS INDEMNITY AGREEMENT</font><font style="font-size: 10pt;"> (this &#8220;<u>Agreement</u>&#8221;) is made as of&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; , 2025 by and between Vendome
          Acquisition Corporation I, a Cayman Islands exempted company (the &#8220;<u>Company</u>&#8221;), and (&#8220;<u>Indemnitee</u>&#8221;).</font></div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">RECITALS</div>
      <div>&#160;</div>
      <div style="text-indent: 72pt; font-size: 12pt;"><font style="font-weight: bold; font-size: 10pt;">WHEREAS</font><font style="font-size: 10pt;">, the Board of Directors of the Company (the &#8220;<u>Board</u>&#8221;) has determined that it is reasonable, prudent
          and necessary for the Company contractually to obligate itself to indemnify, hold harmless, exonerate and to advance expenses on behalf of, persons who serve the Company and its direct and indirect subsidiaries (collectively, the &#8220;<u>Company
            Group</u>&#8221;) to the fullest extent permitted by applicable law and the Charter (as defined below);</font></div>
      <div>&#160;</div>
      <div style="text-indent: 72pt; font-size: 12pt;"><font style="font-weight: bold; font-size: 10pt;">WHEREAS</font><font style="font-size: 10pt;">, this Agreement is a supplement to and in furtherance of the Amended and Restated Memorandum and Articles
          of Association (the &#8220;<u>Charter</u>&#8221;) of the Company and any resolutions adopted pursuant thereto, and shall not be deemed a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder;</font></div>
      <div>&#160;</div>
      <div style="text-indent: 72pt; font-size: 12pt;"><font style="font-weight: bold; font-size: 10pt;">WHEREAS</font><font style="font-size: 10pt;">, Indemnitee may not be willing to serve as an officer or director, advisor or in another capacity without
          adequate protection, and the Company desires Indemnitee to serve in such capacity.&#160; Indemnitee is willing to serve, continue to serve and to take on additional service for or on behalf of the Company on the condition that Indemnitee be so
          indemnified; and</font></div>
      <div>&#160;</div>
      <div style="text-indent: 72pt; font-size: 12pt;"><font style="font-weight: bold; font-size: 10pt;">NOW, THEREFORE</font><font style="font-size: 10pt;">, in consideration of the premises and the covenants contained herein and subject to the provisions
          of the letter agreement dated as of&#160; [&#8226;], 2025, the Company and Indemnitee do hereby covenant and agree as follows:</font></div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">TERMS AND CONDITIONS</div>
      <div>&#160;</div>
      <div>1.&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>SERVICES TO THE COMPANY</u>.&#160; In consideration of the Company&#8217;s covenants and obligations hereunder, Indemnitee will serve or continue to serve as an officer, director, advisor, key employee or any other capacity of any member
        of the Company Group, as applicable, for so long as Indemnitee is duly elected or appointed or retained or until Indemnitee tenders Indemnitee&#8217;s resignation or until Indemnitee is removed.&#160; The foregoing notwithstanding, this Agreement shall
        continue in full force and effect after Indemnitee has ceased to serve as a director, officer, advisor, key employee or in any other capacity of any member of the Company Group, as provided in Section 17.&#160; This Agreement, however, shall not impose
        any obligation on Indemnitee or the Company to continue Indemnitee&#8217;s service to the Company Group beyond any period otherwise required by law or by other agreements or commitments of the parties, if any.</div>
      <div>&#160;</div>
      <div>2.&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>DEFINITIONS</u>.&#160; As used in this Agreement:</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;References to &#8220;<u>agent</u>&#8221; shall mean any person who is or was a director, officer or employee of the Company or a subsidiary of the Company or other person authorized by the Company to act for the
        Company, to include such person serving in such capacity as a director, officer, employee, fiduciary or other official of another corporation, partnership, limited liability company, joint venture, trust or other enterprise at the request of, for
        the convenience of, or to represent the interests of the Company or a subsidiary of the Company.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="text-indent: 36pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The terms &#8220;<u>Beneficial Owner</u>&#8221; and &#8220;<u>Beneficial Ownership</u>&#8221; shall have the meanings set forth in Rule 13d-3 promulgated under the Exchange Act (as defined below) as in effect on the date hereof.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;A &#8220;<u>Change in Control</u>&#8221; shall be deemed to occur upon the earliest to occur after the date of this Agreement of any of the following events:</div>
      <div>&#160;</div>
      <div style="text-indent: 72pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Acquisition of Shares by Third Party</u>.&#160; Other than an affiliate of Vendome Acquisition Sponsor I LLC (the &#8220;<u>Sponsor</u>&#8221;), any Person (as defined below) is or becomes the Beneficial Owner, directly
        or indirectly, of securities of the Company representing fifteen percent (15%) or more of the combined voting power of the Company&#8217;s then outstanding securities entitled to vote generally in the election of directors, unless (1) the change in the
        relative Beneficial Ownership of the Company&#8217;s securities by any Person results solely from a reduction in the aggregate number of outstanding shares of securities entitled to vote generally in the election of directors, or (2) such acquisition was
        approved in advance by the Continuing Directors (as defined below) and such acquisition would not constitute a Change in Control under part (iii) of this definition;</div>
      <div>&#160;</div>
      <div style="text-indent: 72pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Change in Board of Directors</u>.&#160; Individuals who, as of the date hereof, constitute the Board, and any new director whose appointment by the Board or nomination for election by the Company&#8217;s
        shareholders was approved by a vote of at least two thirds of the directors then still in office who were directors on the date hereof or whose appointment or nomination for election was previously so approved (collectively, the &#8220;<u>Continuing
          Directors</u>&#8221;), cease for any reason to constitute a majority of the members of the Board;</div>
      <div>&#160;</div>
      <div style="text-indent: 72pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Corporate Transactions</u>.&#160; The effective date of a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination involving the Company and
        one or more businesses (a &#8220;<u>Business Combination</u>&#8221;), in each case, unless, following such Business Combination:&#160; (1) all or substantially all of the individuals and entities who were the Beneficial Owners of securities of the Company entitled
        to vote generally in the election of directors immediately prior to such Business Combination beneficially own, directly or indirectly, more than 51% of the combined voting power of the then outstanding securities of the surviving or resulting
        entity or the ultimate parent entity that controls such surviving or resulting entity (the &#8220;<u>Successor</u>&#8221;) entitled to vote generally in the election of directors of the Successor (including, without limitation, a corporation which as a result
        of such transaction owns the Company or all or substantially all of the Company&#8217;s assets either directly or through one or more Subsidiaries (as defined below)) in substantially the same proportions as their ownership immediately prior to such
        Business Combination, of the securities entitled to vote generally in the election of directors; (2) other than an affiliate of the Company, no Person (excluding any corporation resulting from such Business Combination) is the Beneficial Owner,
        directly or indirectly, of 15% or more of the combined voting power of the then outstanding securities entitled to vote generally in the election of directors of the successor except to the extent that such Person was the Beneficial Owner, directly
        or indirectly, of 15% or more of the combined voting power of the Company prior to such Business Combination; and (3) a majority of the board of directors (or comparable governing body) of the Successor were Continuing Directors at the time of the
        execution of the initial agreement, or of the action of the Board of Directors, providing for such Business Combination;</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">2</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-indent: 72pt;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Liquidation</u>.&#160; The approval by the shareholders of the Company of a complete liquidation of the Company or an agreement or series of agreements for the sale or disposition by the Company of all or
        substantially all of the Company&#8217;s assets, other than factoring the Company&#8217;s current receivables or escrows due (or, if such shareholder approval is not required, the decision by the Board to proceed with such a liquidation, sale, or disposition
        in one transaction or a series of related transactions); or</div>
      <div>&#160;</div>
      <div style="text-indent: 72pt;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Other Events</u>.&#160; There occurs any other event of a nature that would be required to be reported in response to Item 6(e) of Schedule 14A of Regulation 14A (or any successor rule) (or a response to any
        similar item on any similar schedule or form) promulgated under the Exchange Act (as defined below), whether or not the Company is then subject to such reporting requirement.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u>Corporate Status</u>&#8221; describes the status of a person who is or was a director, officer, trustee, general partner, manager, managing member, fiduciary, employee or agent of the Company or of any other
        Enterprise (as defined below) which such person is or was serving at the request of the Company.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u>Companies Law</u>&#8221; shall mean the Companies Act (As Revised) of the Cayman Islands, as amended from time to time.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u>Cayman Court</u>&#8221; shall mean the courts of the Cayman Islands.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u>Disinterested Director</u>&#8221; shall mean a director of the Company who is not and was not a party to the Proceeding (as defined below) in respect of which indemnification is sought by Indemnitee.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u>Enterprise</u>&#8221; shall mean the Company and any other corporation, constituent corporation (including any constituent of a constituent) absorbed in a consolidation or merger to which the Company (or any
        of its wholly owned subsidiaries) is a party, limited liability company, partnership, joint venture, trust, employee benefit plan or other enterprise of which Indemnitee is or was serving at the request of the Company as a director, officer,
        trustee, general partner, managing member, fiduciary, employee or agent.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u>Exchange Act</u>&#8221; shall mean the Securities Exchange Act of 1934, as amended.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">3</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-indent: 36pt;">(j)&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; &#8220;<u>Expenses</u>&#8221; shall include all direct and indirect costs, fees and expenses of any type or nature whatsoever, including, without limitation, all reasonable attorneys&#8217; fees and costs, retainers, court
        costs, transcript costs, fees of experts, witness fees, travel expenses, fees of private investigators and professional advisors, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees, fax transmission
        charges, secretarial services and all other disbursements, obligations or expenses in connection with prosecuting, defending, preparing to prosecute or defend, investigating, being or preparing to be a witness in, settlement or appeal of, or
        otherwise participating in, a Proceeding (as defined below), including reasonable compensation for time spent by Indemnitee for which he or she is not otherwise compensated by the Company or any third party.&#160; Expenses also shall include Expenses
        incurred in connection with any appeal resulting from any Proceeding (as defined below), including without limitation the principal, premium, security for, and other costs relating to any cost bond, supersedeas bond, or other appeal bond or its
        equivalent.&#160; Expenses, however, shall not include amounts paid in settlement by Indemnitee or the amount of judgments or fines against Indemnitee incurred in any Proceeding by or in the right of the Company.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;References to &#8220;<u>fines</u>&#8221; shall include any excise tax assessed on Indemnitee with respect to any employee benefit plan; references to &#8220;serving at the request of the Company&#8221; shall include any service
        as a director, officer, employee, agent or fiduciary of the Company which imposes duties on, or involves services by, such director, officer, employee, agent or fiduciary with respect to an employee benefit plan, its participants or beneficiaries;
        and if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in the best interests of the participants and beneficiaries of an employee benefit plan, Indemnitee shall be deemed to have acted in a manner &#8220;not opposed to
        the best interests of the Company&#8221; as referred to in this Agreement.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(l)&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; &#8220;<u>Independent Counsel</u>&#8221; shall mean a law firm or a member of a law firm with significant experience in matters of corporation law and that neither presently is, nor in the past five years has been,
        retained to represent:&#160; (i) the Company or Indemnitee in any matter material to either such party (other than with respect to matters concerning Indemnitee under this Agreement, or of other indemnitees under similar indemnification agreements); or
        (ii) any other party to the Proceeding (as defined below) giving rise to a claim for indemnification hereunder.&#160; Notwithstanding the foregoing, the term &#8220;<u>Independent Counsel</u>&#8221; shall not include any person who, under the applicable standards
        of professional conduct then prevailing, would have a conflict of interest in representing either the Company or Indemnitee in an action to determine Indemnitee&#8217;s rights under this Agreement.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(m)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The term &#8220;<u>Person</u>&#8221; shall have the meaning as set forth in Sections 13(d) and 14(d) of the Exchange Act as in effect on the date hereof; provided, however, that &#8220;<u>Person</u>&#8221; shall exclude:&#160; (i) the
        Company; (ii) any Subsidiaries (as defined below) of the Company; (iii) any employment benefit plan of the Company or of a Subsidiary (as defined below) of the Company or of any corporation owned, directly or indirectly, by the shareholders of the
        Company in substantially the same proportions as their ownership of shares of the Company; and (iv) any trustee or other fiduciary holding securities under an employee benefit plan of the Company or of a Subsidiary (as defined below) of the Company
        or of a corporation owned directly or indirectly by the shareholders of the Company in substantially the same proportions as their ownership of shares of the Company.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(n)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The term &#8220;<u>Proceeding</u>&#8221; shall include any threatened, pending or completed action, suit, arbitration, mediation, alternate dispute resolution mechanism, investigation, inquiry, administrative hearing
        or any other actual, threatened or completed proceeding, whether brought in the right of the Company or otherwise and whether of a civil (including intentional or unintentional tort claims), criminal, administrative or investigative or related
        nature, in which Indemnitee was, is, will or might be involved as a party or otherwise by reason of the fact of Indemnitee&#8217;s Corporate Status, whether or not serving in such capacity at the time any liability or expense is incurred for which
        indemnification, reimbursement, or advancement of expenses can be provided under this Agreement but shall not include any Enforcement Proceeding pursuant to Section 14.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">4</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-indent: 36pt;">(o)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The term &#8220;<u>Subsidiary</u>,&#8221; with respect to any Person, shall mean any corporation, limited liability company, partnership, joint venture, trust or other entity of which a majority of the voting power of
        the voting equity securities or equity interest is owned, directly or indirectly, by that Person.</div>
      <div>&#160;</div>
      <div>3.&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>INDEMNITY IN THIRD-PARTY PROCEEDINGS</u>.&#160; To the fullest extent permitted by applicable law and the Charter, the Company shall indemnify, hold harmless and exonerate Indemnitee in accordance with the provisions of this Section
        3 if Indemnitee was, is, or is threatened to be made, a party to or a participant (as a witness, deponent or otherwise) in any Proceeding, other than a Proceeding by or in the right of the Company to procure a judgment in its favor, by reason of
        Indemnitee&#8217;s Corporate Status.&#160; Pursuant to this Section 3, Indemnitee shall be indemnified, held harmless and exonerated against all Expenses (including all interest, assessments and other charges paid or payable in connection with or in respect
        of such Expenses) actually and reasonably incurred by Indemnitee or on Indemnitee&#8217;s behalf in connection with such Proceeding or any claim, issue or matter therein, if Indemnitee acted in good faith and in a manner he reasonably believed to be in
        or not opposed to the best interests of the Company and, in the case of a criminal Proceeding, had no reasonable cause to believe that Indemnitee&#8217;s conduct was unlawful; provided, in no event shall Indemnitee be entitled to be indemnified, held
        harmless or advanced any amounts hereunder in respect of any Expenses, judgments, liabilities, fines, penalties and misconduct.&#160; Indemnitee shall not be found to have committed actual fraud or international misconduct for any purpose of this
        Agreement unless or until a court of competent jurisdiction shall have made a finding to that effect.</div>
      <div>&#160;</div>
      <div>4.&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>INDEMNITY IN PROCEEDINGS BY OR IN THE RIGHT OF THE COMPANY</u>.&#160; To the fullest extent permitted by applicable law and the Charter, the Company shall indemnify, hold harmless and exonerate Indemnitee in accordance with the
        provisions of this Section 4 if Indemnitee was, is, or is threatened to be made, a party to or a participant (as a witness, deponent or otherwise) in any Proceeding by or in the right of the Company to procure a judgment in its favor by reason of
        Indemnitee&#8217;s Corporate Status.&#160; Pursuant to this Section 4, Indemnitee shall be indemnified, held harmless and exonerated against all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee&#8217;s behalf in connection with such
        Proceeding or any claim, issue or matter therein, if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests of the Company.&#160; No indemnification, hold harmless or exoneration for
        Expenses shall be made under this Section 4 in respect of any claim, issue or matter as to which Indemnitee shall have been finally adjudged by a court of competent jurisdiction to be liable to the Company, unless and only to the extent that any
        court in which the Proceeding was brought or the Cayman Court shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, Indemnitee is fairly and reasonably entitled to
        indemnification, to be held harmless or to exoneration.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">5</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div>5.&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>INDEMNIFICATION FOR EXPENSES OF A PARTY WHO IS WHOLLY OR PARTLY SUCCESSFUL</u>.&#160; Notwithstanding any other provisions of this Agreement except for Section 26, to the extent that Indemnitee was or is, by reason of Indemnitee&#8217;s
        Corporate Status, a party to (or a participant in) and is successful, on the merits or otherwise, in defending any Proceeding or in defense of any claim, issue or matter therein, in whole or in part, the defending Company shall, to the fullest
        extent permitted by applicable law and the Charter, indemnify, hold harmless and exonerate Indemnitee against all Expenses actually and reasonably incurred by Indemnitee in connection therewith.&#160; If Indemnitee is not wholly successful in defense of
        such Proceeding (or part thereof) but is successful, on the merits or otherwise, in defense of one or more but less than all claims, issues or matters in such Proceeding, the Company shall, to the fullest extent permitted by applicable law and the
        Charter, indemnify, hold harmless and exonerate Indemnitee against all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee&#8217;s behalf in connection with each successfully resolved claim, issue or matter.&#160; If Indemnitee is not
        wholly successful in defense of such Proceeding (or part thereof), the Company also shall, to the fullest extent permitted by applicable law and the Charter, indemnify, hold harmless and exonerate Indemnitee against all Expenses reasonably incurred
        in connection with a claim, issue or matter related to any claim, issue, or matter on which Indemnitee was successful.&#160; For purposes of this Section and without limitation, the termination of any claim, issue or matter in such a Proceeding by
        dismissal, with or without prejudice, shall be deemed to be a successful result as to the defense of such claim, issue or matter.</div>
      <div>&#160;</div>
      <div>6.&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>INDEMNIFICATION FOR EXPENSES OF A WITNESS</u>.&#160; Notwithstanding any other provision of this Agreement except for Section 26, to the extent that Indemnitee is, by reason of Indemnitee&#8217;s Corporate Status, a witness or deponent in
        any Proceeding to which Indemnitee was not or is not a party or threatened to be made a party, Indemnitee shall, to the fullest extent permitted by applicable law and the Charter, be indemnified, held harmless and exonerated against all Expenses
        actually and reasonably incurred by Indemnitee or on Indemnitee&#8217;s behalf in connection therewith.</div>
      <div>&#160;</div>
      <div>7.&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>ADDITIONAL INDEMNIFICATION, HOLD HARMLESS AND EXONERATION RIGHTS</u>.&#160; Notwithstanding any limitation in Sections 3, 4, or 5, except for Section 26, the Company shall, to the fullest extent permitted by applicable law and the
        Charter, indemnify, hold harmless and exonerate Indemnitee if Indemnitee is a party to or threatened to be made a party to any Proceeding against all Expenses and judgments, fines, penalties and amounts paid in settlement in any Proceeding by or in
        the right of the Company to procure a judgment in its favor (including all interest, assessments and other charges paid or payable in connection with or in respect of such Expenses, judgments, fines, penalties and amounts paid in settlement)
        actually and reasonably incurred by Indemnitee in connection with the Proceeding.&#160; No indemnification, hold harmless or exoneration rights shall be available under this Section 7 on account of Indemnitee&#8217;s conduct which constitutes a breach of
        Indemnitee&#8217;s duty of loyalty to the Company or its shareholder or is an act or omission not in good faith or which involves intentional misconduct or a known violation of the law.</div>
      <div>&#160;</div>
      <div>8.&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; <u>CONTRIBUTION IN THE EVENT OF JOINT LIABILITY</u>.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;To the fullest extent permissible under applicable law and the Charter, if the indemnification, hold harmless and/or exoneration rights provided for in this Agreement are unavailable to Indemnitee in whole
        or in part for any reason whatsoever, the Company, in lieu of indemnifying, holding harmless or exonerating Indemnitee, shall pay, in the first instance, the entire amount incurred by Indemnitee, whether for judgments, liabilities, fines,
        penalties, amounts paid or to be paid in settlement and/or for Expenses, in connection with any Proceeding without requiring Indemnitee to contribute to such payment, and the Company hereby waives and relinquishes any right of contribution it may
        have at any time against Indemnitee.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">6</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-indent: 36pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company shall not enter into any settlement of any Proceeding in which the Company is jointly liable with Indemnitee (or would be if joined in such Proceeding) unless such settlement provides for a
        full and final release of all claims asserted against Indemnitee.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company hereby agrees to fully indemnify, hold harmless and exonerate Indemnitee from any claims for contribution which may be brought by officers, directors or employees of the Company other than
        Indemnitee who may be jointly liable with Indemnitee.</div>
      <div>&#160;</div>
      <div>9.&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>EXCLUSIONS</u>.&#160; Notwithstanding any provision in this Agreement, the Company shall not be obligated under this Agreement to make any indemnification, advance expenses, hold harmless or exoneration payment in connection with any
        claim made against Indemnitee:</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;for which payment has actually been received by or on behalf of Indemnitee under any insurance policy or other indemnity or advancement provision, except with respect to any excess beyond the amount
        actually received under any insurance policy, contract, agreement, other indemnity or advancement provision or otherwise;</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;for an accounting of profits made from the purchase and sale (or sale and purchase) by Indemnitee of securities of the Company within the meaning of Section 16(b) of the Exchange Act (or any successor
        rule) or similar provisions of state statutory law or common law; or</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;except as otherwise provided in Sections 14(f)-(g) hereof, prior to a Change in Control, in connection with any Proceeding (or any part of any Proceeding) initiated by Indemnitee, including any Proceeding
        (or any part of any Proceeding) initiated by Indemnitee against the Company or its directors, officers, employees or other indemnitees, unless (i) the Board authorized the Proceeding (or any part of any Proceeding) prior to its initiation or (ii)
        the Company provides the indemnification, hold harmless or exoneration payment, in its sole discretion, pursuant to the powers vested in the Company under applicable law.&#160; Indemnitee shall seek payments or Advances from the Company only to the
        extent that such payments or Advances are unavailable from any insurance policy of the Company covering Indemnitee.</div>
      <div>&#160;</div>
      <div>10.&#160;&#160;&#160; &#160; &#160;&#160; <u>ADVANCES OF EXPENSES; DEFENSE OF CLAIM</u>.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Notwithstanding any provision of this Agreement to the contrary, except for Section 26, and to the fullest extent not prohibited by applicable law and the Charter, the Company shall pay the Expenses
        incurred by Indemnitee in connection with any Proceeding within ten (10) days after the receipt by the Company of a statement or statements requesting such advances from time to time, prior to the final disposition of any Proceeding.&#160; Advances
        shall, to the fullest extent permitted by law, be unsecured and interest free.&#160; Advances shall, to the fullest extent permitted by law and the Charter, be made without regard to Indemnitee&#8217;s ability to repay the Expenses and without regard to
        Indemnitee&#8217;s ultimate entitlement to be indemnified, held harmless or exonerated under the other provisions of this Agreement.&#160; Advances shall include any and all reasonable Expenses incurred pursuing an Enforcement Proceeding (assuming for this
        purpose all references to a &#8220;Proceeding&#8221; in the definition of Expenses were deemed related to an Enforcement Proceeding), including Expenses incurred preparing and forwarding statements to the Company to support the advances claimed.&#160; This
        Agreement shall constitute Indemnitee&#8217;s undertaking to repay the advanced amounts to the extent that it is ultimately determined that Indemnitee is not entitled to be indemnified, held harmless or exonerated by the Company under the provisions of
        this Agreement, the Charter, applicable law or otherwise, but only if such an undertaking is required by applicable law.&#160; This Section 10(a) shall not apply to any Proceeding for which indemnity is not permitted under Section 9 of this Agreement,
        but shall apply to any Proceeding referenced in Section 9(b) prior to a final determination that Indemnitee is liable therefor.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">7</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-indent: 36pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company will be entitled to participate in the Proceeding at its own expense.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company shall not settle any action, claim or Proceeding (in whole or in part) which would impose any Expense, judgment, fine, penalty or limitation on Indemnitee without Indemnitee&#8217;s prior written
        consent.</div>
      <div>&#160;</div>
      <div>11.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>PROCEDURE FOR NOTIFICATION AND APPLICATION FOR INDEMNIFICATION</u>.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Indemnitee agrees to notify promptly the Company in writing upon being served with any summons, citation, subpoena, complaint, indictment, information or other document relating to any Proceeding, claim,
        issue or matter therein which may be subject to indemnification, hold harmless or exoneration rights, or advancement of Expenses covered hereunder.&#160; The failure of Indemnitee to so notify the Company shall not relieve the Company of any obligation
        which it may have to Indemnitee under this Agreement, or otherwise.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Indemnitee may deliver to the Company a written application to indemnify, hold harmless or exonerate Indemnitee in accordance with this Agreement.&#160; Such application(s) may be delivered from time to time
        and at such time(s) as Indemnitee deems appropriate in his sole discretion.&#160; Following such a written application for indemnification by Indemnitee, Indemnitee&#8217;s entitlement to indemnification shall be determined according to Section 12(a) of this
        Agreement.</div>
      <div>&#160;</div>
      <div>12.&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>PROCEDURE UPON APPLICATION FOR INDEMNIFICATION</u>.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;A determination, if required by applicable law, with respect to Indemnitee&#8217;s entitlement to indemnification shall be made in the specific case by one of the following methods:&#160; (i) if no Change in Control
        has occurred (x) by a majority vote of the Disinterested Directors, even though less than a quorum of the Board, (y) by a committee of Disinterested Directors, even though less than a quorum of the Board, or (z) if there are no Disinterested
        Directors, or if such directors so direct, by Independent Counsel in a written opinion to the Board, a copy of which shall be delivered to Indemnitee, or (ii) if a Change in Control has occurred, by Independent Counsel in a written opinion to the
        Board, a copy of which shall be delivered to the Indemnitee.&#160; The Company promptly will advise Indemnitee in writing with respect to any determination that Indemnitee is or is not entitled to indemnification, including a description of any reason
        or basis for which indemnification has been denied.&#160; If it is so determined that Indemnitee is entitled to indemnification, payment to Indemnitee shall be made within ten (10) days after such determination.&#160; Indemnitee shall reasonably cooperate
        with the person, persons or entity making such determination with respect to Indemnitee&#8217;s entitlement to indemnification, including providing to such person, persons or entity upon reasonable advance request any documentation or information which
        is not privileged or otherwise protected from disclosure and which is reasonably available to Indemnitee and reasonably necessary to such determination.&#160; Any costs or Expenses (including reasonable attorneys&#8217; fees and disbursements) incurred by
        Indemnitee in so cooperating with the person, persons or entity making such determination shall be borne by the Company (irrespective of the determination as to Indemnitee&#8217;s entitlement to indemnification) and the Company hereby agrees to indemnify
        and to hold Indemnitee harmless therefrom.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">8</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-indent: 36pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In the event the determination of entitlement to indemnification is to be made by Independent Counsel pursuant to Section 12(a) hereof, the Independent Counsel shall be selected as provided in this Section
        12(b).&#160; The Independent Counsel shall be selected by Indemnitee (unless Indemnitee shall request that such selection be made by the Board), and Indemnitee shall give written notice to the Company advising it of the identity of the Independent
        Counsel so selected and certifying that the Independent Counsel so selected meets the requirements of &#8220;Independent Counsel&#8221; as defined in Section 2 of this Agreement.&#160; If the Independent Counsel is selected by the Board, the Company shall give
        written notice to Indemnitee advising Indemnitee of the identity of the Independent Counsel so selected and certifying that the Independent Counsel so selected meets the requirements of &#8220;Independent Counsel&#8221; as defined in Section 2 of this
        Agreement.&#160; In either event, Indemnitee or the Company, as the case may be, may, within ten (10) days after such written notice of selection shall have been received, deliver to the Company or to Indemnitee, as the case may be, a written objection
        to such selection; provided, however, that such objection may be asserted only on the ground that the Independent Counsel so selected does not meet the requirements of &#8220;Independent Counsel&#8221; as defined in Section 2 of this Agreement, and the
        objection shall set forth with particularity the factual basis of such assertion.&#160; Absent a proper and timely objection, the person so selected shall act as Independent Counsel.&#160; If such written objection is so made and substantiated, the
        Independent Counsel so selected may not serve as Independent Counsel unless and until such objection is withdrawn or a court of competent jurisdiction has determined that such objection is without merit.&#160; If, within twenty (20) days after
        submission by Indemnitee of a written request for indemnification pursuant to Section 11(b) hereof, no Independent Counsel shall have been selected and not objected to, either the Company or Indemnitee may petition the Cayman Court for resolution
        of any objection which shall have been made by the Company or Indemnitee to the other&#8217;s selection of Independent Counsel and/or for the appointment as Independent Counsel of a person selected by the Cayman Court, and the person with respect to whom
        all objections are so resolved or the person so appointed shall act as Independent Counsel under Section 12(a) hereof.&#160; Upon the due commencement of any judicial proceeding or arbitration pursuant to Section 14(a) of this Agreement, Independent
        Counsel shall be discharged and relieved of any further responsibility in such capacity (subject to the applicable standards of professional conduct then prevailing).</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company agrees to pay the reasonable fees and expenses of Independent Counsel and to fully indemnify and hold harmless such Independent Counsel against any and all Expenses, claims, liabilities and
        damages arising out of or relating to this Agreement or its engagement pursuant hereto.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">9</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div>13.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>PRESUMPTIONS AND EFFECT OF CERTAIN PROCEEDINGS</u>.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In making a determination with respect to entitlement to indemnification hereunder, the person, persons or entity making such determination shall presume that Indemnitee is entitled to indemnification
        under this Agreement if Indemnitee has submitted a request for indemnification in accordance with Section 11(b) of this Agreement, and the Company shall have the burden of proof to overcome that presumption in connection with the making by any
        person, persons or entity of any determination contrary to that presumption.&#160; Neither the failure of the Company (including by the Disinterested Directors or Independent Counsel) to have made a determination prior to the commencement of any action
        pursuant to this Agreement that indemnification is proper in the circumstances because Indemnitee has met the applicable standard of conduct, nor an actual determination by the Company (including by the Disinterested Directors or Independent
        Counsel) that Indemnitee has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that Indemnitee has not met the applicable standard of conduct.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If the person, persons or entity empowered or selected under Section 12 of this Agreement to determine whether Indemnitee is entitled to indemnification shall not have made a determination within thirty
        (30) days after receipt by the Company of the request therefor, the requisite determination of entitlement to indemnification shall, to the fullest extent permitted by law and the Charter, be deemed to have been made and Indemnitee shall be
        entitled to such indemnification, absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee&#8217;s statement not materially misleading, in connection with the request for indemnification,
        or (ii) a final judicial determination that any or all such indemnification is expressly prohibited under applicable law; provided, however, that such 30-day period may be extended for a reasonable time, not to exceed an additional fifteen (15)
        days, if the person, persons or entity making the determination with respect to entitlement to indemnification in good faith requires such additional time for the obtaining or evaluating of documentation and/or information relating thereto.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction, or upon a plea of nolo contendere or its equivalent, shall not (except as otherwise
        expressly provided in this Agreement) of itself adversely affect the right of Indemnitee to indemnification or create a presumption that Indemnitee did not act in good faith and in a manner which Indemnitee reasonably believed to be in or not
        opposed to the best interests of the Company or, with respect to any criminal Proceeding, that Indemnitee had reasonable cause to believe that Indemnitee&#8217;s conduct was unlawful.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;For purposes of any determination of good faith, Indemnitee shall be deemed to have acted in good faith if Indemnitee&#8217;s action is based on the records or books of account of the Enterprise, including
        financial statements, or on information supplied to Indemnitee by the directors, manager, or officers of the Enterprise in the course of their duties, or on the advice of legal counsel for the Enterprise, its Board, any committee of the Board or
        any director, trustee, general partner, manager or managing member, or on information or records given or reports made to the Enterprise, its Board, any committee of the Board or any director, trustee, general partner, manager or managing member,
        by an independent certified public accountant or by an appraiser or other expert selected by the Enterprise, its Board, any committee of the Board or any director, trustee, general partner, manager or managing member.&#160; The provisions of this
        Section 13(d) shall not be deemed to be exclusive or to limit in any way the other circumstances in which Indemnitee may be deemed or found to have met the applicable standard of conduct set forth in this Agreement.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">10</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-indent: 36pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The knowledge and/or actions, or failure to act, of any other director, officer, trustee, partner, manager, managing member, fiduciary, agent or employee of the Enterprise shall not be imputed to
        Indemnitee for purposes of determining the right to indemnification under this Agreement.</div>
      <div>&#160;</div>
      <div>14.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>REMEDIES OF INDEMNITEE</u>.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In the event that (i) a determination is made pursuant to Section 12 of this Agreement that Indemnitee is not entitled to indemnification under this Agreement, (ii) advancement of Expenses, to the fullest
        extent permitted by applicable law and the Charter, is not timely made pursuant to Section 10 of this Agreement, (iii) no determination of entitlement to indemnification shall have been made pursuant to Section 12(a) of this Agreement within thirty
        (30) days after receipt by the Company of the request for indemnification, (iv) payment of indemnification is not made pursuant to Section 5, 6, 7 or the last sentence of Section 12(a) of this Agreement within ten (10) days after receipt by the
        Company of a written request therefor, (v) a contribution payment is not made in a timely manner pursuant to Section 8 of this Agreement, (vi) payment of indemnification pursuant to Section 3 or 4 of this Agreement is not made within ten (10) days
        after a determination has been made that Indemnitee is entitled to indemnification, or (vii) payment to Indemnitee pursuant to any hold harmless or exoneration rights under this Agreement or otherwise is not made in accordance with this Agreement,
        Indemnitee shall be entitled to an adjudication by the Cayman Court to such indemnification, hold harmless, exoneration, contribution or advancement rights.&#160; Alternatively, Indemnitee, at Indemnitee&#8217;s option, may seek an award in arbitration to be
        conducted by a single arbitrator pursuant to the Commercial Arbitration Rules of the American Arbitration Association.&#160; Except as set forth herein, the provisions of Cayman Islands law (without regard to its conflict of laws rules) shall apply to
        any such arbitration.&#160; The Company shall not oppose Indemnitee&#8217;s right to seek any such adjudication or award in arbitration.&#160; Such adjudication or arbitration proceeding is referred to herein as &#8220;Enforcement Proceeding.&#8221;</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In the event that a determination shall have been made pursuant to Section 12(a) of this Agreement that Indemnitee is not entitled to indemnification, any Enforcement Proceeding shall be conducted in all
        respects as a de novo trial, or arbitration, on the merits and Indemnitee shall not be prejudiced by reason of that adverse determination.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In any Enforcement Proceeding, Indemnitee shall be presumed to be entitled to be indemnified, held harmless, exonerated and to receive advancement of Expenses under this Agreement and the Company shall
        have the burden of proving Indemnitee is not entitled to be indemnified, held harmless, exonerated and to receive advancement of Expenses, as the case may be, and the Company may not refer to or introduce into evidence any determination pursuant to
        Section 12(a) of this Agreement adverse to Indemnitee for any purpose.&#160; If Indemnitee commences an Enforcement Proceeding, Indemnitee shall not be required to reimburse the Company for any advances pursuant to Section 10 until a final determination
        is made with respect to Indemnitee&#8217;s entitlement to indemnification (as to which all rights of appeal have been exhausted or lapsed).</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">11</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-indent: 36pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If a determination shall have been made pursuant to Section 12(a) of this Agreement that Indemnitee is entitled to indemnification, the Company shall be bound by such determination in Enforcement
        Proceeding, absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee&#8217;s statement not materially misleading, in connection with the request for indemnification, or (ii) a prohibition
        of such indemnification under applicable law.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company shall be precluded from asserting in Enforcement Proceeding that the procedures and presumptions of this Agreement are not valid, binding and enforceable and shall stipulate in any such court
        or before any such arbitrator that the Company is bound by all the provisions of this Agreement.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company shall indemnify and hold harmless Indemnitee to the fullest extent permitted by law and the Charter against all Expenses (assuming for purposes of this sentence that all references to a
        Proceeding in the definition of Expenses were references to an Enforcement Proceeding) and, if requested by Indemnitee, shall (within ten (10) days after the Company&#8217;s receipt of such written request) pay to Indemnitee, to the fullest extent
        permitted by applicable law and the Charter, such Expenses which are incurred by Indemnitee in connection with any Enforcement Proceeding brought by Indemnitee:&#160; (i) to enforce his rights under, or to recover damages for breach of, this Agreement
        or any other indemnification, hold harmless, exoneration, advancement or contribution agreement or provision of the Charter; or (ii) for recovery or advances under any insurance policy maintained by any person for the benefit of Indemnitee,
        regardless of the outcome and whether Indemnitee ultimately is determined to be entitled to such indemnification, hold harmless or exoneration right, advancement, contribution or insurance recovery, as the case may be (unless such Enforcement
        Proceeding was not brought by Indemnitee in good faith).</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Interest shall be paid by the Company to Indemnitee at the legal rate under Cayman Islands law for amounts which the Company indemnifies, holds harmless or exonerates, or advances, or is obliged to
        indemnify, hold harmless or exonerate or advance for the period commencing with the date on which Indemnitee requests indemnification, to be held harmless, exonerated, contribution, reimbursement or advancement of any Expenses and ending with the
        date on which such payment is made to Indemnitee by or on behalf of the Company.</div>
      <div>&#160;</div>
      <div>15.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>SECURITY</u>.&#160; Notwithstanding anything herein to the contrary, except for Section 26, to the extent requested by Indemnitee and approved by the Board, the Company may at any time and from time to time provide security to
        Indemnitee for the Company&#8217;s obligations hereunder through an irrevocable bank line of credit, funded trust or other collateral.&#160; Any such security, once provided to Indemnitee, may not be revoked or released without the prior written consent of
        Indemnitee.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">12</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div>16.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>NON-EXCLUSIVITY; SURVIVAL OF RIGHTS; INSURANCE; SUBROGATION</u>.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The rights of Indemnitee as provided by this Agreement shall not be deemed exclusive of any other rights to which Indemnitee may at any time be entitled under applicable law, the Charter, any agreement, a
        vote of shareholders or a resolution of directors, or otherwise.&#160; No amendment, alteration or repeal of this Agreement or of any provision hereof shall limit or restrict any right of Indemnitee under this Agreement in respect of any Proceeding
        (regardless of when such Proceeding is first threatened, commenced or completed) or claim, issue or matter therein arising out of, or related to, any action taken or omitted by such Indemnitee in Indemnitee&#8217;s Corporate Status prior to such
        amendment, alteration or repeals, except as may otherwise be expressly set forth in such amendment, alteration or repeals and mutually agreed by Indemnitee and the Company.&#160; To the extent that a change in applicable law, whether by statute or
        judicial decision, permits greater indemnification, hold harmless or exoneration rights or advancement of expenses than would be afforded currently under the Charter or this Agreement, it is the intent of the parties hereto that Indemnitee shall
        enjoy by this Agreement the greater benefits so afforded by such change.&#160; No right or remedy herein conferred is intended to be exclusive of any other right or remedy, and every other right and remedy shall be cumulative and in addition to every
        other right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise.&#160; The assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other
        right or remedy.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Companies Law and the Charter permit the Company to purchase and maintain insurance or furnish similar protection or make other arrangements including, but not limited to, providing a trust fund,
        letter of credit, or surety bond (&#8220;<u>Indemnification Arrangements</u>&#8221;) on behalf of Indemnitee against any liability asserted against Indemnitee or incurred by or on behalf of Indemnitee or in such capacity as a director, officer, employee or
        agent of the Company, or arising out of Indemnitee&#8217;s status as such, whether or not the Company would have the power to indemnify Indemnitee against such liability under the provisions of this Agreement or under the Companies Law, as it may then be
        in effect.&#160; The purchase, establishment, and maintenance of any such Indemnification Arrangement shall not in any way limit or affect the rights and obligations of the Company or of Indemnitee under this Agreement except as expressly provided
        herein, and the execution and delivery of this Agreement by the Company and Indemnitee shall not in any way limit or affect the rights and obligations of the Company or the other party or parties thereto under any such Indemnification Arrangement.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;To the extent that any member of the Company Group maintains an insurance policy or policies providing liability insurance for directors, officers, trustees, partners, managers, managing members,
        fiduciaries, employees, or agents of the Company Group or of any other Enterprise which such person serves at the request of the Company, Indemnitee shall be covered by such policy or policies in accordance with its or their terms to the maximum
        extent of the coverage available for any such director, officer, trustee, partner, managers, managing member, fiduciary, employee or agent under such policy or policies.&#160; If, at the time the Company receives notice from any source of a Proceeding
        as to which Indemnitee is a party or a participant (as a witness, deponent or otherwise), the Company has director and officer liability insurance in effect, the Company shall give prompt notice of such Proceeding to the insurers in accordance with
        the procedures set forth in the respective policies.&#160; The Company shall thereafter take or cause to be taken all necessary or desirable action to cause such insurers to pay, on behalf of Indemnitee, all amounts payable as a result of such
        Proceeding in accordance with the terms of such policies.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">13</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-indent: 36pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In the event of any payment under this Agreement, the Company, to the fullest extent permitted by law and the Charter, shall be subrogated to the extent of such payment to all of the rights of recovery of
        Indemnitee, who shall execute all papers required and take all action necessary to secure such rights, including execution of such documents as are necessary to enable the Company to bring suit to enforce such rights.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company&#8217;s obligation to indemnify, hold harmless, exonerate or advance Expenses hereunder to Indemnitee who is or was serving at the request of the Company as a director, officer, trustee, partner,
        manager, managing member, fiduciary, employee or agent of any other Enterprise shall be reduced by any amount Indemnitee has actually received as indemnification, hold harmless or exoneration payments or advancement of expenses from such
        Enterprise.&#160; Notwithstanding any other provision of this Agreement to the contrary except for Section 26, (i) Indemnitee shall have no obligation to reduce, offset, allocate, pursue or apportion any indemnification, hold harmless, exoneration,
        advancement, contribution or insurance coverage among multiple parties possessing such duties to Indemnitee prior to the Company&#8217;s satisfaction and performance of all its obligations under this Agreement, and (ii) the Company shall perform fully
        its obligations under this Agreement without regard to whether Indemnitee holds, may pursue or has pursued any indemnification, advancement, hold harmless, exoneration, contribution or insurance coverage rights against any person or entity other
        than the Company.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;To the extent Indemnitee has rights to indemnification, advancement of expenses and/or insurance provided by the Sponsor or its affiliates as applicable, (i) the Company shall be the indemnitor of first
        resort (i.e., that its obligations to Indemnitee are primary and any obligation of the Sponsor or its affiliates, as applicable, to advance expenses or to provide indemnification for the same expenses or liabilities incurred by Indemnitee are
        secondary), (ii) the Company shall be required to advance the full amount of expenses incurred by Indemnitee and shall be liable for the full amount of all claims, liabilities, damages, losses, costs and expenses (including amounts paid in
        satisfaction of judgments, in compromises and settlements, as fines and penalties and legal or other costs and reasonable expenses of investigating or defending against any claim or alleged claim) to the extent legally permitted and as required by
        the terms of this Agreement, the Company&#8217;s organizational documents or other agreement, without regard to any rights Indemnitee may have against the Sponsor or its affiliates, as applicable, and (iii) the Company irrevocably waives, relinquishes
        and releases the Sponsor and its affiliates, as applicable, from any and all claims against them for contribution, subrogation or any other recovery of any kind in respect thereof.&#160; No advancement or payment by the Sponsor or its affiliates, as
        applicable, on behalf of Indemnitee with respect to any claim for which Indemnitee has sought indemnification from the Company shall affect the foregoing, and the Sponsor and its affiliates, as applicable, shall have a right of contribution and be
        subrogated to the extent of such advancement or payment to all of the rights of recovery of Indemnitee against the Company.</div>
      <div>&#160;</div>
      <div>17.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>DURATION OF AGREEMENT</u>.&#160; All agreements and obligations of the Company contained herein shall continue during the period Indemnitee serves as a director or officer of the Company or as a director, officer, trustee, partner,
        manager, managing member, fiduciary, employee or agent of any other corporation, partnership, joint venture, trust, employee benefit plan or other Enterprise which Indemnitee serves at the request of the Company and shall continue thereafter so
        long as Indemnitee shall be subject to any possible Proceeding or Enforcement Proceeding (including any rights of appeal thereto) by reason of Indemnitee&#8217;s Corporate Status, whether or not Indemnitee is acting in any such capacity at the time any
        liability or expense is incurred for which indemnification or advancement can be provided under this Agreement.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">14</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div>18.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>SEVERABILITY</u>.&#160; If any provision or provisions of this Agreement shall be held to be invalid, illegal or unenforceable for any reason whatsoever:&#160; (a) the validity, legality and enforceability of the remaining provisions of
        this Agreement (including, without limitation, each portion of any Section, paragraph or sentence of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable)
        shall not in any way be affected or impaired thereby and shall remain enforceable to the fullest extent permitted by law and the Charter; (b) such provision or provisions shall be deemed reformed to the extent necessary to conform to applicable law
        and to give the maximum effect to the intent of the parties hereto; and (c) to the fullest extent possible, the provisions of this Agreement (including, without limitation, each portion of any Section, paragraph or sentence of this Agreement
        containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall be construed so as to give effect to the intent manifested thereby.</div>
      <div>&#160;</div>
      <div>19.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>ENFORCEMENT AND BINDING EFFECT</u>.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company expressly confirms and agrees that it has entered into this Agreement and assumed the obligations imposed on it hereby in order to induce Indemnitee to serve as a director, officer or key
        employee of the Company Group, and the Company acknowledges that Indemnitee is relying upon this Agreement in serving as a director, officer or key employee of the Company Group.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Without limiting any of the rights of Indemnitee under the Charter, this Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and supersedes all
        prior agreements and understandings, oral, written and implied, between the parties hereto with respect to the subject matter hereof.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The indemnification, hold harmless, exoneration and advancement of expenses rights provided by or granted pursuant to this Agreement shall be binding upon and be enforceable by the parties hereto and their
        respective successors and permitted assigns (including any direct or indirect successor by purchase, merger, consolidation or otherwise to all or substantially all of the business and/or assets of the Company, but subject to such successor&#8217;s
        compliance with Section 19(d)), shall continue as to an Indemnitee who has ceased to be a director, officer, employee or agent of the Company or a director, officer, trustee, general partner, manager, managing member, fiduciary, employee or agent
        of any other Enterprise at the Company&#8217;s request, and shall inure to the benefit of Indemnitee and Indemnitee&#8217;s spouse, permitted assigns, heirs, devisees, executors and administrators and other legal representatives.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company shall require and cause any successor (whether direct or indirect by purchase, merger, consolidation or otherwise) to all, substantially all or a substantial part, of the business and/or assets
        of the Company, by written agreement in form and substance satisfactory to Indemnitee, expressly to assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform if no such
        succession had taken place.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">15</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-indent: 36pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company and Indemnitee agree herein that a monetary remedy for breach of this Agreement, at some later date, may be inadequate, impracticable and difficult of proof, and further agree that such breach
        may cause Indemnitee irreparable harm.&#160; Accordingly, the parties hereto agree that Indemnitee may, to the fullest extent permitted by law and the Charter, enforce this Agreement by seeking, among other things, injunctive relief and/or specific
        performance hereof, without any necessity of showing actual damage or irreparable harm and that by seeking injunctive relief and/or specific performance, Indemnitee shall not be precluded from seeking or obtaining any other relief to which
        Indemnitee may be entitled.&#160; The Company and Indemnitee further agree that Indemnitee shall, to the fullest extent permitted by law and the Charter, be entitled to such specific performance and injunctive relief, including temporary restraining
        orders, preliminary injunctions and permanent injunctions, without the necessity of posting bonds or other security in connection therewith.&#160; The Company acknowledges that in the absence of a waiver, a bond or other security may be required of
        Indemnitee by a court of competent jurisdiction.&#160; The Company hereby waives any such requirement of such a bond or other security to the fullest extent permitted by law and the Charter.</div>
      <div>&#160;</div>
      <div>20.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>MODIFICATION AND WAIVER</u>.&#160; No supplement, modification or amendment of this Agreement shall be binding unless executed in writing by the Company and Indemnitee.&#160; No waiver of any provision of this Agreement shall be
        enforceable unless in writing and signed by the party against whom it is to be enforced.&#160; No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions of this Agreement nor shall any
        waiver constitute a continuing waiver.</div>
      <div>&#160;</div>
      <div>21.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>NOTICES</u>.&#160; All notices, requests, demands and other communications under this Agreement shall be in writing and shall be deemed to have been duly given (i) if delivered by hand and receipted for by the party to whom said
        notice or other communication shall have been directed, or (ii) mailed by certified or registered mail with postage prepaid, on the third (3rd) business day after the date on which it is so mailed:</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If to Indemnitee, at the address indicated on the signature page of this Agreement, or such other address as Indemnitee shall provide in writing to the Company.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If to the Company, to:</div>
      <div>&#160;</div>
      <div style="margin-left: 72pt; color: rgb(0, 0, 0);">Vendome Acquisition Corporation I</div>
      <div style="margin-left: 72pt;"><font style="color: rgb(0, 0, 0);">1090 Center Drive Park City, UT 84098Attn:</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);">Scott LaPorta</font></div>
      <div>&#160;</div>
      <div style="margin-left: 72pt; color: rgb(0, 0, 0);">with a copy, which shall not constitute notice, to</div>
      <div>&#160;</div>
      <div style="margin-left: 72pt; color: rgb(0, 0, 0);">Paul Hastings LLP</div>
      <div style="margin-left: 72pt; color: rgb(0, 0, 0);">&#160;&#160;200 Park Avenue</div>
      <div style="margin-left: 72pt;"><font style="color: rgb(0, 0, 0);">&#160;New York, NY 10166Attn:</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);">Gil Savir</font></div>
      <div>&#160;</div>
      <div>or to any other address as may have been furnished to Indemnitee in writing by the Company.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">16</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div>22.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>APPLICABLE LAW AND CONSENT TO JURISDICTION</u>.&#160; This Agreement and the legal relations among the parties shall be governed by, and construed and enforced in accordance with, the laws of the State of New York, without regard to
        its conflict of laws rules.&#160; Except with respect to any arbitration commenced by Indemnitee pursuant to Section 14(a) of this Agreement, to the fullest extent permitted by law, the Company and Indemnitee hereby irrevocably and unconditionally:&#160; (a)
        agree that any action or proceeding arising out of or in connection with this Agreement shall be brought only in the Cayman Court and not in any state or federal court in the United States of America or any court in any other country; (b) consent
        to submit to the exclusive jurisdiction of the Cayman Court for purposes of any action or proceeding arising out of or in connection with this Agreement; (c) waive any objection to the laying of venue of any such action or proceeding in the Cayman
        Court; and (d) waive, and agree not to plead or to make, any claim that any such action or proceeding brought in the Cayman Court has been brought in an improper or inconvenient forum, or is subject (in whole or in part) to a jury trial.&#160; To the
        fullest extent permitted by law, the parties hereby agree that the mailing of process and other papers in connection with any such action or proceeding in the manner provided by Section 21 or in such other manner as may be permitted by law, shall
        be valid and sufficient service thereof.</div>
      <div>&#160;</div>
      <div>23.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>IDENTICAL COUNTERPARTS</u>.&#160; This Agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed to be an original but all of which together shall constitute one and the same Agreement.&#160;
        Only one such counterpart signed by the party against whom enforceability is sought needs to be produced to evidence the existence of this Agreement.</div>
      <div>&#160;</div>
      <div>24.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>MISCELLANEOUS</u>.&#160; Use of the masculine pronoun shall be deemed to include usage of the feminine pronoun where appropriate.&#160; The headings of the paragraphs of this Agreement are inserted for convenience only and shall not be
        deemed to constitute part of this Agreement or to affect the construction thereof.</div>
      <div>&#160;</div>
      <div>25.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>ADDITIONAL ACTS</u>.&#160; If for the validation of any of the provisions in this Agreement any act, resolution, approval or other procedure is required to the fullest extent permitted by law and the Charter, the Company undertakes to
        cause such act, resolution, approval or other procedure to be affected or adopted in a manner that will enable the Company to fulfill its obligations under this Agreement.</div>
      <div>&#160;</div>
      <div>26.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>WAIVER OF CLAIMS TO TRUST ACCOUNT</u>.&#160; Indemnitee hereby agrees that it does not have any right, title, interest or claim of any kind (each, a &#8220;<u>Claim</u>&#8221;) in or to any monies in the trust account established in connection
        with the Company&#8217;s initial public offering for the benefit of the Company and holders of shares issued in such offering, and hereby waives any Claim it may have in the future as a result of, or arising out of, any services provided to the Company
        and will not seek recourse against such trust account for any reason whatsoever.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">17</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div>27.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>MAINTENANCE OF INSURANCE</u>.&#160; The Company shall use commercially reasonable efforts to obtain and maintain in effect during the entire period for which the Company is obligated to indemnify the Indemnitee under this Agreement,
        one or more policies of insurance with reputable insurance companies to provide the officers/directors of the Company with coverage for losses from wrongful acts and omissions and to ensure the Company&#8217;s performance of its indemnification
        obligations under this Agreement.&#160; The Indemnitee shall be covered by such policy or policies in accordance with its or their terms to the maximum extent of the coverage available for any such director or officer under such policy or policies.&#160; In
        all such insurance policies, the Indemnitee shall be named as an insured in such a manner as to provide the Indemnitee with the same rights and benefits as are accorded to the most favorably insured of the Company&#8217;s directors and officers.</div>
      <div>&#160;</div>
      <div style="text-align: center; font-style: italic;">[Signature Page Follows]</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">18</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <div style="text-indent: 72pt;">IN WITNESS WHEREOF, the parties hereto have caused this Indemnity Agreement to be signed as of the day and year first above written.</div>
      <div>&#160;</div>
      <div style="font-weight: bold;">VENDOME ACQUISITION CORPORATION I</div>
      <div>&#160;</div>
      <div>
        <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zaa0e261d0f74476b8f5a711b4cac5224" border="0" cellpadding="0" cellspacing="0">

            <tr>
              <td colspan="1" style="width: 10%; vertical-align: top; padding-bottom: 2px;">
                <div>By:</div>
              </td>
              <td style="width: 15%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
              <td rowspan="1" style="width: 75%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="width: 10%; vertical-align: top;">&#160;</td>
              <td style="width: 15%; vertical-align: top;">
                <div>Name:</div>
              </td>
              <td rowspan="1" style="width: 75%; vertical-align: top;">
                <div>&#160;Scott LaPorta</div>
              </td>
            </tr>
            <tr>
              <td colspan="1" style="width: 10%; vertical-align: top;">&#160;</td>
              <td style="width: 15%; vertical-align: top;">
                <div>Title:</div>
              </td>
              <td rowspan="1" style="width: 75%; vertical-align: top;">
                <div>Chief Executive Officer</div>
              </td>
            </tr>

        </table>
        <div> <br>
        </div>
      </div>
      <div>
        <div style="text-align: center;">[<font style="font-style: italic;">Signature Page to Indemnity Agreement</font>]</div>
        <div style="text-align: center; font-size: 12pt;"> <font style="font-size: 10pt;"><br>
          </font></div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <div style="font-weight: bold;">INDEMNITEE</div>
      <div style="font-weight: bold;"> <br>
      </div>
      <div>
        <div style="text-align: center;">[<font style="font-style: italic;">Signature Page to Indemnity Agreement</font>]</div>
        <div style="text-align: center; font-size: 12pt;"> <font style="font-size: 10pt;"><br>
          </font></div>
        <div style="text-align: center; font-size: 12pt;"> <font style="font-size: 10pt;"><br>
          </font></div>
        <div style="text-align: center; font-size: 12pt;">
          <hr style="height: 2px; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"> </div>
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ny20046456x10_ex5-1image01.jpg
<TEXT>
begin 644 ny20046456x10_ex5-1image01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  V +@# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P"Q\#?A?X>\
M:^%+K4=;%X;B.[:!?)FV+M"J>F/<UJ?$KP;:_":RTWQ#X+U/4+2[^V)"]M+/
MO6X4Y)!&.>G/7K67\#/ <OBGPG=7D7B;6])"7;1>38S;$;"J=Q'KS^E>G:/\
M&M,@UFUU+7-9UC7I;5@\$=_-N16'.<=_I7%3I\T%:.O<^CQ.*5/$2YZK:7V;
M?AV/3[=R\*.R[2RAB/3(KQ_XU32^*_$V@?#ZPE9!>/\ ;-0D3DQPKG&?R)_!
M:];U"[@T^QN+R[<1V]O&TLCG^%5&2?TKYT\!KX_US7M7\=^';#29!JKM#$VH
MNP:.)6P @';@#/\ LUO5>T>YYF AK*LVER[7[O;[MSN/V?M8GAT[5?!VK$C4
MO#]PT*@]6A).TCV!S^!6O7*^:-8F\6^"?B5I/C7Q=::=;6]ZZV%XVGN2C(1C
M+ ]P #_P"OI5'5T5D8,K $$'@BG1EIROH+,*:4U5C:TM=-K]?Q/&?@?_ ,E$
M^)G_ &$%_P#0Y*]3\6_\BKK/_7E-_P"@&O*/@]-'8_%KXC:;<NL=Y-=B>*-C
M@NFYCD>O#*?QKTSX@:A;:9X)UNYO95BB6SE7+'&6*D #W)(%*G\'WE8M-XI6
MZ\OY(Y#]FW_DD>E?]=)__1C5D?%O_DKWPR_Z^7_]"2MW]G:WEM_A'HPF4J9#
M+(H/=3(V#6%\6_\ DKWPR_Z^9/\ T)*E_P )?(VB_P#;JG_;_P"3/9J***Z#
MR HHHH **** "BBB@ HHHH **** "BBB@#F? '@S3O ^DRZ=I$ES)!),9V,[
MAFW$ =@..*Z:N=_L;6O^AHN__ 2W_P#B*/[&UK_H:+O_ ,!(/_B*222LBISE
M4DY2=VRSXP\/P>*?#]UH]Y/<06UR )&MV"L5!SC)!X..:LZ#I-KH6BV6EZ>F
MRTM(EBC!ZX'<^YZFLW^QM:_Z&B[_ / 2#_XBC^QM:_Z&B[_\!(/_ (BBRO<.
M>7+R7TW)O&GAC3_%_A^?1]65S;3%6W1G#HP.05/K5S0=+31M&LM-BGFGBM8E
MA22=MSE1P,GOQQ6;_8VM?]#3=_\ @)!_\11_8VM?]#1=_P#@);__ !%%E>X^
M>7+R7T,CQS\,="\7WT6H7)NK'5H@%6]LI/+DP.F>QQ^=<_'\$-*N+F)]?U[7
M]:AB8,MO>764S[X&?U%=O_8VM?\ 0T7?_@)!_P#$4?V-K7_0T7?_ ("6_P#\
M14NG%N[1M#&5X1Y8RT-VUMXK2VBM[:-(H(E")&@PJJ.  *Y#Q]\.M*\;W.GW
M&IW%]!+8AA$UK*$/S8R>A]*TO[&UK_H:+O\ \!+?_P"(H_L;6O\ H:+O_P !
M(/\ XBJ<5)69E3JSIRYX.S.)_P"%&Z'_ -!OQ)_X'?\ UJ] \):!!X8T.#2[
M2>ZN(82Q$ES)OD.23R?QJK_8VM?]#1=_^ D'_P 11_8VM?\ 0T7?_@)!_P#$
M4HPC'5(NKB:M5<LY71T5%<[_ &-K7_0T7?\ X"0?_$4?V-K7_0T7?_@)!_\
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MQ:E]J\KS/-^QMC[1][=GTSQ]*])^#WB$Z]X/@6X?-[8_Z-,#U.!\K?B/U!H
MN_$?Q4WA71(Y[:W%S?7,RV]M&QPI<]S[5@#3?B:UN+@ZYI"3D;OLOV?Y1_L[
ML5O?$71-+\1:;;Z=J-^EC=-*'LY"X#>8.. ?O=>@KFTTKXFZ2@6TUG2]5B7@
M+<IM<CW./ZT ;OPY\677B"/4+/6+06FKZ=)Y5PB@[6Z_,/R-2>*8/&DFIAO#
M5WI4-AY8!6Z0E]^3GIVZ54\ >,+K6M4U#1]<TY+#6[(!I50Y5U]1^8[GK7=4
M >.V.N?$*]\4ZAH$5[HPO+*)99':$["#C&#USS7?^$(O$\7VK_A*KC3YLE?(
M^R*5QUSG/X5RGA?_ )+CXJ_Z\X__ &2O3J .&\7^)-1TOQYX7TJT:(6>H.PG
M#)ECCT/:NYKRWXB?\E6\"_\ 71_YBO4N] 'C7A+XHWQ\32VGB41+ILUP]M!<
MI'L$<@;@,>X(Q].*]?NG*6LTB=51F'X"O'/ASX=L_%'A?Q7IM^OROJ<C1R <
MQ/CAA_GD5J^!O$5[ITEYX,\4,1J=K$PM)V/%Q'M. #W..GM[B@#H/A+X@O\
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M2-%4G>"-O48QV]:[JBB@#@O&6AW6H?$#PIJ,+PK!9,QD5R0QR>W&/Y5WM%%
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2KVEL&+RL.@)/XCKWHHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ny20046456x10_ex5-1image02.jpg
<TEXT>
begin 644 ny20046456x10_ex5-1image02.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  > <4# 2(  A$! Q$!_\0
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M( ))J?4;'[;)9,7*?9K@3CC.["L,?^/4W5-/74&L][;1;SB8C&0^%88/_?5
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M]Q9R3O&9H]R$2L2P(_'@^WO5)/!20QSQ0W";+I%2=WB!<;22#&?X>N .W&*
M.PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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79B'S7)/S)C'3 ^[[UW-% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>ny20046456x10_ex5-2image01.jpg
<TEXT>
begin 644 ny20046456x10_ex5-2image01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" !M ',# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#ZIHHHH **
M** "L+Q9XITOPM8_:=5GVEN(XEY>0^P_K5WQ!JUOH>C7>I7AQ#;QER.['L![
MDX%?)_B#5=1\4ZQ/J5\Q+.?E!/RQKV4>PKU,MR_ZW)REI%?U8\K,\R6#BDOB
M9T?C/X_ZX;QH/#]K:V42]7E7S9/\!^1KEXOCGX[20,VI6\@_NO:1X/Y &N&D
MLA)*[R2,2S$\"F-IRX^5R#[BOIX9=AHJR@OS/-6/F_BF[GT!X'_:%BNKB*U\
M6V*6V\A?M=KDH#_M(>0/H37O=E=07MK%<VDR3V\JADD1LJP]0:_/B:WD@.6&
M1_>%>W? +QW+HVM0Z'?RDZ7?,%BW'_4RGICV/3ZXKYS.L)3PLH2IJRE<^GR>
MC/,*%647>4+/U6M_FCZ?HHHKQP"BBB@ HHHH **** "BBB@#S'X\R2OX?L;.
M,-Y4UQOEV^BC@?F?TKQ3: FP# QC%>__ !7@9],LYP.(Y2I_$?\ UJ\DO;"*
MX4D ))V8#K]:^JRBK&.'4?-GPO$%*<\4W?HK'D<JE)70]5)%,K;\3:<]M=-+
MM(#'#^Q_^O6+7NIW5T9TYJI%20A 8889!ZT@+02))$2I4AE(Z@BGCBD92XP.
M2>F*^(X@QL:U>-*#NH[^K/V_@3(JF$P%3%UU9U+67]U?YW^ZQ]Q>'+TZEX?T
MR^;[US;1S-]64$_SK1K+\*V;:=X9TFSD&)(+2*-AZ,$ /ZUJ5YZ/D:MN=\NU
MPHHHH("BBB@ HHHH **** *.M:='JNF3V<OW9%P#_=/8_G7B>H:;-8W<EO."
MDL9P0?YU[U6/X@\/VFM1?OALG4?)*HY'L?45C7JXRE'FP<[-='L_^".&%P6(
MERXR%UW6C7_ / -<TS[1$'.W^ZP/<5QFH>%)%R]C(K_[#\8^AKV[6O!>K012
M+!$MTO8QGG\C7.1^%==D?:NEW.?< "O(J<0YW->SG=>D=_G_ ),^FR?(,BP<
M_K,+2?\ >E=?<]/P/')-%U%&P;24_09KT#X.> +S6/$T%]J5LT>F63B5]X_U
MCCE5_/DUZ5H/PWNYI%DUB18(>IBC.7/X]!7I^GV5OI]I';6<2Q0H,!5K?!1Q
M%1\]:/*OQ/:SCBF/L98?#--O2ZV7IYEFBBBO6/SX**** "BBB@ HKRW]HS4]
M1TGP+:3Z-=SVMVVHQ('A;:Q!5^/ID#BM_P"%7C!?%_AI9K@>5JMHWV>^@/!2
M0=\>AZ_GZ5T/#3]BJZVO8S]JN?V?4[.BO-/CCXVE\,>'Q8:06;7=15D@5.6C
M0#+R?@.G_P!:KOP*O[O4_A?I%UJ%S+<W+F7=+*VYFQ*P&3]!0\--4/;O9NPE
M53J>S1WU)7CGQHU36M5\3:-X0\)WLUI?RQR7EQ)$Y4JJJ=H)'8X/YBNI^"_B
M63Q-X#LYKQV;4;4FUNM_WMZ<9/N1BG/"RC159O?I^7WV"-5.;@=W17C7QGGU
M&?X@>"]&L=6OM.M]1=XIFM)=A/S+SZ9J+QCX7\3>"-!N/$&@>,M5O&L1YLUK
MJ!$B2H#R*N&$4HP;FDY;;][$NLTWIHCVJ@5XA\4/%]]?> _!.M:7<SV+ZC>0
MF587*\$?,I]1G->W+]T?2LJM"5**E+K?\"X5%)M(6BO%OC//J5Q\1?!VBV&L
M7VFV^H;HY6M9-I^]U],UK_\ "J=0_P"A^\3_ /?X5K]6@H1G.=N;R?H3[63D
MXQC>QZEFBO+/BUK>K:=-X6\+:)?FRNM9E,$FH/RR(FT$C_:.[_.:ETKX:ZKH
MVK6-YI_C;6Y524-=0WC^:DR=P >F:E8>*@ISE:^VX_:/FY8J]CTZBDHKE-3R
M?]I;_D1M-_["]O\ R>J7CVVG^'OBNW\=Z3"[Z7=!8-9MHQU!^[*!Z_U^IKI_
MC5X8U/Q7X7LK'1HXY+B+4(;AA(X0;%#9Y/U%=K=V-O?Z=)97\*3V\L?ERQ.,
MJPQR#7H0Q$:=*">J]ZZ\G;^D<TJ;E.3]+'C'AG2;OQ#I/BGX@>((RMS>V%Q'
MIL#?\N]L(VP1[G_$]ZZ?]GZ1(?@]H\DK!8T$[,Q/  E?)KM=>T]KCPOJ.G6,
M:JTEG);PI]T E"JCV'2O.-/\)^*-+^!(\,V4$/\ ;DBR0N// 5$>1BQW=/NG
M'XU3K1KTW%NUY*WDK/\ (2@Z<KK71_><1X#^(F@1>//$_BG7Y+L3WD@M[(1V
MSR!+=>G('&<#BM/X4^*]+B^,.N6.D22C1]='VF!98FBVW &6 !]1N_(5Z_X+
M\-6OASPKIFDK%$QMH55WV@[GZL?S)KFOBSX.OM:CT34_#$4*ZUI5XL\62(PR
M?Q#/X#]:U^LT*DY0M9-6O?33;2WD3[*I&*E?5:_YG)_'*:\M_B;X!FTNU6[O
MDDD,,#/L$C;EP"W:KWB2T^)/CFP?1;S2M-\/Z7<$+<S_ &CSG9,\@ ?X?C6U
MXX\*ZQK?Q \$ZS:P1"UTUR]WNE *9(. ._0]*]*%92Q*ITZ?*DVE]VK*5)RE
M*[:3_P CPOXYZ3;Z%X-\$Z599^SV>HPPH3U( QD^YKW-?NCZ5YO\</"NL^*=
M(TB/P_##-<V=ZMRRRR!!@ ]S[U4&J?%L8_XIWP[_ .!1_P#BJF4?;T8>\KJ]
M[NV[&G[.<M';0YWXYP7UU\4O T.DW26E_)N6&=UW"-MW!([UU^@^'?B#:ZQ:
M3ZOXNL[RP20&:!+0*9%[@''%9/Q-\+^+-5\4>$]>T*RLIKO3(]\T<TVQ!)D'
M'J1UJU_:OQ<_Z%WP[_X%'_XJMG)RHPC!QT3O>U]WW(2M4DVGOTN=1\0O ^F^
M.-+BMM0>:">W?S+:YA.'B;V]C@<>U>::Q>^.OA1';WVI:M%XB\,B58I?-7;-
M&#P.>OTY(KT+QM%XU:WTN[\)36"W$&6N[.X'RSD@<!NP'/I]:X_5_#WCOX@R
M6>G^++73=&T"*99KB.VE\V2X*G[OL*C"RM%*I).'5/=>G7[BJJN[Q3YCV"&1
M9H8Y4^ZZAA]"**=&HCC5$&%4  >@HKS&=0ZLS7]7CTBT$C*9)I#LBC'5FK3K
MD]?^?QEHJ2_ZL*64'INR?\!0A,EC@\3W:"5[RVL\\B(1[L?6M/1#JH,T>K+"
M=F-DL?\ '^%7KN8V]M+*(VD*+NV*.6]A61I/B%;_ %'[&]G/;R[#)^]&./I3
M R]*N]=U:2\-O>V\203&,!XLYJ]IVK7T&LKIFL)$9)%+131<!OJ/P-8OAG51
MITFIJ;2ZGW7#',*;@.O6KFDM+XA\01ZF8_)M;,&-%)RQ;W_.@1I:UK4\=\FF
MZ3$LU\PW,6^[&/4U7:U\3Q+YJW]K,XY\DQX!]LXJ/POA_$VO/)S,'"C/9<G_
M  %=70-:F1X>UD:I'*DL9AO(#MEB/8^HJ#POJ5S?S:DMRRL()S&F%Q@<U1M?
MD^(5T(ONM #)CUP*=X'_ ./C6O\ KZ/]: -CQ)=RV.B75S;D++&H*DC/<5AZ
MMK%_%IFC/;RHLUWP[% 1D@=OQK4\9?\ (LWW^X/_ $(5S6O/Y6C^&W*LVTAL
M <G@4(3-B\;Q%IT#7+3VEW'&-SQB/:<=\5N:3?)J6G07<0(61<X/8]"/SK!U
M#6[N^M9+73]*O/-E4IOE3:JY[UL>'[ Z9I%O:,P9D!W$=,DY/\Z!HT:***0P
MK&\3:0^IV\4ELXCO+=M\+GU]*V:* .:AU_4($\N^T:[,Z\%H1N5O>FZ1#?7O
MB1M5N;,VD/D^4J.WS'GTKIZ*8K'->"[6>V.I_:(7BWW!9=XQN'J*!;3Z5XG\
MZVA=[&^_UH1<B-_[W^?6NEHHN%CF=7TV]M-6_M;1U$DC+MG@)QO'J*1O$.HN
MFR#0[L3G@;^%!^N*Z>B@+&%X:TF:S>XO=0</?W)R^.BCTK/GMM0T'6+F[L+9
MKNRNCODB3[RM76T47"QQVHRZIXC5;**QELK1F!FDFX) ["I_%-A*?[%CM(9)
9(X)0#M&=H&.375447"P4444AA1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>ny20046456x10_ex5-2image02.jpg
<TEXT>
begin 644 ny20046456x10_ex5-2image02.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  @ >D# 2(  A$! Q$!_\0
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M(Y^ZW3T-*-7EMIJ-T[]2_"K)$BNV]@ "V,9/K3ZRX]>T^27RTDE+8)&8) "
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M[\]/^NC]/7VK4HH RX]#M5N8YV,TDJ.9,O(3EL8S[?ABM2BB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
.*** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
